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Abstract 
The syntheses of the naturally occurring naphthoquinone fungal metabolites 
dehydroherbarin and anhydrofusarubin as well as the acetal core of marticin are 
described in this thesis. 
 
Starting from 2,4-dimethoxybenzaldehyde, dehydroherbarin was prepared in 11 
steps in an overall yield of 4.5 %. The naphthalene segment of dehydroherbarin was 
constructed and functionalized utilizing reactions including a Stobbe condensation, 
O-allylation, and a Claisen rearrangement with the key step being a regioselective 
phenyliodine bis(trifluoroacetate) mediated methanol addition to the naphthalene. 
The pyran ring was assembled by a lithium aluminium reduction followed by Wacker-
type oxidation reaction. 
 
Two unnatural synthetic naphthoquinones, (3R,4R) 3-hydroxy-7,9-dimethoxy-3-
methly-5,10-dioxo-3,4,5,10-tetrahydro-1H-benzo[g]isochromen-4-yl nitrate and 3,4-
dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-5,10-dione, 
were also produced on route to accessing dehydroherbarin. 
 
Anhydrofusarubin was synthesized from 2,4,5-trimethoxybenzaldehyde in 12 steps in 
an overall yield of 5.3 % by employing the same synthetic methodology developed 
towards the assembly of dehydroherbarin. To our knowledge, this represents the first 
formal synthesis of anhydrofusarubin. 
 
The assembly of model system of the 6,6-bicyclic pyran ring arrangement found in 
the naturally occurring naphthoquinone marticin is also described. 11-
(hydroxymethyl)-9-methyl-10,13-dioxatricyclo[7.3.1.02,7]trideca-2(7),4-diene-3,6-
dione was produced racemically in 9 steps, starting from 2,5-dihydroxyacetophenone 
in a 3.3 % overall yield, with the key reaction again being a Wacker-type oxidation 
reaction 
 
The related 6,7-bicyclic acetal compound, 3,6-dimethoxy-9-methyl-10,13-
dioxatricyclo[7.3.1.02,7]trideca-2,4,6-triene, was also made inadvertently in 7 steps, 
from 2,5-dihydroxyacetophenone in a 6.5 % overall yield.  
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Chapter 1: Introduction to Quinones 
1.1. Quinones Occurrence and Functionality 
The simplest, most apt description of a quinone is a compound containing an 
aromatic diketone chromatophoric group [(O=C-(C=C)n-C=O)] within its structure1. 
Quinones occur widely throughout Nature and are found in bacteria2, fungi3, 
echinoderms2, higher plants4, insects2 and mammals5. Arguably, their most important 
ubiquitous function is linking electron transport chains in metabolic pathways to the 
oxidative processes6. The quinone family differs in size and complexity with 
additional rings and functional groups, examples of which are illustrated in Figure 12. 
 
 
Figure 1: Benzoquinone, naphthoquinone, anthraquinone and anthracycline quinone 
examples  
 
A great amount of invaluable knowledge on these quinones has been collated, 
especially with regards to their structure-activity-relationships5,7-9. 
 
The fundamental principle of quinone reactivity is their ability to act as electrophiles 
and oxidants, where nucleophilic addition to a quinone occurs via a reversible formal 
two-electron reduction (see section 1.2). This redox trait is compelled by the 
formation of the lower energy stabilization-benefits of a fully aromatic system10.  
Chapter 1: Introduction to Quinones 
 
 2 
 
Quinone biological activity is modulated by the presence of ring substituents that 
effectively control their ensuing electrophilic and oxidative properties11. For example, 
the presence of an electron-withdrawing group bestows increased oxidant properties 
on the quinoid moiety, with the resultant hydroquinone being less readily oxidised. 
Conversely with an electron-donating substituent, the oxidative ability is less 
pronounced but the subsequent hydroquinone is more readily oxidised. 
 
This insight into understanding the vital role of quinones in the intrinsic functioning of 
cellular systems, and thus diseases, has led to the creation of many prototypes to 
develop new drugs. Some of the most important medicinal quinones, their origins, 
structures and biological effects will be discussed in the following section. 
 
1.1.1. Chemotherapeutic quinones 
Atovaquone® 1 (Figure 2) is a synthetic hydroxynaphthoquinone with antimalarial 
properties that was synthesized from the lead compound lapachol 2 12. This drug is 
also the only clinical anti-malarial in the class of naphthoquinones13. It is 
metabolically stable and very effective against several other eukaryotic parasites 
including Pneumocystis and Toxoplasma14.  Atovaquone® 1 is an analogue of 
ubiquinone 3 [an essential co-factor of membrane bound enzymes involved in 
adenosine 5'-triphosphate (ATP) formation] and is thus highly lipophilic in nature6. 
This drug acts selectively in sensitive parasites by inhibting their mitochondrial 
electron transport, specifically the enzyme dihydro-orotate dehydrogenase (involved 
in the biosynthesis of pyrimidines).  A combination of atovaquone® 1 and proguanil 
is administered for prophylaxis and treatment of uncomplicated malaria15.  
Structurally atovaquone® 1 is identical to lapachol 2 with regards to the 
naphthoquinone system and position of the hydroxy group. The difference between 
the two compounds is where lapachol 2 possesses a prenyl group at C-2, 
atovaquone® 1 has a chlorinated benzene moiety linked via a cyclohexane ring to 
the naphthoquinone unit. 
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Figure 2 
 
Anthracycline aminoglycosides are important antineoplastic agents that display 
broad-spectrum anti-tumour activity against both leukemias and solid tumours16. 
These molecules are naturally produced by strains of Streptomyces2 (both natural 
and mutant variations), often with further chemical modifications being carried out via 
enzymatic or synthetic means. Daunomycin (or daunorubicin, daunosamine) 4 and 
doxorubicin (or adriamycin) 5 are two anthracycline antibiotics that have outstanding 
clinical utility as anti-cancer agents (Figure 3). Doxorubicin 5, however displays 
serious dose-related toxic side effects, such as cardiac toxicity and myeloma 
suppression17. This led to the synthesis of idarubicin 6, an analogue of doxorubicin 5 
that displays improved pharmacological properties. The core skeleton of these three 
compounds consists of a tetracyclic ring system, of which three of the rings are 
aromatic, thus resulting in a planar portion of the compound. The fourth non-aromatic 
ring is called the aglycone intercalator ring10 and has an aminoglycoside attached to 
it via an oxygen-ether linkage. The anti-tumour activities of anthracyclines are still 
not fully understood, but there are three modes of action that are proposed: (i) 
deoxyribonucleic acid (DNA) intercalation and resulting DNA damage via the 
inhibition of topoisomerase II18, (ii) DNA binding and alkylation and (iii) damage of 
cellular molecules via the production of reactive oxygen species (ROS). These 
mechanisms are discussed further in section 1.2. 
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The mitomycins (mitomycin A 7, mitomycin B 8 and mitomycin C 9) (Figure 4) are a 
class of anti-tumour quinones that were isolated from Streptomyces caespitosus in 
195619. Mitomycin C 9 is used clinically for the treatment of solid tumours, owing to 
its high activity against this cancer type and its reduced toxicity compared to its 
counterparts, mitomycin A 7 and mitomycin B 8. These molecules contain quinone, 
carbamate and aziridine moieties that are ordered as a pyrrolo[1,2-a]indole. This 
unique structural arrangement facilitates the mitomycin's mode of cytotoxic action, 
which is the cross-linkage of DNA (potentially via the bioreductive alkylation process) 
with great efficiency for the specific sequence CpG19. 
 
 
Figure 4 
 
Mitoxantrone 10 (Figure 5) is a synthetic anti-tumour drug designed in the 1970’s20 
to (i) possess structural features predicated to favour DNA intercalation and (ii) have 
significantly reduced cardiac toxicity, which is a crucial problem of antineoplastic 
agents17. This quinone is utilized in the treatment of leukaemia, lymphoma and 
breast cancer10. Mitoxantrone 10, a dihydroxyanthracenedione, contains (i) a para-
quinone moiety with adjacent phenolic substituents in an aromatic system that allow 
for tautomerism and (ii) an ethylene spacer between two nitrogens with hydroxyethyl 
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substituents on the aliphatic amines. The anti-cancer activity of mitoxantrone 10 is 
attributed to its ability to inhibit topoisomerase II20. 
 
 
Figure 5 
 
1.2. Mechanism of Biological Activities 
There are three main accepted modes of biological action of quinones: (i) their 
involvement in the production of ROS, (ii) their role as bioreductive alkylating agents 
and (iii) their participation in DNA intercalation.  
 
1.2.1. Production of reactive oxygen species (ROS)   
The reductive potential of quinone compounds is a well understood process11. The 
one electron or two electron reduction of a quinone leads to the formation of a 
semiquinone radical or hydroquinone respectively (Scheme 1). Within cellular 
systems, there are many natural ubiquitous non-selective reducing enzymes that can 
specifically transfer one electron [nicotinamide adenine dinucleotide phosphate 
(NADPH)-cytochrome P 450, NADPH-cytochrome b5 reductase and NADPH-
ubiquinone oxidoreductase] or two electrons (DT-diaphorase) to quinone 
compounds10. Under aerobic conditions (found in healthy cells or tumours with 
sufficient blood supply) the quinone one-electron bioreduction predominates, 
resulting in the formation of the semiquinone radical that is readily autooxidised back 
to the original quinone by molecular oxygen. This process yields superoxide anion 
radicals (O2.-) and is known as quinone redox cycling. Superoxide anion radicals are 
converted to hydrogen peroxide by superoxide dismutase (SOD). Hydrogen peroxide 
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is then broken down to the labile compounds H2O and O2 by catalase. However, the 
hydrogen peroxide can also rapidly react with intracellular iron21 ions (Fenton 
reaction) to generate highly reactive hydroxyl radicals (HO.) that primarily contribute 
to the cytotoxic effects of ROS. 
 
Scheme 1 
 
The production of ROS is a normal process during cellular aerobic metabolism and 
cells are equipped with sufficient anti-oxidative defence systems including radical 
scavengers such as ascorbic acid or tocopherol and antioxidant enzymes such as 
catalase, SOD and glutathione peroxidase. However, when unnatural quinoid 
compounds are present in aerobic cells, there is an excessive release of ROS that 
results in an oxidant-anti-oxidant imbalance. This accounts for the pathological 
effects produced by these species.  In principle, ROS can potentially react with all 
the components of the cell including nucleic acids, carbohydrates, lipids or 
proteins10. 
 
In theory, ROS creation is possible for all compounds containing a quinone moiety 
that possesses a reductive potential sufficient to accept an electron from the 
mentioned enzymatic reductants. Significant toxicity of anthracyclines17 is attributed 
to ROS production. 
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1.2.2. Bioreductive alkylating agents 
Bioreductive alkylation is another important process by which many quinone 
containing compounds may act. In this process in vivo reduction of the quinone 
substructure results in the formation of a highly reactive quinone methide22. 
Bioreductive alkylation has been shown to be preferential in anaerobic cellular 
environments10 and requires the two electron reduction of the quinone moiety to the 
hydroquinone, conditions contrary to those favouring the production of ROS. In 
particular, solid tumours often have hypoxic cellular regions as the rate of tumour 
growth tends to isolate the central cancer cells away from the vicinity of oxygen (and 
nutrient) rich blood vessels22. The ubiquitous two-electron reducing enzyme DT-
diaphorase is evidently overexpressed in a wide range of tumours and its 
involvement in the reduction of quinones is well established10. Thus, the combination 
of these two factors creates an environment which favours in vivo bioactivation and 
the bioalkylation process, possibly explaining why quinones display superior toxicity 
to oxygen-deficient cells in comparison to their oxygenated counterparts. 
 
The basic mechanism of bioreductive alkylation is illustrated in Scheme 2 and can 
be viewed as taking place over four successive steps22. 
i. Quinone 11 behaves as an intracellular two-electron acceptor and 
undergoes in vivo bioreduction to hydroquinone 12.  
ii. The substituent at the benzylic position of 12 is lost (as HX) through 
mesomeric assisted cleavage, forming quinone methide 13. 
iii. Quinone methide 13, a Michael acceptor, is now primed to readily undergo 
addition to biological nucleophiles, including DNA, proteins, lipids and 
carbohydrates. 
iv. The resulting hydroquinone-biological nucleophile adduct 14 is then 
autooxidized to its biologically inactive form 15. The biological molecule is 
now covalently bonded to the quinone, and is rendered unable to carry out 
its normal cellular function, therefore potentially resulting in apoptosis.  
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Scheme 2 
 
Mitomycin C 9 carries out its anti-tumour activity by this mode of action11. 
Additionally, the anthracycline antibiotics have also been postulated to be 
bioreductive alkylating agents22. 
 
1.2.3. DNA intercalation and Topoisomerase II inhibition 
Early investigations towards understanding the mechanism of action of 
anthracyclines showed that their main target is DNA and that they interact with this 
macromolecule by intercalation between adjacent base pairs23. This DNA binding 
property was shown to possibly contribute to their anti-tumour properties, but does 
not account for the potent activity of these compounds on its own10. The recent 
consensus is that the main mode of anthracycline anti-cancer activity is by the 
inhibition of the enzyme topoisomerase II. In fact, about half of the drugs used 
currently for anti-tumour chemotherapy target this protein7. Topoisomerases are 
mammalian enzymes that regulate DNA topology through transient single-strand 
(topoisomerase I) or double-strand (topoisomerase II) breaks and are therefore 
extensively involved in transcription, replication and chromosome segregation10,24. 
These enzymes make excellent anti-cancer targets, firstly because they are highly 
active in proliferating cells, and secondly, they are potentially cytotoxic molecular 
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scissors (as a result of their ephemeral strand breaking ability). Anthracyclines 
stabilise the topoisomerase II-bridged DNA complex and consequently convert 
topoisomerase II into an endogenous toxin. Topoisomerase II persistently continues 
to produce these bridged DNA complexes whilst the presence of the anthracylines 
causes a major increase in DNA strand breaks. This event causes numerous cellular 
responses that result in cell death25. 
 
1.3. Fusarium solani: Importance and Biosynthesis of Napthoquinone 
Metabolites 
The fungus genus Fusaria, and primarily Fusarium solani (Mart.) Appel & Wr. 
Emend. Snyd. & Hans. is an important plant parasite that contributes to the 
pathological condition  blight26,27. Blight targets the most rapidly dividing areas of the 
plant such as roots and shoots, thus being significantly more destructive in younger 
seedlings compared to older plants28. The symptoms of blight are diverse and 
include: leaf necrosis29, cortical rot30, veinal chlorosis31 and xylem dysfunction 
(reducing water intake and increased vessel plunging). F. solani infects many 
economic crop species, namely: citrus32, tomatoes, maize, radishes, beans, lettuces, 
lentils, rice and peas33. 
 
Due to the damage Fusaria species cause on valuable food plants, there is an 
immense amount of plant pathology research directed at investigating all aspects of 
this fungus. This is an ongoing process and has led to the isolation and structural 
elucidation of a broad range of fungal metabolites, including sugars, organic acids, 
alcohols, hormones, toxins and antibiotics34. These metabolites cover a vast number 
of compound classes and not all will be mentioned. 
 
With regards to this project, we are interested in the phytotoxins created by the 
fungus that contain the naphthoquinone structural framework shown in Figure 6. 
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Figure 6 
 
There are many structural similarities found amongst many of these 
naphthoquinones. To generalise, one could depict these compounds possessing 
three distinct regions: A, B and C. The A region is mostly an aromatic ring containing 
methoxy/hydroxyl groups in varying numbers and substitution patterns. The B region 
is also a ring structure, and usually is present as a quinone moiety. In some cases 
the A region can possess a quinone functionality and the B region may be a 
hydroquinone group. Lastly, the C region is often a ring system consisting of a basic 
pyran/furan/pyridine system, with many possible structural modifications existing.  
 
It is quite common in these naphthoquinones for hydration to occur across positions 
C-3 and C-4 to form a hemiacetal functionality, or dehydration across these positions 
if already hydrated, resulting in an isochromene moiety. A number of these 
phytotoxins contain an acetal linkage at position C-3. 
 
In the C region the R2 group may either be an oxygen or a nitrogen atom. The 
natural occurrence of the pyran ring system is considerably greater than that of the 
furan ring system. 
 
Thus, these selected oxygen containing naphthoquinones can be classified into 3 
main categories: hemiacetals (Table 1), isochromenes (Table 2) and acetals (Table 
3). Structurally similar compounds found in other species are also shown. 
 
Fusarubin 16 and dihydrofusarubin 17 are tautomers, but fusarubin is more 
commonly encountered as this structure is favoured by electronic factors35. 
Fusarubin 16 has many more listed biological activities compared to the other 
tabulated compounds. This can be attributed to the greater natural occurrence of 
fusarubin 16 amongst many fungal species which consequently allows for the 
Chapter 1: Introduction to Quinones 
 
 11 
 
compound to be more easily available for bioactivity screening. The structural 
similarities between fusarubin 16 and other hemiacetals such as delitzchianone A 
22, delitzchianone B 23 and 8-hydroxyherbarin 25 are evident. This suggests that 
these molecules most likely also possess similar biological activities and thus require 
biological testing.  
 
 Table 1: Naphthoquinone hemiacetal compounds found in fungal and plant sources, 
with listed biological activities. 
Hemiacetal Source (s) Bioactivities 
 
F.solani34, 
Neocosmospora 
vasinfectum, 
Neocosmospora 
africana, Nectria 
haematococca, 
Fusarium 
decemcellulare, 
Fusarium 
moniliforme 
Phytotoxic34, 
antimicrobial35 
(Saccharomyces 
cerevisiae, 
Streptomyces albus, 
Mycobacterium 
phlei, Bacillus 
subtilis, 
Staphylocccus 
aureus), cytotoxic 
 
F.solani  
 
F.solani  
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F.solani, Fusarium 
martii 
 
 
N. haematococca  
 
Torula herbarum, 
Amorosia littoralis36, 
Usnea cavernosa37, 
Corynespora sp. 
BA-1076338 
Antibacterial35 (B. 
subtilis), antifungal 
(Bacillus mycoides, 
Pythium 
debaryanum) 
 
Delitzchia winteri39  
 
Delitzchia winteri  
 
Psychotria rubra35 
cytotoxic (KB 
tumour cells) 
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Corynespora sp. 
BA-1076338 
 
 
Anhydrofusarubin 26 is the dehydrated form of fusarubin 16 and thus shares similar 
biological activities. Many of the other compounds in this table need to be tested for 
their biological activity as it is highly probable that they will possess useful 
therapeutic properties. Anhydrofusarubin-lactone 29 and anhydrofusarubin-lactol 30 
are structurally identical to anhydrofusarubin 26 save for the difference in the C-ring, 
which is the lactone functionality in 29 and the lactol functionality in 30 respectively. 
Another structurally similar molecule is the isoquinoline bostrycoidin 34, which 
contains a nitrogen atom in the C-ring section where anhydrofusarubin 26 has an 
oxygen atom. Obionin B 39 is an unusual isochromene that contains an ortho-
quinone moiety. 
 
Table 2: Naphthoquinone isochromene and isoquinoline compounds found in fungal 
and plant sources, with listed biological activities. 
Isochromene Source (s) Bioactivities 
 
F.solani34, 
N.vasinfectum, N. 
africana, 
F.decemcellulare, 
Fusarium spp. PSU-
F15/F1541, 
Fusarium sp. 
BCC1484242 
phytotoxic, 
insecticidal40, anti-
tumour (KB and 
MCF-7)41 
 
Fusarium 
oxysporum 
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Gibberella fujikuroi  
 
F.solani, 
N.haematococca 
 
 
F.solani, 
N.haematococca 
 
 
Torula herbarum 
Antibacterial35 (B. 
subtilis), antifungal 
(B. mycoides, P. 
debaryanum) 
 
N.haematococca, 
Trichopezizella 
nidulus43 
antimicrobial 
 
N.haematococca, 
Trichopezizella 
nidulus43 
antimicrobial 
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Fusarium 
bostrycoides, 
F.solani, 
F.decemcellulare 
F.sp. BCC1484242 
 
 
N.haematococca  
O-Methylbostrycoidin 36
N
O
OOCH3
H3CO
OH
 
F.decemcellulare  
 
Pentas longiflora44 antifungal 
 
Usnea cavernosa37, 
Corynespora sp. 
BA-1076338 
 
 
Fungal extract 
(MSX 63619)45 cytotoxic 
 
The naphthoquinone compounds in Table 3 all contain an acetal linkage at C-3. O-
methyldihydrofusarubin 40 has been shown to display anti-cancer and antibacterial 
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properties. O-Ethylfusarubin 43 and O-methylhebarin 44 possess antifungal activity, 
which is quite an uncommon occurrence considering their fungal origins.  
 
Table 3: Naphthoquinone acetal compounds found in fungal and plant sources, with 
listed biological activities. 
Acetal Source (s) Bioactivities 
 
F.solani, 
Cytotoxic35 (mouse 
leukemia L1210), 
antibiotic (gram 
positive bacteria) 
 
F.solani, F.martii 
Antibacterial35, 
antifungal 
 
F.solani, 
N.haematococca 
 
O-Ethylfusarubin 43
O
OCH2CH3
OH
OHO
H3CO
O
 
F.solani, F.martii 
Antibacterial35, 
antifungal 
 
Torula herbarum 
Antibacterial35 (B. 
subtilis), antifungal 
(B. mycoides, P. 
debaryanum) 
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Marticin 45
O
O
O
OOH
H3CO
OH
OH
O
 
F.solani, F.martii 
phytotoxic, anti-
bacterial, 
antimicrobial35 (S. 
aureus, S. 
pyogenes) 
 
F.solani, F.martii 
phytotoxic, 
antimicrobial35 (S. 
aureus, S. 
pyogenes) 
 
The diastereomers marticin 45 and isomarticin 46 are structurally fascinating 
molecules that possess 6,6-bicyclic pyran ring systems. These acetals display the 
highest phytotoxic activity of the naphthoquinone pigments46,47. Studies have 
demonstrated that they are highly toxic to tomatoes and peas with extensive damage 
to plant tissue at 8-30 mg.kg-1, with toxicity being increased at low pH48. Marticin 45 
and isomarticin 46 have been shown to promote electrolyte loss of host cells which 
subsequently allows amino acids, proteins and ions to be leached from the roots. 
These nutrients are then utilized by the parasitic rhizosphere F.solani for its own 
metabolic needs. The main mechanism of action of the marticins in tissues of higher 
plants still remains to be fully elucidated. However, inhibition of malate or citrate 
dehydration in the citric acid cycle is possible49. 
 
Naturally occurring compounds that contain fused pyran ring systems are rare and a 
few examples of this class of molecule are discussed. 
 
Averufin 47 (Figure 7) is a decaketide quinone intermediate in the biosynthesis of 
the mycotoxins aflatoxins B1 and G150. This molecule possesses a 6-membered 
bicylic fused-pyran ring system that is structurally similar to the system found in 
marticin 45. Isagarin 48 is a medicinal naphthoquinone isolated from the roots of 
Pentas longiflora, and contains a 6,5-bicyclic pyran ring system51. The cytotoxic 
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antibiotic nogalamycin 49 is produced by the bacteria Streptomyces nogalater52. This 
complex compound has a 6,6-bicyclic pyran ring system in the amino sugar region53. 
 
 
Figure 7 
 
1.3.1. Biosynthesis of pyranonaphthoquinones and derivatives   
The overall structural similarities between the naphthoquinones displayed in Tables 
1, 2 and 3 can be attributed to their common biosynthetic origin, which is the 
polyketide synthetase (PKS) pathway54,55. This class of quinone is believed to be 
formed from the variation of the number of coenzyme A esters (an adenine 
nucleotide linked by a 5’-pyrophosphate to pantothenic acid) which results in a 
hypothetical polyketide chain that can further fold and aromatize. The PKS pathyway 
exists primarily in micro-organisms such as fungi, and a few plant species. 
 
Naphthoquinones are heptaketide quinones and thus contain seven keto groups on 
the hypothetical polyketide chain (Scheme 3). 
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Scheme 3 
 
One acetyl coenzyme A unit 50 is combined to six malonyl coenzyme A moieties 51 
in a linear fashion to afford a heptaketide 52 which can “rotate” to afford 53. The 
aromatization of 53 followed by the introduction of oxygen at the two depicted 
positions of 54 yields a hydroquinone. Next, the non-hydrogen bonded hydroxyl 
group is methylated and the coenzyme A protein detaches to give the primary 
alcohol in compound 55. The nucleophilic attack of the primary alcohol on the ketone 
group, followed by autooxidation of the hydroquinone unit produces 
dihydroxyfusarubin 56. Under alkaline conditions (found in the F.solani cultures) 56 
oxidizes spontaneously in air to dihydrofusarubin 17. The hemiacetal functionality in 
dihydrofusarubin 17 readily dehydrates in the presence of mildly acidic conditions to 
produce anhydrofusarubin 26. 
 
Marticin 45 has been deduced to be formed by addition of a C3 unit (shown in red) 
originating from an intermediate of the Krebs cycle such as succinate or oxalacetate 
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to the heptaketide skeleton of dihydrofusarubin 17 or one of its precursors (Scheme 
4) 54. 
 
 
Scheme 4 
 
1.4. Summary of Chapter One 
By comparing the various naphthoquinone structures (section 1.3) and quinone 
structural requirements for biological activity (section 1.2) it is not surprising that 
many of these naphthoquinones display a diverse spectrum of bioactivities based on 
in vivo and in vitro tests. An even more intriguing comparison can be made between 
the structural similarities of the fungal naphthoquinones to the chemotherapeutic 
quinones (section 1.1.1), illustrating the potential medicinal importance of the fungal 
naphthoquinones discussed. 
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Chapter 2: Synthetic Methods for the Assembly of 
Polyhydroxylated Naphthalenes and Cyclic Acetals  
The plethora of potential lead compounds that fungal metabolites present is a 
continuously expanding field and the syntheses directed towards some of these 
naphthoquinones is reviewed in this chapter. The main emphasis is on synthetic 
methods towards creating a polyhydroxylated naphthalene core that is the dominant 
structural characteristic found in many of the naphthoquinones, such as fusarubin 
16, anhydrofusarubin 26, dehydrohebarin 31 and marticin 45. Fused pyran ring 
systems, such as the one found in marticin 45, are also examined and synthetic 
routes accessing these bicyclic acetals are discussed. 
 
2.1. Strategies towards Synthesizing Polyhydroxylated Naphthalene 
Systems 
There are four main synthetic routes that are used to create polyhydroxylated 
naphthalene systems, namely: (i) the Diels-Alder reaction, (ii) Hauser and Staunton-
Weinreb annulations, (iii) formylation-peroxidation reactions and (iv) phenol or 
naphthol para-oxidations using oxidants/catalysts.  
 
2.1.1. Diels-Alder reaction 
The Diels-Alder cycloaddition reaction has been shown to be one of the most 
effective means to obtain simple or complex multi-ring systems1 (Scheme 5). Many 
naphthalene systems have been assembled1,2 using this ring forming reaction, as a 
potentially unlimited number of dienes and dienophiles can be reacted to form the 
naphthalene motif. 
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Scheme 5: Basic Diels-Alder reaction3 
 
Within the scope of polyhydroxylated naphthalene species, there are two main 
classes of dienes that are employed. These are the cyclic dienes and vinyl ketene 
acetal dienes. The cyclic dienes are usually more stable in nature than their open-
chain vinyl ketene acetal counterparts, and initially form adducts4-7 when reacted with 
a dienophile. When dealing with unsymmetrical dienophiles or dienes, there is 
always the possibility of obtaining more than one regioisomeric product. It has been 
shown that the regioselective introduction of a halogen atom (usually a bromine) into 
the dienophile often allows for a single regioisomer to form when the Diels-Alder 
reaction is carried out7-9. 
 
2.1.1.1. Cyclic dienes 
In his PhD dissertation, de Koning demonstrated how a pentamethoxy naphthalene 
system can be synthesized from vanillin in six steps10 (Scheme 6). 2,3-Dibromo-
1,4,5-trimethoxybenzene 57 was obtained from the cheap, commercially available 
vanillin in four steps11,12. 2,3-Dibromo-1,4,5-trimethoxybenzene 57 was treated with 
n-butyllithium (0.9 molar equivalents) at low temperature  to generate a highly 
reactive benzyne intermediate in situ, which was reacted with 2-methoxyfuran 58 to 
generate two adduct regioisomers 59. When subjected to mild acidic conditions 
(silica gel), the adducts 59 ring open to form their mono-naphthol equivalents 60. 
Methylation of these regioisomers 60 yielded the single pentamethoxynaphthalene 
61.  
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Scheme 6: Reagents and conditions: (i)nBuLi, THF, -78 °C, then 58, rt; (ii) H+ (silica 
gel); (iii) K2CO3, Me2SO4, Me2CO, reflux, 68 % over 3 steps. 
 
In another study directed at the synthesis of the building blocks of rubromycins13, 
1,2,4-trimethoxybenzene 62 was brominated with bromine in chloroform (Scheme 
7).  This mono-brominated species 63 was treated with the sterically bulky base 
lithium diisopropylamine and then furan 64, forming adduct 65. Exposure of the 
adduct 65 to catalytic amounts of perchloric acid facilitated regioselective ring-
opening. The resulting phenol 66 was ortho-brominated with pyridinium perbromide 
to afford 2-bromo-5,7,8-trimethoxynaphthalen-1-ol 67. This compound 67 was 
oxidized with ceric ammonium nitrate, reduced with sodium dithionite and methylated 
to provide 2-bromo-1,4,5,7,8-pentamethoxynaphthalene 68. 
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Scheme 7: Reagents and conditions: (i) Br2, CHCl3, 0 °C, 100 %; (ii) LDA, then 64,   
-78 °C to rt, 100 %; (iii) HClO4 (cat.), THF, rt,  100 %; (iv) PHBP, THF, rt, 60 %; (v) 
CAN (20 % in H2O), CH3CN, rt, then Na2S2O4, TBABr (cat.), CH2Cl2, rt, then 
Me2SO4, NaOH, TBABr (cat.), CH2Cl2, rt,  46 % over 3 steps. 
 
2.1.1.2 Open chain dienes 
The majority of these ‘open-chain’ dienes have a skeleton that is based on the 
molecule ethyl acetoacetate 69. Some of the more commonly used dienes have 
been named after their respective creators. The most generally known are 
Brassard’s diene 7014, Chan’s diene 7115, Dane’s diene 7216, Danishefsky’s diene 
7317 and Rawals diene 7417 (Figure 8). 
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Figure 8: Structures of common dienes. 
 
With regards to the synthesis of polyhydroxylated naphthalenes, a few of these 
dienes allow for the introduction of a new ring system containing one (Danishefsky’s 
diene 73) or two (Brassard’s diene 70, Chan’s diene 71) hydroxy groups. Scheme 8 
is an example of the implementation of Diels-Alder methodology in the synthesis of 
pyranonaphthoquinone antibiotics. The brominated 1,4-benzoquinone 75 is obtained 
from (S)-2-methyloxirane in 10 steps18. The reaction of 75 with Chan’s diene 71 
generates naphthoquinone 76 in a low yield of 24 %. The position of the bromine 
atom in 75 regiochemically controls the Diels-Alder reaction as only one regioisomer 
(out of a possible two) forms. Reaction of brominated 1,4-benzoquinone 75 with 
complex diene 77 gives rise to three products 78, 79 and 80 in trace amounts.  
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Scheme 8: Reagents and conditions: (i) 71, C6H6, rt, 24 %; (ii) 77, C6H6, rt, 0.8 % for 
78, 0.2 % for 79, 0.4 % for 80. 
 
The first reported synthesis of dehydrohebarin 31 in 2000 by De Kimpe and co-
workers (Scheme 9) employed the Diels-Alder reaction19. Benzoquinone 81 was 
treated with vinyl ketene acetal diene 82 to undergo a regioselective cycloaddition 
reaction to afford the 1,4-naphthoquinone 83. The phenol substituents in 83 were 
methylated using a combination of silver(I) oxide and methyl iodide to yield 6,8-
dimethoxy-2-methyl-1,4-naphthoquinone 84. Reaction of 84 with acetonylpyridinium 
chloride 85 and triethylamine resulted in the formation of 3-acetonylnaphthoquinone 
86 in a 79 % yield. Naphthoquinone 86 was selectively monobrominated using N-
bromosuccinimide with a catalytic amount benzoyl peroxide to provide 3-acetonyl-2-
bromomethyl-1,4-naphthoquinone 87.  Treatment of 87 with triethylamine in refluxing 
toluene facilitated the selective cyclization to the natural product dehydrohebarin 31 
in an 84 % yield. 
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Scheme 9: Reagents and conditions: (i) 82, THF, -78 °C, 76 %; (ii) Ag2O, CH3I, 
CHCl3, rt, 95 %; (iii) 85, Et3N, CH3CN, rt, 79 %; (iv) NBS, benzoyl peroxide, CCl4, 
reflux, 80 %; (v) Et3N, toluene, reflux, 84 %. 
 
2.1.1.3 Evaluation of Diels-Alder reaction in the synthesis of  hydroxylated 
naphthoquinones 
There is no doubt of the versatility, applicability and synthetic prowess of the Diels-
Alder reaction with regards to formation of aromatic rings in natural product 
synthesis. Theoretically one could create almost any desired ring system and 
substituent arrangement pattern. However, there are a few problems that the Diels-
Alder reaction poses, especially when employed towards creating polyhydroxylated 
naphthoquinones. These are: (i) regioselectivity is an issue when a halogen is not 
present in the dienophile and thus formation of multiple regioisomers is possible; (ii) 
some of the desired dienes (such as in Figure 8 and Scheme 8) are tricky to make 
and/or expensive (2-methoxyfuran 58) or difficult (furan 64) to obtain; (iii) reactions 
can be very low yielding (see Scheme 8) and thus can potentially be carried out only 
at the end of the synthesis. These limitations must be taken into account when 
designing routes to access substituted naphthalenes or naphthoquinones. 
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2.1.2. Annulation reactions 
An annulation reaction can be defined as a transformation resulting in the addition of 
a new ring to a compound via two novel bonds20. 
 
2.1.2.1. Hauser annulation 
The Hauser annulation reaction involves the annulation of an acceptor possessing a 
polarised/activated multiple bond 88 with a 3-(nucleofugal) benzo[c]furanone, for 
example 89 to form a naphthol/naphthoquinone annulated product 9020. The 
proposed mechanism of the Hauser annulation is depicted in Scheme 10. The first 
step is the deprotonation of a phthalide such as 89 at C-3 with the ensuing anion 91 
undergoing Michael addition with the acceptor 88, forming carbanion 92. The lactone 
functional group on carbanion 92 then undergoes an intramolecular Dieckmann 
cyclization to yield intermediate 93. Electronic movement within 93 results in the 
expulsion of benzenesulfinate ion, giving quinone 94. Base-promoted 
tautomerization and subsequent protonation of 94 results in formation of annulated 
ring system 90, which can for example, be protected as the para-aromatic dimethyl 
ether. 
 
 
Scheme 10 
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In a reported synthesis of thysanone, a human rhinovirus (HRV) 3C-protease 
inhibitor, a Hauser annulation was employed to create the required tetra-
hydroxylated naphthalene framework21 (Scheme 11). Diethyl 2,4-
dimethoxybenzamide 95 was regioselectively formylated using ortho-lithiation with 
subsequent dimethylformamide quenching to provide formylbenzamide 96. 
Treatment of 96 with hydrochloric acid and acetic acid facilitated the intramolecular 
cyclization to give 3-hydroxy-5,7-dimethoxyphthalide 97. Phthalide 97 was converted 
to cyanophthalide 98 with potassium cyanide. With the required cyanophthalide 98 in 
hand, the Hauser annulation was now possible. The cyanophthalide 98 was reacted 
with sec-butyllithium (to generate a carbanion) and ethyl acrylate (a Michael 
acceptor) to deliver the desired tetra-oxygenated naphthalene 99. 
 
 
Scheme 11: Reagents and conditions: (i) tBuLi, THF, -78 °C, then DMF, 99 %; (ii) 
CH3CO2H, 10 % HCl, reflux, 85 %; (iii) KCN, conc. HCl, 0 °C then rt, 85 %;  (iv) 
sBuLi, THF, -78 °C, ethyl acrylate, -78 °C, 54 %. 
 
2.1.2.2. Staunton-Weinreb annulation 
The Staunton-Weinreb annulation process (Scheme 12) is fashioned around a 
reaction discovered independently by Weinreb and Staunton during their 
investigations on the synthesis of polyketide natural products22. A substrate 
structural requirement for the Staunton-Weinreb annulation is the presence of an 
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alkoxy substituent ortho to the ester of for example 100 to allow formation of the 
intermediate chelate 101. The chelated species 101 reacts with enone 102 to give 
enolate 103 which leads to annulation product 104. The exact sequence of steps for 
the transformation of 103 to 104 is still uncertain. 
 
 
Scheme 12 
 
A recent study towards the synthesis of naphthoquinones by Brimble and co-workers 
produced an efficient route to dehydroherbarin 3123 (Scheme 13). The starting 
materials lactone 105 and aromatic coupling partner 106 were synthesized from 4-
hydroxy-6-methyl-2H-pyran-2-one and 2,4-dihydoxy-6-methylbenzoate respectively. 
Staunton-Weinreb annulation of 105 and 106 afforded naphthol 107 in a low yield of 
27 %. Naphthol 107 was treated with diisobutylaluminium hydride to facilitate 
reduction and hydrogenation of the lactone functionality to form isochromene 108. 
Oxidation of 108 with salcomine 109 under an oxygen atmosphere produced 
dehydroherbarin 31. 
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Scheme 13: Reagents and conditions: (i) LDA, THF, -78 °C to rt,  27 %; (ii) DIBAL-H, 
THF, rt, 67 %; (iii) 109, O2(g), CH3CN, rt, 72 %. 
 
2.1.2.3. Evaluation of annulation reactions towards hydroxylated 
naphthoquinones 
The Hauser and Staunton-Weinreb annulation reactions both have considerable 
strengths when applied to the synthesis of hydroxylated naphthoquinones. They both 
allow for the regioselective introduction of a varied number of oxygenated 
substituents to the naphthoquinone framework. However, both these reactions also 
have their pitfalls. In the Hauser annulation, the formation of the phthalide (such as 
98) may not be a trivial process and includes multiple steps, some of which are 
carried out a low temperature and may require the use of the highly toxic compound 
potassium cyanide. The Staunton-Weinreb annulation is limited only to systems that 
have alkoxy groups adjacent to an ester and can be problematic when stereogenic 
centres are present in the enone (such as 105) fragment22. Thus the use of these 
reactions comes with caution (Hauser annulation) and structural limitations 
(Staunton-Weinreb annulation). 
 
2.1.3. Formylation/peroxide oxidation 
Another creative approach to polyhydroxylated naphthalene systems is the 
introduction of a formyl group through the use of the Vilsmeier–Haack reaction that 
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can be sequentially transformed into a phenol or naphthol substituent under Baeyer-
Villiger conditions24.  An example of this was employed in an investigation towards 
the synthesis of hybocarpone (Scheme 14).  The starting naphthalene 110 in this 
pathway already possesses a pentamethoxynaphthalene core that was derived by 
means of a Diels-Alder reaction, and thus its synthesis will not be covered. The 
Vilsmeier-Haack formylation of naphthalene 110 afforded the 1,2,4,6,8-
pentamethoxynaphthalene-5-aldehyde 111. Exposure of the aromatic aldehyde 111 
to acidic hydrogen peroxide produced the 2,3,5,7-tetramethoxy-1,4-naphthoquinone 
112 in a 72 % yield. The reductive methylation of the naphthoquinone 112 gave the 
hexamethoxynaphthalene 113.  
 
 
Scheme 14: Reagents and conditions: (i) POCl3, DMF, CH2Cl2, then NaOAc, H2O, 
83 %; (ii) H2O2, H2SO4, CH3OH, 72 %; (iii) Na2SO4, Me2SO4, KOH, NBu4Br, THF, 
H2O, rt, 74 %.  
 
2.1.4. Phenolic para-oxidation via oxidants/catalysts 
Another route to polyoxygenated naphthoquinones is the oxidation of the para-
position relative to a phenolic (or naphtholic) substituent (Scheme 15). This strategy 
is commonly used in the synthesis of natural products25-28 and is usually carried out 
late in the synthesis. This oxidation can be achieved via a vast array of reagents, 
including: salcomine29, Fremy’s salt24, Ph2Se2O330, ceric ammonium nitrate9, 
Chapter 2: Synthetic Methods for the Assembly of Polyhydroxylated Naphthalenes and 
Cyclic Acetals 
 
 36 
 
hypervalent iodide compounds31 [PIFA, PhI(OAc)2, PhI(CF3CO2)2], thallium nitrate4 
and by a Jones oxidation. It often occurs that more than one of the oxidants must be 
tested to achieve the desired oxidation reaction, if at all. These kinds of oxidations 
are notoriously difficult and often give ortho-oxidized products31,32.  
 
 
Scheme 15 
 
2.1.4.1. Phenyliodine bis(trifluoroacetate) para-methyl-ether insertion 
The hypervalent iodine reagent phenyliodine bis(trifluoroacetate) (PIFA) was 
mentioned in the previous section (2.1.4) as an oxidant that can be used for the 
regioselective para-oxidation of phenols. The typical PIFA oxidation procedure 
requires a source of oxygen, and thus water is used as a co-solvent for this 
purpose31,32. An example of this is shown in Scheme 16 where the naphthol 114 is 
oxidised to the pseudohydroxyquinone equivalent 115 with PIFA. 
 
 
Scheme 16 
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A major flaw of this oxidation is that yields are very low (often less then 50 %) and an 
acidic iron(III) solution (for oxidation of pseudohydroxyquinone) is often necessarily 
added to facilitate the formation of the desired quinone moiety. A discovery was 
recently made by Kozlowski and co-workers32 that showed that methanol could be 
utilized instead of water as an oxygen source (Scheme 16). This finding allowed for 
the regioselective insertion of an aromatic methyl-ether group onto the naphthalene 
ring 114 forming pseudomethoxyquinone 116. This process directly resulted in 
significantly higher yields of the desired product (more than 80 %). Effectively this is 
the addition of a nucleophile (methanol) to an electron rich oxygenated aromatic 
system.  
 
2.2. Selected Syntheses of Naturally Occurring Fused-Cyclic Acetals 
Fused cyclic acetals constitute the structural framework of few natural products (see 
section 1.3), but these complex ring systems have induced considerable interest in 
synthetic chemists. The principle of cyclic acetal formation is actually a simple 
process and the most common example of this is illustrated in Scheme 1733.  
 
 
Scheme 17 
 
Acetals are often utilized as carbonyl protecting groups for aldehydes and ketones in 
synthetic organic chemistry. The reaction of a carbonyl compound such as 117 with 
a diol 118 in the presence of a Brönsted or Lewis acid catalyst results in the 
formation of an acetal/dioxane 119. A typical procedure employs para-
toluenesulfonic acid as a catalyst in refluxing toluene, which allows for the 
continuous removal of water from the reaction mixture using a Dean-Stark 
apparatus. A mixture of o-esters or molecular sieves can also provide effective water 
removal through chemical reaction or physical sequestration respectively. Cyclic 
acetals offer stability against many types of nucelophiles and bases. Deprotection is 
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carried out by (i) acid catalyzed transacetalization in acetone or (ii) hydrolysis in wet 
solvents or aqueous acid. 
 
2.2.1. Synthesis of cyclic acetals via Wacker-oxidations 
As mentioned in the previous paragraph, acetal formation requires a diol and a 
carbonyl compound. This is easily achieved for carbonyl protection purposes when 
this reaction process is intermolecular. However, with regards to natural product 
cyclic pyran systems, the acetal synthesis is intramolecular in nature and creating 
three reactive functionalities in close proximity is synthetically difficult. Ideally, one 
would envisage the timely introduction of an intramolecular carbonyl group, such as 
a ketone, into a system with two alcoholic groups primed for nucleophilic attack, and 
hence acetal formation.  
 
The Wacker oxidation was discovered in 1958 and involves the oxidation of ethylene 
120 to acetaldehyde 121 using palladium(II) chloride as a catalyst and copper(II) 
chloride as the sacrificial oxidant under an oxygen atmosphere34 (Scheme 18). This 
reaction was extended to more complex olefins and it was found that in general, 
terminal alkenes 122 were transformed into methyl ketones 123, as opposed to 
aldehydes. 
 
 
Scheme 18 
 
Thus, the Wacker oxidation is a reaction that allows for planned introduction of a 
ketone functional group and has consequently been used extensively in the creation 
of cyclic acetals. 
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Isagarin 48 was synthesized by Ploysuk et al. in 2007 in five steps35 (Scheme 19) 
using the Wacker oxidation as a key step in their synthesis. 2-Bromonaphthoquinone 
124 was allylated at C-3 by a radical allylation process using vinyl acetic acid and 
ammonium persulfate in aqueous acetonitrile forming the allylated naphthoquinone 
125. Reductive methylation of naphthoquinone 125 with tin(II) chloride and dimethyl 
sulfate afforded methyl-ether protected naphthoquinone 126.  Treatment of 126 with 
n-butyllithium (allowing for a bromine-lithium exchange) and the O-silyl protected 
aldehyde 127 at low temperature provided naphthoquinone 128. Desilylation of 
naphthoquinone 128 with tetra-n-butylammonium fluoride, followed by a Wacker 
oxidation gave the cyclic acetal compound 129 in good yield (71 %). Ceric(IV) 
ammonium nitrate oxidative demethylation of cyclic acetal naphthoquinone 129 
afforded isagarin 48 as a racemic mixture. This is the only example of this type of 
Wacker oxidation on an aromatic substrate. 
 
 
Scheme 19: Reagents and conditions: (i) vinyl acetic acid, (NH4)2S2O4, AgNO3, 
CH3CN/H2O, 60-70 °C, 72 %; (ii) SnCl2, HCl, EtOH, 50 °C; (iii) Me2SO4, KOH, 65 °C, 
75 %; (iv) nBuLi, THF, -78 °C, then 127, 70 %; (v) TBAF, THF, rt, 87 %; (vi) PdCl2, 
CuCl2, O2, DME, 65 °C, 71 %; (vii) CAN, MeCN, H2O, rt, 95 %. 
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The synthesis of the degradation products of daphniphyllum alkaloids (which are 
aliphatic bicyclic acetals) was conducted by Kongkathip and co-workers in 199936 
(Scheme 20). Reduction of synthesized ester 130 produced triol 131, which 
underwent intramolecular ketalization under Wacker oxidation conditions to yield 
acetal 132 in a 63 % yield over two steps. The bicyclic acetal 132 consists of a 6,5-
fused bicyclic ring system. 
 
 
Scheme 20: Reagents and conditions: (i) LAH, rt; (ii) PdCl2, CuCl2, O2, DME, 65 °C, 
63 % (over 2 steps). 
 
In the synthesis of amberketal and a homologue37, Kongkathip and colleagues 
subjected diol 133 to a Wacker oxidation affording the 5,6-fused bicyclic ring system 
134 (Scheme 21).  
 
 
Scheme 21: Reagents and conditions: (i) PdCl2, CuCl2, O2, DME, 65 °C, 55 %. 
 
In a short synthesis of a bark beetle pheromone, the aliphatic 1,2-diol 135 was 
oxidised under Wacker oxidative conditions to yield the desired cyclic acetal 
brevicomin 136 in a 45% yield38 (Scheme 22). Brevicomin 136 also possesses a 5,6- 
fused bicyclic ring system. 
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Scheme 22: Reagents and conditions: (i) PdCl2, CuCl2, O2, DME, 65 °C, 45 %. 
 
In yet another synthesis the target compound was a potent attractant of the striped 
ambrosia beetle, Trypodendron lineatum OLIV39. The final step of the synthetic 
pathway was the oxidation of the diastereomeric alkene system 137 with 
palladium(II) chloride and copper(II) chloride in anhydrous tetrahydrofuran (Scheme 
23). A mixture of the desired cyclic acetals; endo-138 and exo-1,3-dimethyl-2,9-
dioxabicyclo [3.3.1] nonane 139 was formed in a 50 % yield. 
 
 
Scheme 23: Reagents and conditions: (i) PdCl2, CuCl2, O2, THF, rt, 50 %. 
 
The formal total synthesis of (-)-saliniketals was investigated by Yadav et al. in 
200940. One of the salient features of their synthesis was an intramolecular Wacker-
type oxidation. Advanced intermediate 1,3-diol 140 was treated with PdCl2 and CuCl2 
in tetrahydrofuran under an oxygen atmosphere to form [3.2.1]-dioxabicycle 141 
(Scheme 24). 
 
 
Scheme 24: Reagents and conditions: (i) PdCl2, CuCl2, O2, THF, 0 °C, 90 %. 
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2.2.2. Novel methods to access cyclic acetals 
Other than the Wacker oxidation reaction, there are a few other synthetic strategies 
that allow for cyclic acetal creation on aromatic targets that are of interest to us in 
this thesis. Four of these methods are reported. 
 
The anthraquinone averufin 47 is an important intermediate in the biosynthesis of 
aflatoxin B1, and Townsend et al. have reported its synthesis in 198841. It was earlier 
noted (see section 1.3) that averufin 47 contains a fused 6,6-bicyclic pyran ring 
system. The synthetic manner by which this fragment of the compound was 
assembled is shown in Scheme 25. The benzylic aldehyde 142 was reacted with 
protected ketone 143, which was pre-exposed to n-butyllithium (thus underwent a 
bromine lithium exchange), providing substrate 144. Treatment of the protected 
acetal compound 144 with concentrated sulfuric acid for 24 hours facilitated selective 
deprotection to furnish the desired cyclic acetal 145. 
 
Scheme 25: Reagents and conditions: (i) 143, nBuLi, THF, -10 °C, 4 h, 89 %; (ii) 
H2SO4 conc., CH3COOH (50 %), rt, 26 h, 67 %. 
 
The gold-catalyzed reactions of 2-(ynol)aryl aldehydes were investigated by Le-Ping 
and co-workers in 201042. Benzobicyclo[n.3.1]acetals were produced when triazole-
gold catalysts were used. 2-(6-Hydroxyhex-1-ynyl)benzaldehyde 146 was smoothly 
transformed into the benzobicyclo[4.3.1]acetal 147 using their gold-triazole catalyst 
(Scheme 26). The acetal 147 consists of a 6,8-fused bicyclic ring system. 
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Scheme 26: Reagents and conditions: (i)Triazole-Au (5 mol %), CH2Cl2, rt, 1 h,      
82 %. 
 
The use of a 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) induced oxidative 
coupling of a variety of isochromans and alcohols was studied by Xu and co-workers 
in 199343. Of particular interest in this study was the isochromane substrate 148 
which was treated with DDQ to yield the aromatic fused-pyran 149 (Scheme 27). 
 
 
Scheme 27: Reagents and conditions: (i) DDQ, CH2Cl2, rt, 70 %. 
 
An interesting manner to access cyclic acetals was discovered as a test reaction by 
Wünsch44. The reaction of 2-(2-bromophenyl)-acetaldehyde acetal 150 with n-
butyllithium and aldehyde 151 produced intermediate 152. This, in turn, was treated 
with hydrochloric acid to afford the 6-membered bicylic acetal compound 153 in a 42 
% yield (Scheme 28). 
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Scheme 28: Reagents and conditions: (i) nBuLi, THF, -80 °C, 55 %; (ii) HCl, CH2Cl2, 
rt, 42 %. 
 
2.3. Project Goals 
Based on the literature presented in the preceeding chapters, the importance of 
quinones and naphthoquinones both biologically and structurally is well illustrated. In 
addition, there is a need for further research with regards to uncovering potentially 
useful biological activities of the fungal naphthoquinones, many of which have not 
been adequately studied (see section 1.3).  The isolation of the naphthoquinones 
from natural sources for this purpose is a possibility, but unpredictable structural 
variance and quantity of material greatly limit this option. Thus a promising probable 
route to access these desired metabolites is through synthetic means. However, 
there are also many problems associated with this approach (such as expensive 
reagents, low yields) and there is a general need for simpler, more robust synthetic 
pathways to access in particular the oxygenated core of some of these 
naphthoquinones. 
 
Ongoing synthetic research in our laboratories has resulted in some valuable input 
towards the synthesis of fungal naphthoquinones. J. Oliveira had successfully 
completed synthetic routes to benzylic hemiacetal 154 and benzylic isochromene 
15545 (Scheme 29). A comparison of these two substrates with the B and C-ring 
sections (see Figure 6) of the hemiacetals (Table 1) and isochromenes (Table 2) 
can render them as suitable model systems/intermediates. In Oliveira’s synthesis, 
2,5-dihydroxybenzoic acid 156 was allylated/methallylated to afford 157. A Claisen 
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rearrangement facilitated the rearrangement of the allyl/methyallyl group to the 
desired C-2 position to yield 158, which was then methylated to afford the aromatic 
methyl ether 159. This protected species 159 was then reduced with lithium 
aluminium hydride to furnish the primary alcohol 160. The allyl/methallyl group was 
then oxidized (Wacker oxidation for the allyl group/ozonolysis for the methallyl group) 
to afford hemiacetal 154 and isochromene 155. 
 
 
Scheme 29: Reagents and conditions: (i) K2CO3, allyl bromide/methallyl chloride, 
Me2CO, reflux, 84 %/50 %; (ii) neat, 170 °C/180 °C;  (iii) Me2SO4, K2CO3, Me2CO, 
reflux, 87 %/33 % over 2 steps; (iv) LAH (2 equivalents), Et2O, rt, 98 %/90 %; (v) 
PdCl2, CuCl2, O2, DMF/H2O, rt, 50 % for 155, 20% for 154, or O3, CH3OH, -40 °C,   
18 % for 155, 81% for 154. 
 
The next step forward for Oliveira was to incorporate the synthetic knowledge 
derived from Scheme 29 into a more complex naphthalene system that would 
enable the complete synthesis of two naturally occurring naphthoquinones. This 
vision was nearly realised, by employing a Stobbe condensation strategy to smoothly 
create the desired naphthoquinone system 166 (Scheme 30). The Stobbe 
condensation of aldehyde 161 with diethyl succinate followed by cyclization with 
sodium acetate in acetic anhydride produced acetate 162. The acetate of 162 was 
deprotected with sodium hydroxide to yield 163, which was methallylated to form 164 
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and subjected to Claisen rearrangement conditions at high temperature to furnish 
phenol 165. The salcomine oxidation of this phenol produced quinone 166, but due 
to low yields of the reaction no further progress was made. There was an attempt to 
complete the construction of ring-system C by bypassing the oxidation, and instead 
carrying out the protection of naphthol 165. The naphthol 165 was protected as a 
methyl ether producing 167, which was reduced with lithium aluminium hydride to 
yield alcohol 168. The alcohol 168 was subjected to ozonolysis with 169 as the 
desired target, but unfortunately none of the desired product was isolated. 
 
 
Scheme 30: Reagents and conditions: (i) Diethyl succinate, KOBut , tBuOH, reflux; 
NaOAc, Ac2O, reflux, 77% over two steps; (ii) NaOH, EtOH/H2O, HCl conc., 92%; (iii) 
K2CO3, methallyl chloride, Me2CO, reflux, 97 %; (iv) neat, 180 °C, 83 %; (v) 
salcomine, O2(g), DMF, 18%, (vi) Me2SO4, K2CO3, Me2CO, reflux, 82 %; (vii) LAH (2 
equivalents), Et2O, rt, 81 %. 
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Schemes 29 and 30 provided us with a foundation in the synthetic pursuit of these 
naphthoquinone systems for this PhD. The general aims of this project are to build 
on the previous research done and to complete a robust, feasible synthetic route to 
the fungal metabolites such as dehydroherbarin 31 and anhydrofusarubin 26. 
 
We also have an interest in expanding this work in creating the 6,6-bicyclic fused 
pyran naphthoquinone marticin 48. There are no reported syntheses of this 
naphthoquinone and therefore the synthesis poses a challenging task. 
2.3.1. Direct project objectives 
The first objective was to create quinone equivalents of hemiacetal 154 and 
isochromene 155 (prepared by Oliveira), such as 170 and 171 respectively by 
oxidation. We then planned to carry out Diels-Alder reactions on these 
benzoquinones in an attempt to convert them to naphthoquinone systems (Scheme 
31). This could be done by using a commercial diene such as 2-methoxyfuran 58 
and if the reaction is successful, we could employ Brassards diene 70 in the 
reaction. This will allow for the addition of the “A-ring” (see Figure 6) with the 
substitution pattern found in naphthoquinones such dehydroherbarin 31 and herbarin 
21, if the regiochemistry was correct. 
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Scheme 31 
 
The second aim of the PhD was to complete and extend the work started by Oliveira 
on the use of the Stobbe condensation for the synthesis of the desired 
naphthoquinones, starting with for example 2,4-dimethoxybenzaldehyde 172. 
Dehydroherbarin 31 seemed to be a suitable naphthoquinone target for this 
methodology, as shown in a partial retrosynthesis outlined in Scheme 32. 
Dehydroherbarin 31 potentially could be obtained by the salcomine23 oxidation of 
phenol 173, which in turn can be formed from the deprotection of 174. The 
isochromene 174 we hoped could be derived from the Wacker oxidation of alcohol 
175, which is the reduction product of ester 176. Ester 176 could be formed from 
protection of phenol 177 that is made from 2,4-dimethoxybenzaldehyde 172 in four 
steps using Stobbe condensation methodology27. 
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Scheme 32 
 
The third aim of this PhD was to apply the methodology developed from the 
synthesis of dehydroherbarin 31 to a more highly oxygenated and related 
naphthoquinone target, anhydrofusarubin starting with 1,2,4-trimethoxybenzaldehyde 
178 (Scheme 33). The synthesis of anhydrofusarubin 26 will be our objective for the 
following reasons: (i) the synthesis of anhydrofusarubin 26 has never been 
accomplished; (ii) it possesses potent anti-tumour activity and the preparation of 
larger amounts of material will allow for further biological studies. 
 
 
Scheme 33 
 
Chapter 2: Synthetic Methods for the Assembly of Polyhydroxylated Naphthalenes and 
Cyclic Acetals 
 
 50 
 
The fourth aspect of this PhD to be researched would be to assemble a model 
system of the 6-membered bicyclic acetal skeleton found in marticin 45. A racemic 
mixture of compound 179 is our initial model target (Scheme 34). The first 
retrosynthetic step led us to the 1,3-diol compound 180, which should form 179 if 
subjected to a Wacker oxidation. This 1,3-diol 180 can be made from the selective 
reduction of the 1,3-diketone 181. This step could be problematic as it requires the 
reduction of two ketone functionalities in the presence of an ester. However, in 
theory this should be possible by using for example a selective enzymatic procedure. 
The diketone could be obtained from the Claisen condensation reaction of ketone 
182 with diethyl oxalate. Ketone 182 we hoped could be made from the commercially 
available 2,5-dihydroxyacetophenone 183 in three steps27.  
 
 
Scheme 34 
 
Finally, and if time permitted, once the synthetic methodology to create acetal model 
compound 179 is established, as well a viable method for the synthesis of the 
pentaoxygenated naphthalene, these methods could be combined and applied to the 
synthesis of marticin 45 (Scheme 35) from 18410. 
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Scheme 35 
 
We also wish to investigate the anti-tumour activity of all target quinones where 
initially the potential for bioactivity will be assessed in an in vitro MTT assay on two 
colon cancer cell lines: CaCo-2 and HT-29 as well as the breast cancer cell line MCF 
7 at the Medical School of our University. 
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Chapter 3: The Synthesis of Dehydroherbarin and 
Anhydrofusarubin  
3.1. A Diels-Alder Approach to Naphthoquinones 
Our initial approach for the assembly of the oxygenated naphthoquinone system was 
to build onto the work started by Oliveira1. We envisaged carrying out Diels-Alder 
reactions on the quinone equivalents of the aromatic compounds hemiacetal 154 
and isochromene 155, in other words the benzoquinones 170 and 171 respectively 
(Scheme 31).  
 
3.1.1. Deprotection of dimethyl ethers 
The desired aromatic dimethyl ether hemiacetal 154 and isochromene 155 were both 
synthesized based on the reported methodology1. The ceric ammonium nitrate 
deprotection of the aromatic dimethyl ethers presented itself as the simplest first 
approach for the preparation of benzoquinones2. The ceric ammonium nitrate (CAN) 
-mediated oxidation process proved successful, and benzoquinones 170 and 171 
were furnished as dark red amorphous solids in yields of 55 % and 63 % respectively 
(Scheme 36). 
 
 
Scheme 36 
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The reaction conditions for the oxidation were the same for both substrates. An 
aqueous solution of CAN was added dropwise to the aromatic dimethyl ethers 154 
and 155 which were dissolved in acetonitrile. The reaction progress was visible as 
the lightly coloured solution intensified to an orange solution, signalling the formation 
of a quinone chromophore in situ. 
 
The formation of the benzoquinones 170 and 171 was confirmed spectroscopically, 
using 1H NMR, 13C NMR and IR spectroscopy. The 1H NMR spectra of 170 and 171 
displayed no aromatic methoxy-ether peaks, which was the first clear sign that the 
oxidation reaction had been successful. The 1H NMR spectrum of 170 showed the 
quinone protons, each as a doublet at 6.71 ppm and 6.80 ppm, and the methyl group 
as a singlet at 1.47 ppm, as expected. The 13C NMR and IR spectra for both 
compounds confirmed the presence of the newly formed quinone nuclei. The two 
carbonyl signals for the hemiacetal quinone 170 (187.4 ppm and 186.7 ppm) and 
isochromene quinone 171 (184.8 ppm and 184.2 ppm) were present in the 13C NMR 
spectra. There was also an absence of signals arising from aromatic methyl ethers in 
both cases in the 13C NMR spectra. The IR spectral data clearly depicted carbonyl 
stretching frequencies at 1738 cm-1 and 1654 cm-1 for the hemiacetal quinone 170 
and 1652 cm-1 and 1600 cm-1 for the isochromene quinone 171.  
 
3.1.2. Attempted Diels-Alder reaction of benzoquinones 
With the desired benzoquinones in hand, the next step was to utilize the Diels-Alder 
reaction to form the required naphthoquinone derivative. Use of these quinone 
compounds as dienophiles represents a classical approach to the Diels-Alder 
reaction for two reasons: (i) the quinone contains no halogen atom which controls 
regioselectivity3 when an unsymmetrical diene is employed and (ii) there is no 
possibility of the formation of a highly reactive benzyne4 intermediate which greatly 
improves the reaction time. These ‘classical’ Diels-Alder reactions are notoriously 
slow and chlorinated or benzene-like solvents are normally used5,6.  The first reaction 
tested was the reaction using equal molar equivalents of isochromene quinone 171 
and symmetrical diene, furan 64, in dichloromethane stirred at room temperature. 
We anticipated the potential formation of the naphthoquinone adduct 185 as shown 
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in Scheme 37. After 72 h, with no visible change in the reaction, the mixture was 
refluxed with continuous monitoring by TLC. There was still no visible product 
formation by TLC and as the boiling point of the diene furan 64 is only 32 ºC, there 
was no point changing to a higher boiling solvent, unless it was a sealed tube 
reaction.  
 
 
Scheme 37 
 
Repeating the reaction with dienophile 170 and furan 64 was also not successful. 
The diene was therefore changed to 2-methoxyfuran 58 with a higher boiling point. If 
successful, the combination of hemiacetal quinone 170 and 2-methoxy furan 58 
would form regioisomeric adducts 186 (Scheme 38). 
 
 
Scheme 38 
 
This reaction appeared more promising as the reaction mixture rapidly changed 
colour upon addition of the diene 58 in dichloromethane. However, work-up and 
purification of the mixture showed that all that had occurred was decomposition and 
all the starting material was consumed. Carrying out the reaction at lower 
temperatures (0 °C to -40 °C) made no impact on minimising the observed 
decomposition. Once again a similar fate was observed when using isochromene 
quinone 171. Using chloroform as a solvent, either at ambient temperature or at 
reflux, did not result in reaction for either dienophile, however no decomposition was 
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observed in these cases. The next solvent that was used was dichlorobenzene. 
When dienophile 170 and 2-methoxyfuran 58 were refluxed in dichlorobenzene an 
orange compound formed. Unfortunately attempts to purify this product by column 
chromatography were disappointing as the orange material decomposed when 
exposed to silica.  
 
At this point it was deemed acceptable to abandon this Diels-Alder route and move 
towards the next planned approach to the synthesis of the required oxygenated 
naphthoquinones. 
 
3.2. Synthesis of Dehydroherbarin and Unusual Analogues 
The second synthetic route we planned to employ towards building the naphthalene 
skeleton of dehydroherbarin 31 was based on Stobbe condensation methodology, 
followed by a Friedel-Crafts acylative cyclisation reaction to generate the 
naphthalene nucleus. This approach for the assembly of naphthalene systems has 
been implemented with high success as described in the literature7,8.  
 
3.2.1. Naphthalene core construction 
The Stobbe condensation reaction (Scheme 39) commences with a base-promoted 
(usually potassium tert-butoxide) enolization of a succinate ester, that subsequently 
acts as a nucleophile by attacking a ketone or aldehyde producing an 
alkylidenesuccinic acid9. For our purposes, we used diethyl succinate 187 and 
sodium ethoxide as the base, and 2,4-dimethoxybenzaldehyde (172) as the 
electrophile. The reaction was carried out in refluxing tetrahydrofuran for 2 h, 
followed by treatment with hydrochloric acid that is required to first neutralize the 
unreacted sodium ethoxide and protonate the cis-alkylidene acid 188. 
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Scheme 39 
 
The acid 188 was isolated by solvent extraction and immediately subjected to 
conditions for the naphthalene ring-forming process (Scheme 40), which was 
achieved by subjecting 188 to refluxing acetic anhydride in the presence of sodium 
acetate for 3 h. 
 
 
Scheme 40 
 
This Friedel-Crafts acylative procedure resulted in the formation of the desired 
naphthalene skeleton 189 in a good yield of 83 % over two steps. The 1H NMR 
spectrum clearly displayed four meta-coupled (J = 1.1 to 1.9 Hz) aromatic protons 
between 6.5 and 8.8 ppm, confirming the presence of the correctly substituted 
naphthalene core. The ester side chain was also shown to be present by a 
characteristic quartet at 4.42 ppm and accompanying triplet at 1.42 ppm that 
integrated for two and three protons respectively.  The singlet integrating for three 
protons at 2.47 ppm indicated the presence of the acetate group. The 13C NMR 
spectrum contained two carbonyl peaks at 169.3 and 166.3 ppm corresponding to 
both ester carbonyls. The two aromatic methyl ether moieties gave rise to signals at 
55.4 and 55.8 ppm. These findings were in accordance with the literature 
spectroscopic data for this compound7. 
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3.2.2. Pyran ring system assembly 
With the required basic naphthalene core (compound 189) in place, the next stage 
was the construction of the unsaturated pyran ring system. By retrosynthesis the 
isochromene 174 can be disconnected to give the primary alcohol 175 (Scheme 41). 
We believed that 174 could be synthesized from 175 by means of a Wacker 
oxidation reaction. Compound 175 could be obtained from naphthalene 189 by the 
introduction of an allyl group at position C-2 of 189 followed by the reduction of the 
ester group of 189 into a primary alcohol. 
 
 
Scheme 41 
 
3.2.2.1. Allyl chain introduction  
We planned to introduce an allyl moiety at position C-2 of naphthalene 189 via a 
Claisen rearrangement from an adjacent naphthol, but we first needed to remove the 
acetate group and replace it with an allyl chain. Thus, the next step in our synthesis 
was the hydrolysis of the acetoxy functionality in naphthalene 189 under basic 
conditions (Scheme 42). Substrate 189 was dissolved in methanol, treated with an 
aqueous solution of potassium hydroxide and stirred for 6 h at room temperature. 
We also expected the saponification of the ethyl ester group under these conditions. 
On completion of the reaction, organic solvent was removed and the residue was 
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acidified with hydrochloric acid to form the intermediate 190. Naphthalene 190 was 
not purified but was immediately dissolved in dry acetone and heated under reflux in 
the presence of potassium carbonate and excess allyl bromide to produce diallylated 
naphthalene 191 as a yellow solid in an 83 % yield over two steps (Scheme 42). 
 
 
Scheme 42 
 
The 1H NMR spectrum of 191 lacked the ester and acetate signals observed in the 
spectrum of the precursor, but included six new signals that indicated the 
introduction of two allyl groups. A multiplet at 6.14 ppm could be assigned to two 
overlapping vinylic CH groups. The signals for the ester and aryl ether chain vinylic 
CH2 protons were observed at 5.25 ppm and 5.39 ppm respectively. The methylene 
protons of the ether allyl chain were found at 4.74 ppm as a doublet (J = 5.2 Hz), 
which was upfield from the ester allyl chain methylene protons that were assigned as 
a doublet of triplets (J = 5.6 and 1.3 Hz) at 4.86 ppm. Six new signals were visible in 
the 13C NMR spectrum also corresponded to the presence of two allyl groups. Vinylic 
CH signals were observed at 133.2 ppm (OCH2CH=CH2) and 132.6 ppm 
(COOCH2CH=CH2), with the two vinylic CH2 signals upfield at 118.0 ppm 
(OCH2CH=CH2) and 117.6 ppm (COOCH2CH=CH2). Lastly the methylene carbon 
signals were both found in the expected region (50-70 ppm10), at 69.2 ppm 
(OCH2CH=CH2) and 65.5 ppm (COOCH2CH=CH2). 
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With the required aromatic O-allyl substituent in place we could now carry out the 
sigmatropic Claisen rearrangement by heating the aromatic diallyl compound 191 
neat at 180 °C for 18 h (Scheme 43). The reaction proceeded smoothly, affording a 
product (192) with increased polarity, implying the presence of a free naphthol.  
 
 
Scheme 43 
 
The 1H NMR spectrum of the product displayed only three aromatic signals as 
expected, (i.e. one less than the precursor) and the appearance of a D2O 
exchangeable naphthol proton signal at 5.84 ppm. The allyl chain methylene protons 
shifted significantly upfield to 3.94 ppm as the allyl chain had shifted from oxygen to 
carbon which also marked the reaction’s success. The 13C NMR spectrum also 
contained clear evidence of the naphthol allyl group migration, as the C-allyl CH2 
group appeared at 31.7 ppm compared to at 69.2 ppm in the starting material. This 
substantial upfield shift correlates to the allyl moiety being attached to the 
naphthalene ring via a carbon-linkage and no longer via an oxygen-linkage. The 
presence of the naphthol hydroxyl group was observed in the IR spectrum as a 
broad peak at 3539 cm-1. The mass spectrum of 192 confirmed the same molecular 
ion as the parent compound 191 as expected. 
 
The next step towards the synthesis of the isochromene precursor 174 required the 
reduction of the allyl ester functionality. However, we needed to first protect the free 
naphthol moiety. Based on our planned subsequent synthetic conditions, we decided 
that a tert-butyldimethylsilyl (TBDMS) protecting group would suffice for the naphthol 
protection. Furthermore this protecting group is introduced under very mild 
conditions and generally in high yields8. Thus, the treatment of naphthol 192 with 
TBDMSCl, imidazole and catalytic amounts of dimethylaminopyridine (DMAP) in dry 
acetonitrile afforded the protected naphthol 193 in a 93 % yield (Scheme 44). 
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Scheme 44 
 
The 1H NMR spectrum of 193 was very indicative of the reaction’s success. The 
appearance of methyl protons at 0.23 ppm and 1.13 ppm that integrated for six and 
nine protons respectively, together with the disappearance of the naphthol proton at 
5.84 ppm from the starting material, all indicated that the desired product had 
formed. Three new signals were present in the 13C NMR spectrum, which could all 
be assigned to the presence of a tert-butyldimethethylsilyl protecting group. These 
were at 26.1 ppm and -2.9 ppm for the methyl carbon atoms, whereas the tertiary 
carbon atom directly attached to the silicon atom appared at 18.8 ppm. The IR 
spectrum of the product lacked the free hydroxyl stretching frequency present in the 
IR spectrum of starting material 192, whilst the HRMS data confirmed the mass of 
the desired product. 
 
3.2.2.2. Allyl ester reduction and Wacker oxidation 
With the naphthol protected, the reduction of the allyl ester of 193 to a primary 
alcohol could now be carried out. Excess lithium aluminium hydride was used for this 
conversion (Scheme 45), which was smoothly carried out in dry tetrahydrofuran at 
0°C to yield the desired primary alcohol 175 as a clear oil. 
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Scheme 45 
 
The 1H NMR spectrum of 175 was devoid of the three signals that corresponded to 
the allyl ester chain protons, but still contained the three signals of the allyl group at 
C-2 of the naphthalene nucleus. The emergence of a singlet at 4.79 ppm was 
suggestive of a benzylic CH2 which confirmed that the allyl ester group reduction was 
successful. The 13C NMR spectrum also showed the disappearance of three allyl 
ester carbon signals but a new signal at 64.4 ppm was once again indicative of a 
CH2 group adjacent to an aromatic ring system. The ester carbonyl carbon atom was 
also absent in the 13C NMR spectrum. The spectral data of the primary alcohol 
correlate with those reported for this compound8. 
 
With the aromatic primary alcohol 175 in hand, possessing an allyl chain at position 
C-2 of the naphthalene nucleus, the scene was now perfectly set to carry out a 
Wacker oxidation to create a dihydropyran ring. This ring forming process is 
facilitated by a palladium catalyst that enables nucleophilic attack on the proximal 
alkene system11. The exact mechanistic details of this reaction are still under 
investigation, but its major features are generally accepted11 as shown in Scheme 
46. The alkene pi orbitals in naphthalene 175 coordinate to the palladium catalyst to 
form palladium-alkene pi-complex 194. Next, one of the chloride atoms is possibly 
replaced by a water molecule to give complex 195. The syn addition of water to the 
alkene forms a (β-hydroxyalkyl)palladium complex such as 196. The β-hydride 
elimination process gives enol 197 that tautomerizes to ketone compound 198. The 
primary alcohol group of 175 is poised for the formation of a six-membered pyran 
ring, prompting the ketalisation of ketone 198. This event is immediately followed by 
a dehydration reaction to afford pyran ring-containing naphthalene compound 174. 
This reductive elimination of 196 forms Pd(0) and hydrochloric acid. The sacrificial 
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oxidant CuCl2 reoxidizes Pd(0) to Pd(II) in situ whilst Cu(II) is reduced to Cu(I). 
Molecular oxygen serves as the terminal oxidizing agent for the reaction and it 
maintains the active catalytic system by reoxidizing Cu(I) to Cu(II). 
 
 
Scheme 46 
 
The Wacker oxidation on our substrate 175 was performed in a combined 
dimethylformamide and water solvent system with PdCl2 (0.1 equivalent) catalyst 
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and CuCl2 (1.0 equivalent) under an oxygen atmosphere. The mixture was stirred 
vigorously for a much longer duration (24 h) compared to normal reaction times12 (2 
h) due to the low solubility of the strongly non-polar species 175. The isochromene 
product 174 was afforded in a moderate yield of 52 %, with the remainder of the 
material being unreacted starting material.  
 
Given that isochromene compound 174 was the only isolated product, and with no 
expected ketone intermediate species 198 present, we propose that the Wacker 
oxidation reaction of our substrate proceeds via a different path compared to the one 
presented in Scheme 46. The strongly nucleophilic primary benzylic alcohol oxygen 
atom undergoes an intramolecular attack (Scheme 47) of the electrophilic palladium-
alkene pi-complex 194 to yield intermediate 199 which undergoes β-hydride 
elimination to give 200. The alkene group of compound 200 rearranges to a lower 
energy isomer, which is the isochromene 174. It should be noted that a similar 
reaction was reported by S. Pelly in her PhD thesis9. 
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Scheme 47 
 
The structure of the pyran ring containing compound 174 was confirmed by the 
spectral data. The 1H NMR spectrum of 174 lacked the three C-2 allyl chain proton 
signals but instead displayed the isochromene proton (at C-4) and isochromene 
methyl protons (at C-3) at 6.02 ppm and 2.05 ppm respectively. The rest of the 1H 
NMR spectrum was concordant with that of the parent molecule, affirming that the 
protected naphthalene system remained intact. In the 13C NMR spectrum the 
presence of a methyl carbon atom at 19.2 ppm, methine carbon at 97.8 ppm and C-3 
considerably upfield at 156.5 ppm confirmed the existence of the isochromene 
system. There was also a visible downfield shift of the benzylic CH2 group from 64.4 
ppm in the parent compound to 69.3 ppm in the product. The HRMS data for the 
product was found to be 387.1984 amu which was in accordance with the calculated 
value of 387.1992 amu for a molecular formula of C22H31O4Si. 
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3.2.3. Naphthoquinone formation 
Now that the naphthalene core and pyran ring system of dehydroherbarin 31 were 
constructed, the last phase was to oxidize the naphthalene system to a 
naphthoquinone. This first required the removal of the TBDMS protecting group, 
followed by the implementation of a selective para-oxidation reagent. 
 
3.2.3.1. tert-Butyldimethylsilyl deprotection  
The selective removal of a TBDMS alcohol protecting group is a fairly trivial 
procedure13 which simply entails treating the TBDMS protected compound 174 with 
tetra-n-butylammonium fluoride in dry tetrahydrofuran at ambient temperature 
(Scheme 48). The expected deprotected phenol 173 was isolated as a white 
crystalline solid that displayed increased polarity on silica gel TLC compared to the 
starting material. 
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Scheme 48 
 
The 1H NMR spectrum of 173 closely resembled that of the parent compound 174 as 
expected, but lacked the two signals corresponding to the TBDMS group. A new 
naphthol proton signal emerged at 7.94 ppm. The existence of this moiety was also 
supported by the hydroxyl stretching frequency at 3348 cm-1 visible in the IR 
spectrum. The 13C NMR spectrum of 173 also confirmed that the TBDMS removal 
was successful as the three signals responsible for this group were absent. 
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3.2.3.2. Salcomine naphthoquinone oxidation  
With compound 173 available, the last step was the oxidation of the naphthol to a 
para-naphthoquinone as found in the target compound dehydroherbarin 31 (Scheme 
49).  
 
Scheme 49 
 
We envisaged that this oxidation reaction could be achieved by employing the 
salcomine catalyst 109, N,N’-bis-(salicylidene)ethylenediaminocobalt(II). This 
commercially available oxidation reagent has been shown in the literature to 
successfully carry out this process on a variety of naphthol systems7,14-16.  However, 
the desired oxidation reaction did not occur with our substrate 173. Instead, the 
salcomine catalyst 109 facilitated the oxidation of the enol ether of the pyran ring to 
produce dicarbonyl 201 (Scheme 50). This was an unexpected result as the catalyst 
109 has never before been shown to perform an oxidation reaction of this type. The 
reaction was then carried out in dimethylformamide, which is another solvent used 
for salcomine oxidations, but unfortunately this led to the same undesired product 
201 being formed.  
 
 
Scheme 50 
 
We postulated that the isochromene ring, which is a “disguised” enol-ether system, is 
electron rich and thus more susceptible to oxidation. The acetate and aldehyde 
functional groups in the product support this idea, implying that an “ozonolysis-like” 
reaction had occurred at the alkene enol ether moiety. 
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The spectroscopic data of 201 was markedly different to that of the expected product 
dehydroherbarin 31 and starting material 173. The 1H NMR spectrum of 201 
contained three naphthalene protons as found in the precursor compound, depicting 
that the para-oxidation did not occur as this would involve the disappearance of one 
of these aromatic signals. An acetate methyl signal appeared at 2.09 ppm, as well as 
an aldehyde peak at 10.26 ppm. The naphthol hydrogen displayed a significant 
downfield shift to 13.49 ppm (also with improved signal intensity) owing to hydrogen 
bonding to the adjacent aldehyde group. In the 13C NMR spectrum, the absence of 
the pyran ring was confirmed by the lack of the three peaks contributing to the 
dehydrated isochromene system. The appearance of the acetate methyl carbon 
atom shift at 21.0 ppm and two carbonyl signals as 170.4 ppm and 195.2 ppm 
reinforced our proposed structure of product 201. The IR spectrum contained a 
broad hydroxyl stretching band and two sharp carbonyl bands at 1737 cm-1 and 1620 
cm-1, which correlate with compound 201. Fortunately, we were able to crystallize the 
salcomine oxidation product, and hence X-ray crystallography confirmed the 
structure of the compound (Figure 9). 
 
Figure 9 
 
3.2.3.3. Ceric ammonium nitrate naphthoquinone oxidation  
Since the salcomine oxidation reaction was unsuccessful we opted to test other 
selective para-oxidizing agents. Ceric ammonium nitrate (CAN) is commonly used 
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for the demethylation of aromatic para-dimethyl ether systems2. This reagent has 
also been demonstrated to oxidize electron-rich naphthols to their respective 
naphthoquinone equivalents17. Thus, we attempted the desired oxidation reaction 
shown in Scheme 49 by employing CAN as the oxidant. The reaction was carried 
out in an acetonitrile/water solvent system, to afford a product that we initially 
believed to be dehydroherbarin 31, but was later spectroscopically determined to be 
naphthoquinone 202 (Scheme 51).  
 
 
Scheme 51 
 
Our initial confusion regarding the reaction was that both the 1H NMR and 13C NMR 
spectral data of compound 202 were very similar to those of dehydroherbarin 3118. 
The 1H NMR spectrum of 202 contained only two major differences to that of parent 
compound 173: (i) there are two aromatic protons present that display meta-coupling 
(J = 2.4 Hz) which implies that oxidation to the naphthoquinone had worked and (ii) 
the isochromene methyl group shifted upfield by 0.4 ppm to 1.57 ppm. These 
findings were in close accordance with dehydroherbarin 31. The hydrogen atom at 
C-4 appeared at 6.00 ppm. The quinone functionality was clearly observed in the 13C 
NMR spectrum of 202 as carbonyl signals appeared at 183.3 ppm and 180.6 ppm, 
likewise in dehydroherbarin 31. The only two considerable irregularities between the 
13C NMR spectra of naphthoquinone 202 and dehyrohebarin 31 were the shifts of C-
3 (95.9 ppm in 202 and 161.5 ppm in 31) and C-4 (73.3 ppm in 202 and 93.8ppm in 
31). Overall this data suggested that the structure of the product was similar to that 
of the target compound, but contained substantial structural differences across the 
alkene functionality. 
 
An X-ray crystal structure of our product 202 (Figure 10) gave the conclusive 
evidence we required.  
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Figure 10 
 
The crystal structure confirmed that the oxidation of the phenolic moiety to a quinone 
was successful, but there was also evidence that the enol ether ring system had 
once again undergone a reaction. The isochromene functionality was now absent 
and a nitrate moiety and a hydroxyl functionality had added across the alkene. 
 
This bizarre reaction was undesired but fascinating none-the-less. There was some 
literature precedence19 for this “nitration” reaction and the mechanistic postulate is 
outlined in Scheme 52. We propose that the nitration/hydration process occurs 
before oxidation to the quinone. The first step is the single electron oxidation of the 
alkene of 173 by CAN which furnished radical cation species 203. It is reasonable to 
assume that the radical centre becomes hydrated to form the hemiacetal 204. The 
cationic site of 204 could be quenched by a nitrate anion from CAN to yield 
intermediate 205, which then undergoes a formal oxidation by CAN of the naphthol 
to form the isolated product 202.  
 
Compound 202 was found to be stable to mildly acidic solutions and could be stored 
at room temperature without any traces of decomposition. 
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Scheme 52 
 
3.2.4. Tetraoxygenated naphthalene system formation 
Given our inability to oxidize naphthol 173 to our target naphthoquinone, 
dehydroherbarin 31, we decided to test an alternative synthetic approach. The 
oxidation pattern in dehydroherbarin 31 is a 1,4,6,8-tetraoxygenated naphthalene 
core. Thus a logical synthetic plan would be to introduce the required oxygen 
substitution pattern of the naphthalene nucleus earlier in the synthesis, since this 
had proven to be a challenging final step. 
 
Hence the tetraoxygenated isochromene 206 could be disconnected to aromatic allyl 
ester 207 (Scheme 52). Compound 207 we hoped could be synthesized from 
naphthalene 192 where extra oxygenation para to the naphthol would be required. 
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Scheme 52 
 
3.2.4.1. Phenyliodine bis(trifluoroacetate) para-methyl-ether insertion 
It was previously mentioned (see section 2.1.4.1) that PIFA 208 (Figure 11) in 
methanol solvent enabled the regioselective addition of a methoxy group into a 
naphthol system20. Thus we subjected our naphthol 192 to these reagents and 
effectively presumably formed the pseudohydroxyquinone 209 (Scheme 53). This 
unstable compound was not isolated and was immediately exposed to sodium 
ethoxide base for 20 min at ambient temperature to afford the desired aromatized 
tetraoxygenated naphthalene system 210 in a 60 % yield over two steps. 
 
 
Figure 11 
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Scheme 53 
 
The 1H NMR spectrum of naphthalene 210 showed the emergence of a new 
aromatic methyl ether signal at 3.82 ppm and naphthol proton signal at 5.58 ppm. 
These observations combined with the disappearance of the C-8 aromatic hydrogen 
signal strongly supported the notion of the para-methyl-ether insertion being 
successful. The 13C NMR spectrum also confirmed the presence of another methoxy 
group on 210 as the data revealed three aromatic methoxy substituents in the 55-65 
ppm range and similarly there were now four aromatic carbon-oxygen bonded atoms 
in the 145-158 ppm region. The IR spectrum showed the presence of a hydroxyl 
functional group at 3257 cm-1. The HRMS data for compound 210 was in agreement 
with its calculated mass. 
 
The accepted mechanism for this process is shown in Scheme 5420,21. Treatment of 
192 with PIFA 208 affords intermediate 211 which then undergoes nucleophilic 
attack by a molecule of methanol at the para position. This nucleophilic attack is 
followed by the elimination of the hypervalent iodine substituent at the naphthol 
position to form pseudohydroxyquinone 209. The tautomerization of 209 to naphthol 
210 was achieved with sodium ethoxide base (or potassium tert-butoxide). 
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Scheme 54  
 
3.2.4.2. Phenol methylation 
Having succeeded in making the desired tetraoxygenated core of dehydroherbarin 
31, the next step was to protect the free naphthol as a methyl ether, as this “reactive” 
functional group may be problematic with subsequent synthetic steps that use metal 
ions. The methylation of a naphthol moiety is a simple process and the naphthol 210 
was refluxed in dry acetone in the presence of potassium carbonate and 
dimethylsulfate to afford the aromatic methyl ether 212 in a high yield of 89 % 
(Scheme 55).  
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Scheme 55 
 
The 1H and 13C NMR spectra of 212 were very similar to that of compound 210. The 
1H NMR spectrum of 212 contained a total of four methyl ether signals at 3.95 ppm, 
3.92 ppm, 3.86 ppm and 3.84 ppm, each accounting for three protons. The absence 
of the hydroxyl proton signal was also noted in the 1H NMR spectrum, as well as in 
the IR spectrum. The presence of four aromatic methoxy signals was also evident in 
the 13C NMR spectrum as four methyl ether carbon atoms were observed in the 55-
64 ppm range. The HRMS data for compound 212 confirmed the existence of the 
newly installed aromatic methyl ether. 
 
3.2.5. Pyran ring development 
With our new improved synthetic plan being successful thus far, we could now 
progress towards assembling the isochromene ring. The methodology we planned to 
use for the construction of the pyran ring would be the same as before. Therefore, 
we needed to simply reduce the allyl ester to a primary alcohol followed by a Wacker 
oxidation to allow for ring closure. 
 
3.2.5.1. Allyl ester group reduction and Wacker oxidation 
The lithium aluminium hydride reduction of the allyl ester naphthalene 212 was 
initially performed in dry tetrahydrofuran (as previously done) but no reaction 
occurred. Changing the solvent to diethyl ether proved fruitful as primary alcohol 
naphthalene 213 was isolated as a white crystalline solid in a yield of 84 % (Scheme 
56). 
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Scheme 56 
 
The NMR spectroscopic data of naphthalene 213 contained many similar traits to 
those seen in the first reduction reaction which formed the related compound 175. 
The 1H NMR spectrum of 213 lacked the three signals originating from allyl ester 
chain hydrogens, but contained a benzylic CH2 which strongly implied that the 
reduction of the allyl ester group had occurred. The emergence of a hydroxyl 
stretching band at 3481 cm-1 in the IR spectrum reinforced this credence. In the 13C 
NMR spectrum the disappearance of three allyl ester carbon atoms was evident, as 
was the appearance of a CH2 at 57.4 ppm was seen. The identity of the benzylic CH2 
functionality was further confirmed by a DEPT 90 NMR experiment. The HRMS data 
for naphthalene 213 was in agreement with the calculated value for this compound. 
 
The next step towards the pyran ring assembly was the Wacker oxidation (see 
Scheme 47). Much to our delight, this reaction worked exactly the same as carried 
out before, but with shorter reaction times (2 h) as the primary alcohol 213 displayed 
high solubility in the solvent system (Scheme 57). The isochromene 214 had a lower 
polarity on TLC compared to the starting material 213 as expected. 
 
 
Scheme 57 
 
The 1H NMR spectrum of 214 was remarkably simpler than that of the precursor 213 
and the C-2 allyl chain proton signals were clearly absent. The unsaturated pyran 
ring protons were observed at 1.99 ppm (CH3), 5.27 ppm (C-1 CH2 protons) and 5.94 
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ppm (C-4 CH proton). Four aromatic methyl ether signals and two aromatic 
naphthalene protons were also present which implied that the naphthalene core was 
intact. The 13C NMR spectrum of 214 contained three new peaks which 
corresponded to the existence of the isochromene ring system. These were (i) C-3 
atom shift at 156.1 ppm, (ii) the C-4 methine carbon at 95.8 ppm and (iii) methyl 
atom signal at 21.0 ppm. The HRMS data for the product was found to be 339.1209 
amu which was in accordance with the calculated value of 339.1208 amu for 214. 
 
3.2.6. Dehydroherbarin formation via para-methyl ether oxidation 
The naphthalene compound 214 possessed both the tetraoxygenated pattern and 
pyran ring system found in dehydroherbarin 31. The last step that remained was to 
convert 214 into dehydroherbarin 31 by the selective oxidative demethylation of the 
aromatic para-methyl ethers of the substituted naphthalene (Scheme 58).  
 
 
Scheme 58 
 
Based on literature precedence, there were three possible reagents/reactions that 
could facilitate this step. These were: (i) CAN22, (ii) silver(II) oxide23 and (iii) PIFA24. 
The CAN oxidation of naphthalene 214 was executed as before in an 
acetonitrile/water reaction medium, but unfortunately this led to the formation of an 
uncharacterisable mixture of products (Scheme 59)22. No trace of compound 202 
was observed in the analysis of the crude reaction mixture. 
 
 
Scheme 59 
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Treatment of the naphthalene 214 with silver(II) oxide and nitric acid in dioxane 
solvent23 also proved futile as the result of this reaction was an array of unidentifiable 
products (Scheme 60). 
 
 
Scheme 60 
 
With the previous two oxidations being unsuccessful, the last procedure to test 
employed the hypervalent iodine reagent PIFA 208. In this process, when PIFA 208 
is used in an acetonitrile/water solvent system it effectively functions as an oxidizing 
agent24. Naphthalene 214 readily dissolved in the reaction medium and was reacted 
with 1.5 equivalents of PIFA 208 over a duration of 2 h (Scheme 61). The result of 
this reaction was the successful formation of our target compound dehydroherbarin 
31, albeit in a low yield of 25 %.  
 
 
Scheme 61 
 
Since dehydroherbarin 31 is a natural product, we validated the success of its 
synthesis by comparing our NMR spectroscopic data with the literature spectral 
information of this naphthoquinone18. The 1H NMR spectrum of dehydroherbarin 31 
is essentially the same as the precursor 214 except that the 1H NMR spectrum of 
dehydroherbarin 31 only contains two aromatic methyl ether peaks at 3.92 ppm and 
3.95 ppm. In the 13C NMR spectrum of 31 two quinone carbonyl signals are visible 
downfield at 180.9 ppm and 182.3 ppm, which confirm the presence of the para-
quinone motif. This spectrum is also marked by the disappearance of two methoxy 
carbon atom peaks, adding to the notion that the selective oxidative demethylation 
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reaction had worked. This represents the third reported synthesis of dehydroherbarin 
31. 
 
The proposed mechanism of this PIFA 208 oxidative demethylation process is 
displayed in Scheme 622. Intermediate 215 depicts how PIFA 208 acts as an 
electron sink for the dimethyl ether aromatic system, with the resultant loss of 
OCOCF3. The phenyliodonio moiety then functions as a good leaving group as 
shown in intermediate 216, which then undergoes a nucleophilic addition reaction 
with water at the newly formed methyl oxonium functionality. A second water 
molecule adds to the alternate methyl oxonium group, followed by the loss of 
methanol overall from intermediate 217 to afford the intermediate shown in Scheme 
62 which led to dehydroherbarin 31. It can also be assumed that hydrophobic 
aggregation between the iodine (III) compound and the substrate encourages the 
reaction progression in an aqueous medium. 
 
Scheme 62 
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The PIFA oxidation of naphthalene 214 was repeated in order to obtain more 
dehydroherbarin 31. This process was carried out on a larger scale and more dilute 
compared to the previous reaction conditions. This “dilute” oxidative demethylation 
reaction led to the formation of the unusual naphthoquinone diol 218 (Scheme 63) 
which was isolated as a brown amorphous solid in a low yield of 24 %. This result 
was unexpected, as the initial reaction (done under more concentrated conditions 
Scheme 61), afforded only the desired product 3. The effect of scaling this reaction 
up has not been further evaluated, and is a case for future work.  
 
 
Scheme 63 
 
It was quite interesting that the NMR spectra of diol compound 218 very closely 
resembled the data for the unusual compound 202. This was not surprising given the 
single structural difference between these two naphthoquinones. The 1H NMR 
spectrum of 218 varied from the proton spectrum of 202 in only a single aspect: that 
is, that the hydrogen atom shift at C-4 in 218 was significantly more upfield at 4.35 
ppm. The remainder of the 1H NMR suggested that the same naphthoquinone 
skeleton found in 202 was also present in naphthoquinone 218. The 13C NMR 
spectrum of 218 contained the quinone carbonyl signals at 181.1 ppm and 182.8 
ppm. In the IR spectrum, these ketone carbonyls were also observed at 1725 cm-1 
and 1649 cm-1. The distinctive hemiacetal carbon peak at 95.9 ppm and adjacent 
methyl carbon shift at 24.5 ppm were also seen in the 13C NMR spectrum. 
Confirmation of our proposed structure of 218 was provided by the HRMS analysis.  
 
The stereochemistry of the alcohol-containing carbon atoms in naphthoquinone 218 
was not clearly distinguishable using NMR techniques and future work would 
possibly entail aquiring this information by crystallographic means. 
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3.3. Synthesis of Anhydrofusarubin 
The next stage in this PhD project was to apply the newly developed methodology 
from the synthesis of dehydroherbarin 31 towards the more complex 
naphthoquinone, anhydrofusarubin 26.  Comparing dehydroherbarin 31 and 
anhydrofusarubin 26 on a structural basis, there are two substantial differences 
(Figure 12): (i) anhydrofusarubin 26 has a pentaoxygenated pattern on the 
naphthalene framework and (ii) the second ring system of 26 contains a para-
substituted hydroquinone functional group. These structural variations, when 
considered from a synthetic viewpoint imply the following adaptations: (i) the starting 
material should possess the required first-ring oxygenated substitution arrangement 
and (ii) the para-quinone oxidation and adjacent hydroquinone formation should be 
conducted at the end of the synthesis, given their highly reactive and thus sensitive 
nature. 
 
 
Figure 12 
 
The planned synthesis of the pyran ring of 26 will be the same as used in 31, whilst 
the PIFA methyl-ether insertion shall also be attempted to construct the 
pentaoxygenated naphthalene framework. 
 
3.3.1. Naphthalene nucleus assembly 
The construction of the naphthalene segment of anhydrofusarubin 26 should follow 
the same reactions as previously employed (see section 3.2.1) but requires the 
starting material 2,4,5-trimethoxybenzaldehyde 178, which inherently contains the 
desired oxygen substitution pattern of one of the rings in the final product. Therefore 
2,4,5-trimethoxybenzaldehyde 178 was subjected to a Stobbe condensation with 
diethyl succinate 187 and sodium ethoxide base (Scheme 64) in boiling 
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tetrahydrofuran for 2 h. The reaction mixture was then made acidic, and the 
intermediate was isolated by extraction and immediately reacted with anhydrous 
sodium acetate in refluxing acetic anhydride to facilitate the required Friedel-Crafts 
acylative process. This afforded the naphthalene 162 in a yield of 82 % over two 
steps. 
 
Scheme 64 
 
The 1H NMR signals of 162 compared very well with those of naphthalene 189, save 
for two differences. There were two aromatic methyl ether signals at 3.81 ppm and 
3.98 ppm that accounted for nine protons, which equated to three methoxy groups 
residing on the molecule. The aromatic region only displayed three naphthalene 
proton signals as expected. Naphthalene 162 is not a novel compound and 
spectroscopic data compared well with the existing literature data,1, 23 confirming that 
the reaction had been successful. 
 
3.3.2. Allyl chain introduction and rearrangement 
With the naphthalene core in hand, the required functional group manipulations 
could be performed to allow for the formation of the third ring, the unsaturated pyran. 
 
3.3.3.1. Saponification and deacetylation with subsequent allylation  
These steps are the same in principle as those dicussed in section 3.2.2.1: base 
induced saponification and deacetylation of 162 to form intermediate 219, followed 
by O-allylation of the resulting naphthol. Thus, 162 was dissolved in methanol, and 
exposed to aqueous potassium hydroxide (Scheme 65). Upon complete conversion 
of starting material, the reaction mixture was acidified and intermediate 219 isolated 
by filtration. The crude 219 residue was dissolved in acetone and refluxed in the 
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presence of excess allyl bromide and potassium carbonate. The diallylated 
naphthalene 220 was isolated in an 84 % yield over two steps. 
 
 
Scheme 65 
 
The NMR spectral data for compound 220 validated that the naphthalene now 
contained two allyl chains that replaced the former ethyl ester group and acetate 
substituents. The ether bound allyl chain introduced three new signals in the 1H NMR 
spectrum at 4.71 ppm (OCH2CH=CH2), 5.32-5.35 ppm (OCH2CH=CH2) and 6.15-
6.27 ppm (OCH2CH=CH2). The allyl ester similarly also contributed to the 
emergence of three peaks at 4.87 ppm (COOCH2CH=CH2), 5.41-5.57 ppm 
(COOCH2CH=CH2) and 5.97-6.28 ppm (COOCH2CH=CH2, overlapped with 
OCH2CH=CH2). The 13C NMR spectrum of 220 lacked the four peaks found in the 
precursor 162 that originated from the acetate and ethyl ester functionalities, but six 
new signals were observed for the newly installed allyl ester and allyl ether groups. 
The HRMS for naphthalene 220 was in agreement with the calculated mass. 
 
3.3.3.2. Allyl chain rearrangement  
The repositioning of the phenolic allyl ester moiety 220 to C-2 could now be tested 
by heating the substrate at high temperature. It was found that the Claisen 
rearrangement of 220 required a temperature of 190 °C. The reaction progress was 
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difficult to monitor as the starting compound 220 and product 221 possessed the 
same Rf on TLC, but fortunately 1H NMR spectroscopic analysis of the crude mixture 
proved useful. 
 
 
Scheme 66 
 
Since this reaction was performed previously on substrate 191, we were aware of 
the two main changes to look for in data: that is the presence of a free naphthol and 
an allyl ester group situated at C-2. The IR spectrum contained a broad hydroxyl 
stretching band at 3280 cm-1 which was the first sign that the reaction had worked. 
The 1H NMR spectrum of Claisen product 221 further illustrated this by depicting 
three informative changes, (i) signals from the C-allyl group methylene protons 
emerged upfield at 3.89 ppm, (ii) the C-2 aromatic proton peak disspeared and (iii) 
the naphtholic proton signal appeared at 10.08 ppm. The signal arsing from the allyl 
CH2 substituent had moved upfield to 30.1 ppm, confirming the new carbon-carbon 
bond formation as seen in the 13C NMR spectrum. Once again the HRMS analysis 
supported the structure of 221. 
 
3.3.3. Pyran ring construction: test of reactions on intermediate species 
The naphthalene 221 is an important intermediate in the synthesis of 
anhydrofusarubin 26. At this stage, we planned to form the pyran ring as before (see 
Scheme 57) to test the viability of these steps on the new substrate before 
introduction of additional oxygenation on the second ring. In order to achieve this, we 
were required to protect the naphthol, reduce the allyl ester to the benzylic alcohol 
223 and then employ a Wacker oxidation on 223 to hopefully yield the target 169 
(Scheme 67). 
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Scheme 67 
 
3.3.3.1. Naphthol methylation  
The naphthol 221 was methylated with dimethyl sulfate using potassium carbonate 
as a base to afford the aromatic tetramethyl ether 222 in a 90 % yield (Scheme 68). 
 
 
Scheme 68 
 
The IR spectrum of 222 was devoid of a hydroxyl stretching band, while the 1H NMR 
spectrum contained no naphthol signal. A fourth aromatic methyl ether signal was 
observed in the 1H NMR spectrum at 4.02 ppm, whilst the 13C NMR spectrum also 
displayed a total of four aromatic methyl ether carbon atom signals in the 56 ppm to 
63 ppm range. The HRMS data supported the presence of the additional methoxy 
group. 
Chapter 3: The Synthesis of Dehydroherbarin and Anhydrofusarubin 
 
 87 
 
3.3.3.2. Allyl ester reduction and Wacker oxidation  
With the naphthol protected, the allyl ester of 222 could now be promptly reduced. 
The effective reducing agent lithium aluminium hydride smoothly facilitated this step 
by converting the ester group of 222 to its respective primary alcohol to yield product 
223 (Scheme 69). 
 
 
Scheme 69 
 
Naphthalene 223 is a known compound and the NMR spectroscopic data 
corresponded to the literature values24. The 1H NMR of 223 showed the appearance 
of the benzylic methylene protons at 4.76 ppm, with the expected loss of three allyl 
ester chain signals and the carbonyl signal. The DEPT 90 NMR experiment verified 
that the peak at 63.6 ppm in the 13C NMR spectrum was due to a CH2 moiety. 
 
Now that the benzylic alcohol 223 was available we reacted this starting material 
under Wacker oxidation conditions (Scheme 70) and gratifyingly the isochromene 
system was formed as a white crystalline product 169. 
 
 
Scheme 70 
 
The 1H and 13C NMR spectroscopic data showed the disappearance of the C-2 allyl 
chain, but contained evidence of the isochromene portion of 169. The pyran ring 
protons in the 1H NMR spectrum were observed at 2.00 ppm (CH3), 5.12 ppm (C-1 
methylene protons) and 6.09 ppm (C-4 methine proton). Similarly in the 13C NMR 
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spectrum, the isochromene ring carbon atoms emerged in the typical regions, at 20.1 
ppm (CH3), 156.1 ppm (C-3) and 96.0 ppm (C-4). The HRMS data for the product 
was found to be 339.1207 amu which was in line with the calculated value of 
339.1208 amu for 169. 
 
Now that we had tested methodology on naphthalene 221, we could proceed to 
implement this methodology on the pentaoxygenated framework which would lead to 
anhydrofusarubin 26. However, this first required the preparation of the 
pentaoxygenated naphthalene core. 
 
3.3.4. Synthesis of pentaoxygenated naphthalene system by PIFA methyl ether 
insertion  
PIFA 208 in methanol would again be utilized to introduce the methyl ether motif 
onto a naphtholic system (see section 3.2.4.1). The starting material 221 was 
dissolved in methanol and treated with 1.3 equivalents of PIFA 208 for 10 min to 
produce pseudohydroxyquinone 224 (Scheme 71). This intermediate was 
immediately exposed to sodium ethoxide to yield the tautomerized product 225 as an 
orange amorphous solid. The success of this reaction was a considerable step 
forward towards synthesizing anhydrofusarubin 26, as the assembly of the desired 
pentaoxygenated naphthalene 225 was now achieved. 
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Scheme 71 
 
Analysis of the 1H NMR spectrum of 225 showed the appearance of a total of four 
aromatic methyl ether signals between 3.78 ppm and 3.98 ppm, and the 
disappearance of the aromatic proton at C-8. The naphthol signal was still visible at 
10.24 ppm and also gave its distinctive stretching band at 3215 cm-1 in the IR 
spectrum. The 13C NMR spectrum showed four aromatic carbon-oxygen bonded 
atoms in the expected range of 145-154 ppm. Thorough examination of the 
accompanying two-dimensional spectra (specifically HMBC and HSQC) revealed 
that a fifth aromatic carbon-oxygen bonded atom was situated unusually upfield at 
115.1 ppm, overlapped with the allyl group terminal alkene protons. The increased 
mass of product 225 compared to its precursor 221 was accurately determined 
utilizing HRMS. 
 
3.3.5. Synthesis of pyran ring on pentaoxygenated naphthalene core 
The next three steps of the anhydrofusarubin synthesis follow the same procedures 
tested in section 3.3.3. Thus we planned to methylate the naphthol, reduce the allyl 
ester to a benzylic alcohol and then convert the product to the required isochromene. 
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3.3.5.1. Naphtholic methylation  
Naphthol 225 was efficiently methylated to afford 226 in an 81% yield by exposure to 
dimethyl sulfate and potassium carbonate in refluxing acetone (Scheme 72). 
 
 
Scheme 72 
 
The 1H NMR spectrum of 226 contained five aromatic methyl ether signals at 3.73 
ppm, 3.75 ppm, 3.77 ppm, 3.93 ppm and 3.95 ppm. The 13C NMR spectrum clearly 
depicted the existence of five aromatic methyl ether moieties in the range of 56.7 
ppm to 63.8 ppm. The presence of the pentaoxygenated naphthalene was again 
confirmed by five aromatic carbon-oxygen bonded atoms, with the unusual 
positioning of one of these again at 115.8 ppm. 
 
3.3.5.2. Primary alcohol formation and Wacker oxidation  
Reduction of the allyl ester group of naphthalene 226 to 227 was achieved through 
treatment with lithium aluminium hydride in diethyl ether for 2 h (Scheme 73). 
Purification of the resultant primary alcohol 227 proved problematic, and as such it 
was not purified further and was subsequently subjected to a palladium-catalyzed 
Wacker oxidation. The reaction time was 2 h with a constant stream of molecular 
oxygen bubbling through the solution. The result of these two processes was the 
formation of the isochromene 228 in a somewhat disappointing yield of 49 %. 
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Scheme 73 
 
The 1H NMR spectrum of 228 provided a very clear image of the newly “simplified” 
naphthalene system. There were nine signals in this spectrum, five accounting for 
aromatic methyl ether groups (3.74-3.99 ppm), one for the remaining naphthalene 
proton (6.64 ppm), and three for the pyran ring [2.00 ppm (CH3), 5.27 ppm (C-1 CH2) 
and 6.03 (C-4 CH)]. The 13C NMR spectrum contained the five aromatic carbon-
oxygen bonded atom peaks at 136.8 ppm, 142.6 ppm, 147.3 ppm, 150.0 ppm and 
153.3 ppm. The allyl chain carbon signals were absent. The isochromene ring 
signals emerged in close proximity to those found in the previous pyran-ring 
containing compounds (sections 3.2.2.2, 3.2.5.1. 3.3.3.2).  
 
3.3.6. Anhydrofusarubin synthesis via regiospecific and regioselective 
demethylation reactions 
The bulk of the synthesis towards anhydrofusarubin 26 had now been completed 
and all that remained was the para-oxidation, to produce naphthoquinone 229, 
followed by subsequent demethylation of the remaining aromatic methyl ethers to 
form the naphthazarin moiety 26 (Scheme 74). 
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Scheme 74 
 
3.3.6.1. Quinone introduction through silver (II) oxide oxidative demethylation 
Silver(II) oxide has been shown to be an effective reagent for the oxidation of 
aromatic dimethyl ethers and has preferential oxidative selectivity towards the most 
electron-rich ring in a given system25. Thus, we postulated that the most electron-rich 
ring in naphthalene 228 would be the ring bearing the three methoxy substituents 
and should provide the desired quinone product if reacted with silver(II) oxide in the 
presence of nitric acid. Following this hypothesis, we dissolved 228 in 1,4-dioxane 
with 5.0 equivalents of silver(II) oxide that remained as a colloidal suspension 
(Scheme 75). Concentrated nitric acid (6 M) was added dropwise to the mixture 
which was reacted for 5 min, resulting in the formation of an intensely coloured 
solution. Work-up of the reaction and purification by column chromatography led to 
the isolation of what we assumed were two quinone products, the first as an orange 
crystalline compound and the second as a dark red amorphous solid. 
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Scheme 75 
 
NMR spectroscopic analysis of both compounds confirmed that two aromatic methyl 
ethers were now absent in both products. The data also confirmed that the 
remainder of the naphthalene systems were intact. However, the problem that arose 
was that these naphthoquinones were isomers (both had the same HRMS values) of 
each other, with one being the desired para-quinone 229 and the other presumably 
an unwanted ortho-quinone 230, neither of which could be accurately and 
unambiguously assigned using NMR spectroscopic techniques (including all types of 
two dimensional experiments). Luckily, given the crystalline nature of the major 
product, we were able to grow good quality crystals that allowed for the required 
structural elucidation by X-ray crystallography. Figure 13 shows that the first product 
isolated was indeed the target para-quinone 229. Therefore, by process of 
elimination, the minor red product was labelled as the ortho-quinone 230. Figure 14 
shows the colour of these intensely coloured compounds as a solution in 
dichloromethane. 
 
Now knowing the exact structures of the two products, the NMR spectra can be 
analysed in more detail. The only difference in the 1H NMR spectra of the parent 
compound 228 and naphthoquinone products 229 and 230 is the loss of two 
aromatic methyl ether peaks, accounting for six protons in the starting material. 
Interestingly, all three methoxy signals in the para-quinone 229 are in close proximity 
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3.3.6.2. Anhydrofusarubin formation by boron trichloride selective 
demethylation 
The last step that remained in our synthetic route was the selective deprotection of 
two aromatic methyl ethers. This transformation was successfully achieved by 
employing boron trichloride, a Lew
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the selectivity of this reagent. Naphthoquinone 
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trichloride. This reaction was eventually warmed to room temperature and quenched 
with water. Purification of the reaction mixture yielded anhydrofusarubin 
purple solid (Figure 15). 
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ppm. These changes in relation to parent quinone 229 provided evidence for the 
presence of the dihydroquinone moiety. The 13C NMR spectrum contained two 
signals resulting from the para-quinone motif at 178.0 ppm and 182.8 ppm, and only 
one peak due to a methyl ether carbon atom. The recorded melting point range was 
195-196 °C which was in close accordance with the reported literature value of 199-
202 °C29. The HRMS data for anhydrofusarubin 26 was found to be 288.0633 amu 
which was in line with the calculated value of 288.0635 amu for our molecular 
formula of C15H12O6. This represents the first total synthesis of anhydrofusarubin 26. 
 
3.4. Concluding Remarks Pertaining to the Synthesis of 
Dehydroherbarin and Anhydrofusarubin 
Using a novel approach to constructing highly oxygenated naphthoquinones, we 
have successfully synthesized two natural products: dehydroherbarin and 
anhydrofusarubin. Dehydroherbarin 31 was made from the commercially available 
2,4-dimethoxybenzaldehyde 172 in 11 steps in an overall yield of 4.5 % (Scheme 
77) and anhydrofusarubin 26 was made from the commercially available 2,4,5-
trimethoxybenzaldehyde 178 in 12 steps in an overall yield of 5.3 % (Scheme 78).  
 
Our synthesis of dehydroherbarin 31 is longer than the other two listed syntheses for 
this naphthoquinone16,18, however our process was focused on creating new 
methodology towards accessing highly oxygenated naphthalene compounds 
(Scheme 77). This plan was successfully accomplished. There are three key stages 
in our synthesis of dehydroherbarin 31: (i) the Stobbe condensation approach 
towards the synthesis of the naphthalene core, (ii) PIFA aromatic methyl ether 
insertion to efficiently and regioselectively introduce the required oxygenation pattern 
of the substrate and (iii) isochromene ring assembly using Wacker-type chemistry. 
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Scheme 77 
 
The synthesis of anhydrofusarubin 26 was efficiently executed based on the 
synthetic framework developed in the pursuit of 31. The steps are very similar with 
the only considerable differences/challenges being the last demethylation reaction.  
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Scheme 78 
 
Two unusual synthetic naphthoquinones 202 and 218 were also inadvertently made 
(Figure 16). Naphthoquinone 202 was produced from a CAN-mediated process 
whereas diol 218 was isolated when carrying out a PIFA demethylation under dilute 
conditions. 
 
 
Figure 16 
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Chapter 4: A Model Study Towards the Synthesis of a 
Marticin Fused Bicyclic Pyran System  
4.1. Approach to a Model Bicyclic Acetal Ring System 
The naphthoquinone marticin 45, as mentioned previously (section 1.3), possesses 
a 6,6-bicyclic pyran ring system as well as a pentaoxygenated naphthalene nucleus. 
This complex ring arrangement is fascinating from a synthetic perspective and to 
date there has been no reported synthesis of this compound. Thus we decided to 
investigate a synthetic route to assemble the fused bicyclic pyran system in marticin 
45. 
 
 
 
Considering that marticin 45 contains four rings within its structural framework, the 
synthesis of which would initially prove to be a daunting task, we opted to first work 
on a simpler benzylic model system of the 6-membered bicyclic acetal skeleton. 
Therefore compound 179 (as a racemic mixture) was chosen as our model target 
and its retrosynthetic analysis is shown in Scheme 79. Target compound 179 could 
be produced from the Wacker oxidation of 1,3-diol 180 by means of an 
intramolecular acetal formation. The 1,3-diol 180 can be obtained from the 
chemoselective reduction of both ketones of 181. The diketone could be produced 
as the product of a Claisen condensation reaction of diethyl oxalate 231 and the 
aromatic ketone 182. Ketone 182 has been previously prepared in three steps from 
the commercially available 2,5-dihydroxyacetophenone 1831. 
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Scheme 79 
 
4.1.1. Selective allylation of 2,5-dihydroxyacetophenone 
The first step of our model pathway entailed the selective monoallylation of 2,5-
dihydroxyacetophenone 183. According to literature2 precedent, reacting 1.3 molar 
equivalents of both allyl bromide and potassium carbonate base with 183 promotes 
the formation of only the monoallyl product 243 (Scheme 80). This process was 
effectively repeated in refluxing acetone for 18 h to afford 243 in an 86 % yield. This 
difference in chemoselectivity between the two phenolic motifs is attributed to the 
hydrogen bonding between the phenol group at C-6 and adjacent benzylic ketone 
moiety, which effectively renders this phenol less reactive. 
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Scheme 80 
 
The 1H NMR spectrum of compound 243 contained eight signals of which the 
addition of an allyl chain accounts for three. These three were (i) the oxygen-bonded 
CH2 protons at 4.47 ppm, appearing as a doublet of doublets (J = 5.3 and 1.3 Hz), (ii) 
the two vinylic CH protons which had remarkable resolution and the cis (doublet of 
doublets) and trans (doublet of triplets) protons could be individually assigned at 5.28 
ppm and 5.38 ppm respectively (see Figure 16) and (iii) the vinylic CH at 6.02 ppm 
was observed as a doublet of doublet triplets (J = 17.2, 10.5 and 5.3 Hz).  
 
 
Figure 16 
 
The remainder of the peaks corresponded to those of the parent molecule. The 
benzylic ketone methyl group appeared as an intense singlet at 2.58 ppm with the 
phenol appearing at 11.86 ppm. The considerable downfield occurrence of the 
phenol hydroxyl owing to hydrogen bonding confirmed the success of this 
chemoselective reaction. Three aromatic hydrogen atoms were observed as signals 
at 6.86 ppm (doublet, J = 9.0 Hz, H-3), 7.08 ppm (doublet of doublets, J = 9.0 and 
3.0 Hz) and 7.17 ppm (doublet, J= 3.0 Hz, H-6). The 13C NMR spectrum 
corroborated the 1H NMR spectrum, indicating the presence of an allyl group. The 
methylene carbon peak emerged in the region expected for a carbon bonded to 
oxygen3 at 69.8 ppm, with the vinylic CH2 downfield at 117.8 ppm. Lastly the vinylic 
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CH signal appeared at 133.1 ppm. As a whole, the NMR spectra for the mono-
allylated product 243 were in perfect agreement with those reported in the 
literature1,2.
 
 
4.1.2. Thermal Claisen rearrangement and subsequent methylation  
The next two steps in the synthesis were (i) the regioselective rearrangement of the 
allyl group of mono-allylated compound 243 to C-2 in 244 and (ii) the methylation of 
the resulting hydroquinone to form the aromatic dimethoxy containing compound 182 
(Scheme 81)2,3. Thus 243 was heated for 18 h at 140 °C to facilitate the formation of 
the desired Claisen rearrangement product 244. The hydroquinone 244 was then 
methylated with dimethyl sulfate and potassium carbonate in boiling acetone to 
produce 182 in a 76 % yield. 
 
 
Scheme 81 
 
In the 1H NMR spectrum of 244, there were three clear observations to confirm that 
the allyl chain rearrangement was successful: (i) there was the emergence of a 
second phenolic hydrogen peak at 7.93 ppm, (ii) the allyl chain methylene protons, 
formerly bonded to oxygen, moved significantly upfield to 3.35 ppm and (iii) only two 
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aromatic protons were visible.  These two aromatic hydrogens exhibited ortho-
coupling constants (J = 9.0 Hz) from which it was inferred that they were adjacent in 
proximity, thus confirming that the reaction was indeed regioselective. The 13C NMR 
spectrum also indicated the migration of the allyl group, as the allyl CH2 group 
appeared as a signal at 31.4 ppm compared to at 69.8 ppm in the precursor. 
 
In comparison, the 1H NMR spectrum of compound 182 contained two new singlets 
from the methoxy groups at 3.73 ppm and 3.75 ppm with the disappearance of 
hydroquinone signals. In the 13C NMR spectrum two methyl ether shifts were 
overlapped at 55.9 ppm. 
 
The NMR data for both 244 and 182 were in accordance with the data reported in 
the literature3. 
 
4.1.3. Claisen condensation reaction 
Now with substrate 182 in hand we could attempt a Claisen condensation reaction. 
This desired transformation has been carried out successfully in the literature on 
aromatic ketones and therefore we followed reported procedures4,5. Compound 182 
was reacted with 2.0 molar equivalents of diethyl oxalate 231 and sodium ethoxide 
base for 3 h, followed by work-up of the reaction by the addition of hydrochloric acid 
to yield Claisen condensation product 181a as a yellow solid in a 90 % yield 
(Scheme 82). 
 
 
Scheme 82 
 
The proposed mechanism for this Claisen condensation process is shown in 
Scheme 83. Exposure of 182 to ethoxide base forms the enolate 245, which attacks 
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the carbonyl carbon of the diethyl oxalate ester to form intermediate 246. This 
intermediate species 246 eliminates the alkoxide anion to produce the 1,3-diketone 
181b that loses an acidic alpha proton to ethoxide. The resultant enolate species 
247 is acidified in the reaction work-up to yield the tautomerized 1,3-diketone 181a. 
 
 
Scheme 83 
 
The spectral data of product 181a contained conclusive proof of the success of the 
reaction. The 1H NMR spectrum displayed three new signals: (i) the ethyl ester 
peaks were observed at 1.34 ppm (CH3, triplet, J = 7.1 Hz) and 4.31 ppm (CH2, 
quartet, J = 7.1 Hz), accounting for a total of five protons and (ii) the enol hydrogen 
signal appeared at 6.58 ppm as a singlet. The 13C NMR spectrum contained the 
ethyl ester peaks at 13.9 ppm (CH3) and 62.4 ppm (CH2). Two carbonyl signals were 
also seen at 197.6 ppm (C=O) and 164.5 ppm (CO2). The carbon atoms of the enol 
moiety were present at 162.3 ppm [COCH=C(OH)] and 105.9 ppm [COCH=C(OH)]. 
The position of the enol was determined by two-dimensional NMR experiments 
(HMBC and HSQC). The IR spectrum contained a hydroxyl band at 3007 cm-1, with 
two carbonyl stretching frequencies present at 1738 cm-1 and 1730 cm-1. This 
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confirmed the presence of the enol, ketone and ester moieties.  The HRMS data for 
the product was found to be 321.1338 amu which was in accordance with the 
calculated value of 321.1342 amu for our molecular formula of C17H21O6. 
 
4.1.4. Sodium borohydride reduction of 1,3-diketone 
Our next planned step was the selective reduction of this 1,3-diketone 181a to its 
corresponding 1,3-diol counterpart 180 which is depicted in Scheme 83. 
 
 
Scheme 83 
 
The mild reducing agent sodium borohydride (NaBH4) was chosen as the reagent for 
this task and has been shown to efficiently reduce 1,3-diketones to their respective 
1,3-diols equivalents, albeit in a racemic fashion6,7. Compound 181a was dissolved 
in ethanol and treated with 2.0 equivalents of NaBH4 at ambient temperature. 
Unfortunately the outcome of this reaction was only decomposition (Scheme 84). 
Changing the solvent to methanol yielded the same negative result. This was an 
unexpected finding as alcoholic solvents are commonly employed for this reaction. 
 
 
Scheme 84 
 
Thus, we searched for another suitable non-alcoholic solvent medium and found that 
tetrahydrofuran served this purpose (Scheme 85). The reaction in this case afforded 
a yellow liquid product, compound 248. This single secondary alcohol-containing 
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compound 248 was not our desired product as we required the reduction of both 
ketone groups (Scheme 83). The benzylic ketone motif of 248 appeared to be 
resilient to NaBH4 reduction at ambient temperature so we increased the reaction 
temperature to reflux for an extended duration, with constant monitoring. This 
process once again only yielded the starting material 248.  
 
 
Scheme 85 
 
The NMR spectra of 248 were very similar to those of the parent compound 181a. 
The reduction of the enol functionality was apparent in the 1H NMR spectrum as the 
newly formed methylene protons were visible as two well resolved couple of doublet 
of doublets at 3.23 ppm and 3.39 ppm. The hydrogen atom attached to the carbon of 
the secondary alcohol was observed downfield as a broad singlet at 4.56 ppm. The 
13C NMR spectrum, however, clearly showed the existence of the benzylic ketone 
carbonyl carbon atom at 204.4 ppm. The secondary alcohol carbon emerged 
considerably upfield at 66.9 ppm with the newly formed CH2 appearing at 61.6 ppm. 
The nature of these two carbon atoms was determined using a DEPT 90 NMR 
experiment. The HRMS of this compound was in accordance with its calculated 
value.  
 
4.1.5. Wacker Oxidation of secondary alcohol 248 
Compound 248 was not our desired substrate but investigating the outcome of a 
Wacker oxidation on this compound on a theoretical basis suggested that it may 
indeed form a 6,6-bicyclic pyran ring system (Scheme 86). If successful, the Wacker 
oxidation product 249 could undergo an intramolecular attack of the alcohol moiety 
on the electrophilic ketone to form intermediate 250. The newly generated 
nucleophilic ion of 250 could in turn attack the benzylic ketone group to afford 
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bicyclic compound 251, which can be protonated to give cyclic hemiacetal compound 
252, although this may be unstable. 
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Scheme 86 
 
This reaction was tested experimentally and it was found that the reaction at ambient 
temperature only led to the recovery of starting material (Scheme 87). Extending the 
duration of the reaction made no impact on the reaction. 
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Scheme 87 
 
We found that increasing the reaction temperature to 70 °C facilitated the reaction 
(Scheme 88). The Wacker oxidation product 249 was isolated as a clear oil in a 67% 
yield. The isolation of 249 was unexpected because it meant that the reaction did not 
spontaneously undergo the cyclic ring-forming process as postulated. We then 
proposed that either the secondary alcohol may not be a sufficiently strong 
nucleophile to attack the newly formed ketone group, or that the reversibility of the 
reaction limited the formation of the expected product. It is also possible that the 
benzylic ketone group allows for limited flexibility and consequently prevents the 
attack of the secondary alcohol on the ketone. 
 
 
Scheme 88 
 
The 1H NMR spectrum of Wacker oxidation product 249 contained a few key 
differences compared to the precursor substrate 248. The transformation of the 
alkene portion of the allyl chain was apparent as the benzylic CH2 was a singlet 
(compared to a doublet in 248) that moved downfield to 3.70 ppm. There was also a 
new methyl peak that appeared at 2.18 ppm, which is adjacent to the newly formed 
ketone motif. The 13C NMR spectrum now contained two ketone signals as expected, 
at 204.3 ppm and 206.3 ppm, with the methyl peak emerging at 29.6 ppm. The IR 
spectrum contained a single broad carbonyl stretch at 1738 cm-1, which could 
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account for the three carbonyl functionalities if overlaps of the signals are 
considered. The HRMS data confirmed the calculated mass of compound 249. 
 
We then attempted to transform the secondary alcohol into a better nucleophile by 
the selective deprotonation of the secondary alcohol hydrogen atom as this could 
possibly lead to the reaction in Scheme 89. Thus we tested a few suitable bases that 
could facilitate this process: sodium hydride, sodium ethoxide and potassium tert-
butoxide. The careful addition (less then one equivalent) of each of these bases 
unfortunately did not allow for the isolation of any identifiable product(s). 
 
 
Scheme 89 
 
At this point we decided to change our approach towards accessing the bicyclic 
acetal ring system. 
 
4.2. Modified Route Towards Construction Of Bicyclic Acetal Rings  
As we were unable to reduce the benzylic ketone group to a secondary alcohol using 
NaBH4, we decided to employ the significantly stronger reducing agent LAH for this 
task. This reagent should reduce both the carbonyl groups and the ethyl ester motifs 
to alcohols (Scheme 90), converting compound 181a to the racemic triol 253. If triol 
253 is subjected to a Wacker oxidation, it should preferentially form the 6,6-bicyclic 
pyran ring system, acetal 254. 
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Scheme 90 
 
4.2.1. Lithium aluminium hydride reduction of 1,3-diketone and ethyl ester 
functionalities 
The first part of our new synthetic plan was the LAH reduction of compound 181a 
and this was carried out at -10 °C in tetrahydrofuran. This process led to the isolation 
of a single product, 1,2-diol compound 255 in a low yield of 30 % (Scheme 91). The 
enol and ethyl ester groups were reduced to a secondary and primary alcohol 
respectively, but the benzylic ketone remained intact as was observed in the NaBH4 
reduction. 
 
 
Scheme 91 
 
The NMR spectroscopic data for 1,2-diol 255 closely resembled those of alcohol 
248. The reduction of the ethyl ester motif was evident in the 1H NMR spectrum as 
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the disappearance of the characteristic two peaks (triplet and quartet signals) of the 
ethyl group of the ester, and the emergence of the primary alcohol methylene 
protons at 3.63 ppm (J = 11.7 and 2.8 Hz) and 3.48 ppm (J = 11.3 and 6.6 Hz), 
which was observed as two doublet of doublets. In the 1,2-diol 255 the reduction of 
one of the ketones was also visible as the proton next to the secondary alcohol 
(COCH2CH(OH)) appeared as a multiplet at 4.29 ppm. The adjacent CH2 protons 
appeared as a doublet (J = 6.1 Hz) at 2.96 ppm. The 13C NMR spectrum contained 
the ketone carbon atom at 207.3 ppm, with the two new CH2 signals seen upfield at 
65.8 ppm (CH2OH) and 47.7 ppm  [COCH2CH(OH)]. The secondary alcohol carbon 
appeared as a signal at 68.6 ppm. The ketone carbonyl stretching frequency was 
observed at 1738 cm-1 in the IR spectrum, with the broad alcohol bands occurring at 
3015 cm-1. The HRMS data confirmed the mass of the1,2-diol compound 255. 
 
This was an unusual result as the benzylic ketone moiety was even impervious to 
reduction by LAH. We therefore decided to increase the temperature of the reaction 
in an attempt to force this reaction to occur. The 1,2-diol 255 was treated with LAH 
and heated at reflux for 3 h, frustratingly and surprisingly only to afford the 1,4-diol 
256 (Scheme 92). 
 
 
Scheme 92 
 
A proposed mechanism for the transformation of 255 to the 1,4-diol 256 is illustrated 
in Scheme 93. Compound 255 may eliminate water in the refluxing reaction mixture 
to produce enol 257, which could tautomerize to aldehyde 258. The benzylic ketone 
and resulting aldehyde are then both reduced by LAH to form the 1,4-diol 256. 
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Scheme 93 
 
The 1H NMR spectrum of compound 256 contained a few distinct signs as evidence 
for the formation of the 1,4-diol. The benzylic CH signal appeared as a doublet of 
doublets (J = 9.6 and 3.2 Hz) at 4.85 ppm, with the primary alcohol giving rise to a 
mutiplet at 3.65 ppm. The two central methylene groups were seen upfield between 
1.64-2.03 ppm as overlapping signals. Five CH2 peaks were now observed in the 13C 
NMR spectrum at 29.9 ppm (ArCH2CH=CH2), 30.3 ppm [CH(OH)CH2CH2], 34.3 ppm 
[CH(OH)CH2CH2], 62.7 ppm (CH2OH) and 114.9 ppm (ArCH2CH=CH2). The 
reduction of the benzylic ketone was determined by the absence of the former 
downfield ketone peak and the appearence of a signal at 71.4 ppm arising from the 
secondary alcohol carbon. The nature of the CH and CH2 carbon atoms was 
resolved by a DEPT 90 NMR experiment. The IR spectral data exhibited a broad 
alcohol stretching band at 3373 cm-1 and no carbonyl frequency was observed, 
which was also indicative of the reduction of the benzylic ketone. 
 
4.2.2. Wacker oxidation of 1,4-diol system 
The 1,4-diol 256 was an unwanted side product, but on examining this system from 
the perspective of cyclic acetal ring formation, we realised that it may be of some 
benefit to us. Thus we assessed the prospect of subjecting 256 to a Wacker 
oxidation, which potentially would result in the formation of a 6,7-bicyclic pyran ring 
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system (Scheme 94). This ring arrangement would contain the wrong size acetal 
system compared to those of our desired model system 254, but it would give us 
valuable insight into whether our methodology for constructing these bicyclic 
compounds was possible. Therefore, we subjected 1,4-diol 256 to Wacker oxidation 
conditions for 2 h. Once again, we heated the mixture at 70 °C as this temperature 
was required for the reaction to progress. Much to our delight, the tricylic compound 
259 was isolated as a clear oil in a 72 % yield. 
 
 
Scheme 94 
 
The 1H NMR spectrum of the bicyclic acetal 259 was quite remarkable as all four of 
the methylene protons in this molecule were diastereotopic and displayed very 
unusual chemical shifts. The original benzene skeleton remained intact as the two 
aromatic methyl ether peaks (overlapped) and two aromatic signals (overlapped) 
were observed at 3.77 ppm and 6.66 ppm respectively. The benzylic CH proton at C-
1 appeared as a multiplet at 5.15 ppm. The benzylic CH2 hydrogens at C-8 were 
enantiotopic and the first proton emerged as a doublet (J = 16.8 Hz) at 2.49 ppm and 
the second proton was found 0.5 ppm downfield at 3.04 ppm also as a doublet (J = 
16.8 Hz). The non-equivalent protons at C-13 were observed at 1.76 ppm and 2.60 
ppm. Similarly, the enantiotopic protons of C-12 appeared at 1.32 ppm and 1.54. The 
CH2 protons at C-11 were observed as a doublet of doublet of doublets at 3.56 ppm 
(J = 11.8, 3.3 and 2.0 Hz) and a doublet of doublets at 3.80 ppm (J = 11.8 and 1.5 
Hz). Lastly, the methyl group at C-3 appeared as a singlet at 1.48 ppm and 
accounted for three hydrogens as expected. The 13C NMR spectrum of 259 
contained four CH2 signals, compared to five in the precursor 256, and these 
emerged at 27.6 ppm (C-12), 32.4 ppm (C-1), 33.6 ppm (C-8) and 60.4 ppm (C-11). 
The position of C-9 was very distinctive of the presence of the acetal group and it 
appeared in the expected region at 97.4 ppm. The methyl carbon atom at 25.0 ppm 
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also supported the structure of 259. The IR spectrum showed no hydroxyl stretching 
band which was in accordance with structure 259. The HRMS of acetal 259 was in 
agreement with the calculated mass of this compound. 
 
The success of this reaction supported our proposed formation of the 6,6-bicyclic 
pyran ring system 254 from the triol 253, provided that the diol 180 could be 
synthesized. 
 
4.2.3. Chemoselective TBDMSCl protection of 1,2-diol primary alcohol 
We have established that the standard LAH reduction of the Claisen condensation 
product 181a forms the 1,2-diol 255. We also discovered that increasing the 
temperature of this reaction promotes the formation of the 1,4-diol 256. By examining 
our postulated mechanism (Scheme 93) of the formation of 1,4-diol 256 from 1,2-diol 
255, we realised that it may be possible to prevent the loss of water from the 1,2-diol 
255 by protecting the primary alcohol of 255. This would effectively avert the 
formation of the 1,4-diol 256 and possibly allow the reduction of the benzylic ketone 
to occur exclusively. Thus we decided to protect the primary alcohol of the 1,2-diol 
255 with a TBDMS group (Scheme 95). Our substrate 255 contains two alcohol 
groups which potentially could both be protected with TBDMSCl, however we know 
that the primary alcohol should react first. In order to exploit this difference in 
reactivity, we treated 255 with TBDMSCl and imidazole (base) in a portion-wise 
manner at 0 °C in acetonitrile solvent. The result was the successful isolation of the 
TBDMS protected alcohol 260. 
 
 
Scheme 95 
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The NMR spectra of the TBDMS-protected compound 260 were similar to the 
spectra of the precursor 1,2-diol 255. The 1H NMR spectrum of 260 contained two 
new signals from the TBDMS moiety, i.e. the two sets of methyl group peaks at 0.00 
ppm and 0.83 ppm which accounted for a total of fifteen protons. The methylene 
hydrogens adjacent to the benzylic ketone motif (COCH2CH(OH)), appeared as two 
doublet of doublets at 2.91 ppm (J = 17.9 and 7.8 Hz)  and 3.04 ppm (J = 17.9 and 
4.4 Hz) whereas the CH2 next to the TBDMS-protected oxygen atom was seen at 
3.56 ppm as a multiplet. The secondary alcohol hydroxyl signal was observed at 
2.97 ppm. The 13C NMR spectrum possessed three new signals as expected from 
the TBDMS group, these were at: -5.4 ppm [OSi(CH3)2C(CH3)3]., 18.3 ppm 
[OSi(CH3)2C(CH3)3)], and at 25.9 ppm [OSi(CH3)2C(CH3)3]. The HRMS data for the 
product was found to be 395.2254 amu which was in accurate accordance with the 
calculated value of 395.2245 amu for the molecular formula of C21H35O5Si. 
 
4.2.4. Lithium aluminium hydride reduction of protected alcohol and 
subsequent Wacker oxidation  
With the TBDMS product 260 in hand, we could attempt the LAH reduction of the 
benzylic ketone to an alcohol. Compound 260 was refluxed in tetrahydrofuran in the 
presence of LAH for 2 h (Scheme 96). TLC analysis revealed that the starting 
material was depleted after this duration and we proceeded to work up the reaction 
and purify potential products. This process proved futile as we realized that the 
product(s) formed decomposed on the silica gel chromatography column. Thus we 
opted to skip the purification step and immediately carry out a Wacker oxidation on 
the crude material from the LAH reduction (Scheme 96). This reaction was done at 
70 °C for 2h and successfully resulted in the formation of our desired target 
compound 254 as a white solid in a yield of 67 % over two steps. 
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Scheme 96 
 
Acetal 254 did not contain the TBDMS protecting group that was present in the 
starting material 260 which meant it was cleaved during the LAH reduction step. 
Thus the addition of the TBDMS group to 1,2-diol 255 assisted the benzylic ketone 
reduction and thereafter was removed in situ. The triol 253 was the likely unstable 
intermediate from our initial LAH reduction reaction and its possible transformation to 
acetal 254 via the Wacker oxidation is shown in Scheme 97. 
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Scheme 97 
 
The alkene motif in the allyl chain of triol 253 is oxidised to a ketone by a Wacker 
oxidation process to afford intermediate 261. The newly formed ketone group of 261 
is protonated and is consequently attacked by one of the secondary alcohol moieties 
as shown in 262, which results in the development of hemiacetal 263. The 
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hemiacetal group of 263 is protoated to afford 264 and subsequently dehydrates to 
produce the intermediate 265. The benzylic secondary alcohol attacks the strongly 
electrophilic oxocinium carbonyl motif which generates the bicyclic acetal compound 
266. Unstable acetal 266 undergoes deprotonation to produce the more stable 
species 254, which is our isolated product. There are a few contradictions in this 
proposed mechanism that warrant further explanation: (i) the primary alcohol group 
in triol 253 is a better nucleophile then either of the secondary alcohol moieties, but 
we believe that the driving force of the 1,3-diol acetal combination over the 1,4-diol 
acetal fusion is the lower energy stabilisation benefit of forming a 6,6-bicyclic ring 
system over a 6,7-bicyclic ring system and (ii) the ability of the secondary alcohol to 
act as a suitable nucleophile in this scenario compared to compound 249 can be 
attributed to the increased flexibility found in the triol skeleton of 253. 
 
The triol precursor 253 was produced by employing the non-stereoselective reducing 
agent LAH and given the 1,3-diol relationship between the secondary alcohol groups 
there are therefore four possible stereoisomers of 253. These are the two trans-diol 
diastereomers 253a and 253b and the two cis-diol diastereomers 253c and 253d 
(Figure 18).  
 
 
Figure 18 
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Therefore, based on these possible precursor triol stereoisomers (Figure 18), acetal 
254 should occur as a mixture of four diastereomers: that is, 254a and 254b and 
their respective mirror images (Figure 19).  
 
 
Figure 19 
  
These structural predictions are in accordance with our experimental findings. The 
1H NMR spectrum of 254 contained a mixture of two compounds, which were found 
in a 2.3 :1 ratio (Table 4). We were able to grow crystals of 254 and thus obtain vital 
crystallographic data that confirmed that the major diastereomers [(R,R) and (S,S)] 
(~ 65 %) were 254a and its mirror image (Figure 20) and the minor diastereomers 
[(R, S) and (S,R)] (~ 35 %) were 254b and its mirror image (Figure 21). This further 
implied that triols 253a and 253b were the major isomers whereas triols 253c and 
253d were the minor isomers. 
 
Table 4: 1H NMR signals of diastereomers 254a and 254b. 
Proton 254a (Shift in ppm) 254b (Shift in ppm) 
H-5/H-5* 6.64 (d, J = 8.8 Hz) 6.64 (d, J = 8.8 Hz) 
H-4/H-4* 6.67 (d, J = 8.8 Hz) 6.67 (d, J = 8.8 Hz) 
H-1/H-1* 5.40 (brd, J = 3.9 Hz) 5.25 (brd, J = 9.1 Hz) 
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OCH3 3.77 (s), 3.76 (s) 3.77 (s), 3.76 (s) 
H-12a/H-12a* 2.09–2.02 (m) 2.30 (ddd, J = 13.0, 10.1, 
5.3 Hz) 
H-12b/H-12b* 1.40 (dt, J = 12.9, 2.0 Hz) 1.57 (ddd, J = 13.0, 11.1, 
1.55 Hz) 
H-11/H-11* 3.83 (m) 4.09–4.03 (m) 
CH2OH 3.48 (br s) 3.60–3.54 (m, CHaHbOH), 
3.41–3.35 (m, CHaHbOH) 
H-8a/H-8a* 2.98 (d, J = 18.8 Hz) 2.83 (d, J = 17.3 Hz) 
H-8b/H-8b* 2.85 (d, J = 18.8 Hz) 2.59 (d, J = 17.3 Hz) 
CH3 1.53 (s) 1.52 (s) 
 
Between these two diastereomers there are a few substantial differences observed 
in the 1H NMR spectra. The coupling constant of the broad doublet of H-1 is 3.9 Hz 
in the major product and is 9.1 Hz in the minor diastereomer. The proton H-12a of 
the major product appeared as a multiplet where H-12b is resolved as a doublet of 
triplets (J = 12.9, 2.0 Hz), whereas both H-12a* and H-12b* for the minor acetal 
product are seen as a doublet of doublet of doublets (J = 13.0, 10.1, 5.3 Hz) and (J = 
13.0, 11.1, 1.55 Hz). 
 
In the 13C NMR spectra the signals of the diastereomers 254a and 254b were found 
in unequal ratios. However, the signals for these isomers were very close to each 
other as expected. The important C-9 /C-9* peaks appeared at 96.0 ppm and 97.4 
ppm respectively. Each diastereomer contains three CH2 signals and these were 
observed at 65.9 ppm (CH2OH)/ 64.9 ppm (CH2OH*) 32.8 ppm (C-8)/33.2 ppm (C-
8*) and 30.4 ppm (C-12)/32.8 ppm (C-12*). The acetal ring CH signals occurred at 
65.7 ppm (C-1)/ 65.0 ppm (C-1*) and 68.3 ppm (C-11)/ 66.7 ppm (C-11*). The 
methyl carbon peaks appeared downfield at 29.5 ppm (CH3) and 24.6 (CH3*). 
 
The X-ray crystal structures of 254a (Figure 20) and 254b (Figure 21) provided us 
with conclusive structural evidence for the existence of the 6,6-bicyclic acetal rings. 
The important stereochemistry of the diastereomers was unambiguously assigned 
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with this information.  As mentioned previously, the major diastereomers were 254a 
and its mirror image and the minor diastereomers were 254b and its mirror image.  
 
 
Figure 20 
 
 
Figure 21 
 
Chapter 4: A Model Study Towards the Synthesis of a Marticin Fused Bicyclic Pyran 
System 
 
 124 
 
4.3. Structural Adjustments of 6,6-bicyclic pyran ring system 
With the tricyclic ring system in place we attempted to transform 254 to a model 
system that closely resembled marticin 45. This entailed oxidizing the primary 
alcohol group of acetal 254 to a carboxylic acid (compound 267) and oxidizing the 
aromatic methyl ethers of 267 to a para-quinone to afford 268 (Scheme 98).  
 
 
Scheme 98 
 
4.3.1. Aliphatic primary alcohol oxidation 
The acetal ring system of 254 is sensitive to acidic and basic media and this limited 
our choice of aliphatic alcohol oxidizing reagents as many of these procedures 
require such conditions in their reaction processes8,9. Due to these constraints we 
had to carry out this transformation over two steps, as we found no suitable mild 
process that was feasible overall. We thus decided to first use the Dess-Martin 
periodinane catalyst 270 which is a mild reagent that can potentially oxidize the 
primary alcohol of 254 to the aldehyde 26910 (Scheme 99). If this was successful we 
would then employ a sodium chlorite oxidation11 of aldehyde 269 to the carboxylic 
acid 267. The acetal 254 was dissolved in dichloromethane and reacted with 270 at 
room temperature over a 24 h period. Unfortunately, the work-up and column 
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chromatography of the reaction afforded no identifiable product(s) or starting 
material.  
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Scheme 99 
 
The acetal fragment of 254 did not appear to tolerate the oxidation process on the 
aliphatic alcohol. We therefore decided to move onto the next planned step from 
Scheme 98 which was the oxidation of the aromatic system in acetal 254 to the 
quinone. 
 
4.3.2. Ceric ammonium nitrate oxidation of bicylic acetal ring product 
Based on our previous success with CAN as an oxidizing agent12 (see section 3.1.1) 
of aromatic compounds, we decided to employ this reagent for our attempted 
quinone formation, which is shown in Scheme 100. Acetal 254 was dissolved in 
acetonitrile whilst the CAN was added slowly in an aqueous medium over a 30 min 
period. The desired compound quinone 271 was isolated as a mixture of 
diastereomers (271a and 271b, Figure 22) in a high yield of 89 %. The quinones, as 
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expected, possessed a bright red colour, compared to the white starting material, 
and they were considerably more polar as was observed by silica gel TLC analysis. 
 
 
Scheme 100 
 
The proportions of 271a and 271b were also found to be in a 2.3: 1 ratio which was 
determined from the 1H NMR spectrum and this was in accordance with the findings 
for the precursor compound 254. 
 
 
Figure 22 
 
The NMR spectral data of 271 strongly supported that the reaction went as planned. 
In the 1H NMR spectrum, the existence of the two diastereomers 271a and 271b was 
clearly evident, as was the loss of the aromatic methyl ether signals. The remainder 
of the proton peaks were the same as those found for the precursor 254 (see Table 
4) and will therefore not be discussed. The 13C NMR spectrum contained the 
expected four quinone signals at 185.3 ppm and 184.7 ppm for the major 
diastereomer 271a and at 186.4 ppm and 185.3 ppm for the minor diastereomer 
271b. There was also an absence of aromatic methyl ethers peaks in the 50-60 ppm 
range. The IR spectral data included a quinone stretching band at 1754 cm-1. 
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4.4. Concluding Remarks Pertaining to the Synthesis of Bicyclic Acetal 
Ring Systems. 
During the course of this PhD we have successfully assembled a model system of 
the 6,6-bicyclic pyran ring arrangement found in the naturally occurring 
naphthoquinone marticin 45. This model compound 271 was produced as a racemic 
mixture of 271a and 271b in 9 synthetic steps in a 3.3 % overall yield (Scheme 101). 
An interesting side product that was synthesized en route to 271 was the 6,7-bicyclic 
acetal compound 259 that was made in 7 steps in a 6.5 % overall yield (Scheme 
102). Synthesis of both of these bicyclic acetal compounds employed the 
commercially available 2,5-dihydroxyacetophenone 183 as starting material. 
 
The key stages in the synthesis of quinone 271 were: (i) the Claisen condensation 
reaction with diethyl oxalate 231, (ii) TBDMSCl protection of the primary alcohol 
group of 255 and (iii) the LAH reduction followed by immediate Wacker oxidation of 
260.   
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Scheme 101 
 
The reactions pertaining to 6,7-bicyclic acetal compound 259 were similar to those 
towards quinone 271, with the only unique step being the LAH reduction of 255 to 
the 1,4-diol 256. 
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Scheme 102 
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Chapter 5: Summary and Future Work  
5.1. Synthesis of Naphthoquinones 
New synthetic methodology pertaining to the synthesis of tetraoxygenated and 
pentaoxygenated naphthoquinones was successfully developed in this PhD project.  
The naturally occurring fungal naphthoquinones dehydroherbarin 31 and 
anhydrofusarubin 26 were synthesized by employing this novel methodology.  
Dehydroherbarin 31 was made from the commercially available 2,4-
dimethoxybenzaldehyde 172 in 11 steps in an overall yield of 4.5 % (Scheme 103). 
This is the third reported synthesis of this secondary metabolite. 
 
 
Scheme 103 
 
Two unnatural synthetic naphthoquinones 202 and 218 were also produced on route 
to accessing dehydroherbarin 31 (Figure 23). 
 
 
Figure 23 
 
Anhydrofusarubin 26 was made from the commercially available 2,4,5-
trimethoxybenzaldehyde 178 in 12 steps in an overall yield of 5.3 % (Scheme 104). 
This is the first total synthesis of anhydrofusarubin. 
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Scheme 104 
 
5.2. A Model Study towards the Synthesis of a Marticin Fused Bicyclic 
Pyran System 
A model system of the 6,6-bicyclic pyran ring arrangement found in the naturally 
occurring naphthoquinone marticin 45 was successfully synthesized. The model 
compound 271 was produced as a racemic mixture of 271a and 271b in 9 steps, 
starting from commercially available 2,5-dihydroxyacetophenone 183 in a 3.3 % 
overall yield (Scheme 105). 
 
 
Scheme 105 
 
We also synthesized the 6,7-bicyclic acetal compound 259 in 7 steps, from 2,5-
dihydroxyacetophenone 183 in a 6.5 % overall yield (Scheme 106).  
 
 
Scheme 106 
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5.3. Future Work 
5.3.1. Cancer screening of synthesized naphthoquinones 
The biological testing for anti-tumour activity of all target compounds is still planned 
and will be carried out in the near future. Very preliminary results have indicated that 
the poor solubility of the quinones in water could be a problem. 
 
5.3.2. Synthesis of anhydrofusarubin-lactone and anhydrofusarubin-lactol 
The naphthoquinones anhydrofusarubin-lactone 29 and anhydrofusarubin-lactol 30 
are two other fungal metabolites from the genus Fusaria that closely resemble 
anhydrofusarubin 26. These compounds contain the same pentaoxygenated core as 
anhydrofusarubin 26 and only differ by possessing an oxygen substituent at position 
C-1 (Figure 24). The synthesis and biological activities of these two 
naphthoquinones have never been reported. Thus a synthetic route to these 
compounds would allow for the investigation of their biological properties and 
possibly determine their structural importance. 
 
Scheme 103 
 
Figure 24 
 
Based on the noted structural similarities we propose that these two 
naphthoquinones could be synthesized by employing a few minor modifications to 
the synthetic pathway used to assemble anhydrofusarubin 26 (Scheme 107). The 
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allyl ester of naphthalene 226 (produced in eight steps from 2,4,5-
trimethoxybenzaldehyde 178) can be converted to a carboxylic acid, compound 272, 
by a saponification reaction under basic conditions. The Wacker oxidation of acid 
272 would result in the formation of lactone 273. The silver(II) oxidation and boron 
trichloride demethylation of 273 would yield anhydrofusarubin-lactone 29. 
Alternatively, lactone 273 could be selectively reduced to lactol 274 by DIBAL. 
Oxidative and selective demethylation processes would potentially afford 
anhydrofusarubin-lactol 30. 
 
 
Scheme 107 
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5.3.3. Synthesis of fusarubin by hydration of anhydrofusarubin 
There is literature precedence for the addition of a water molecule across a 
dehydrated isochromene ring system to form a hemiacetal. This process entails 
refluxing the substrate in toluene in the presence of catalytic amounts of p-
toluenesulfonic acid, and could be applied to the pentaoxygenated isochromene 228 
to potentially form hemiacetal 275 (Scheme 108). The oxidation and demethylation 
of 275 would yield fusarubin 16, which is the hydrated form of anhydrofusarubin 26. 
 
 
 Scheme 108 
 
5.3.4. Synthesis of acetal Naphthoquinones using Wacker methodology 
The Wacker oxidation is usually carried out in a water/dimethylformamide solvent 
system. Water molecules have been proposed to participate in the reaction and 
could be added to the substrate from the catalyst via syn addition (see Scheme 46). 
There is some literature on alternative solvent systems for the Wacker oxidation2, 
such as methanol or ethanol. Essentially, these solvents could also play a role in the 
reaction, as a water molecule has been proposed to, and this would result in the 
formation of an acetal derivative as opposed to the usual hemiacetal. If this 
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methodology was applied to our pentaoxygenated naphthalene 227 (Scheme 109), 
we could form acetal 276 which can be oxidized and demethylated to afford the 
naturally occurring naphthoquinone 277. 
 
 
Scheme 109 
 
The natural products, O-methylfusarubin 41 and O-ethylfusarubin 43 potentially 
could be synthesized in this manner which would be a novel approach to assembling 
naphthoquinones containing acetal moieties (Figure 25). 
 
 
Figure 25 
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5.3.5. Diastereoselective Synthesis of Marticin 
Considering that we have an efficient route to assemble a pentaoxygenated 
naphthalene core and methodology towards accessing the bicyclic acetal ring 
system of marticin, it would be possible to combine this synthetic knowledge and 
apply it to the synthesis of marticin 45. Naphthalene 227 could be oxidized to an 
aldehyde and the desired ester/alcohol side chain could be stereoselectively added 
(A) to afford 278 (Scheme 110). The Wacker oxidation (B) of 278 would potentially 
form the bicyclic acetal compound 279 which could be oxidized and demethylated 
(C) to yield marticin 45. 
 
 
Scheme 110 
 
5.4. References 
1. Kesteleyn, B., De Kimpe, N., Van Puyvelde, L., Synthesis, 1999, 11, 1881-
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Chapter 6: Experimental Procedures  
6.1. General Modus Operandi 
6.1.1. Purification of solvents and reagents 
Solvents utilized for chromatographic techniques (ethyl acetate and n-hexane) were 
distilled preceding use by means of conventional distillation processes. The solvents 
employed in reactions were first dried over the suitable drying agent, followed by 
distillation under an inert atmosphere (argon or nitrogen gas). Acetonitrile and 
dichloromethane were distilled over calcium hydride, whereas tetrahydrofuran was 
distilled over sodium with benzophenone as an indicator. All the required chemicals 
or reagents were obtained from FLUKA, SIGMA-ALDRICH or MERCK and were 
used without further purification.  
 
6.1.2. Chromatography procedures 
Normal chromatography was performed with silica gel 60 (Macherey-Nagel, particle 
size 0.063-0.200 mm) adsorbent, with both isocratic and gradient eluent systems 
being employed. Thin layer chromatography (TLC) of the compounds was executed 
on Macherey-Nagel Alugram Sil G/UV254 plates pre-coated with 0.25 mm silica gel 
60. The TLC plates were viewed under UV light (λ 254 nm and 366 nm). 
 
6.1.3. Spectroscopic and physical data 
Nuclear magnetic resonance (NMR) spectra were recorded on either a Bruker 
AVANCE 300 MHz or a Bruker AVANCE III 500 MHz spectrometer. All spectra were 
recorded in CDCl3, or d6-acetone. All chemical shift values are reported in parts per 
million referenced against trimethylsilane which is given an assignment of zero parts 
per million. Coupling constants (J-values) are given in Hertz (Hz). 
 
The infra-red spectra were recorded on a Bruker Tensor 27 standard system 
spectrometer. Measurements were made by loading the sample directly onto a 
diamond cell. The measurments are reported on the wavenumber scale (ν/cm-1). 
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Melting points were determined on a Reichert hot-stage microscope, and remain 
uncorrected. 
 
High resolution mass spectra were obtained with a Waters-LCT-Premier mass 
spectrometer. The sample was dissolved in methanol to a concentration of 2 ng/µl 
and introduced by direct infusion. The ionization mode was electrospray positive with 
a capillary voltage of 2500 V and a desolvation temperature of 250 °C using nitrogen 
gas at 250 L/hr. 
 
The intensity data was recorded on a Bruker APEX II CCD area detector 
diffractometer with graphite monochromated Mo Kα radiation (50 kV, 30 mA) with 
temperature of measurement at 173(2) K, using the APEX 21 data collection 
software. The collection method involved ω-scans of width 0.5 and 512×512 bit data 
frames. The data reduction was achieved by means of the program SAINT+ and face 
indexed absorption corrections were made using XPREP2. 
 
Crystal structures were solved employing direct methods using SHELXTL2. Non-
hydrogen atoms were first refined isotropically followed by anisotropic refinement by 
full matrix least-squares calculations based on F2 using SHELXTL. The hydrogen 
atoms were first located in the difference map then positioned geometrically and 
allowed to ride on their respective precursor atoms. Diagrams and publication 
material were generated using SHELXTL, PLATON151 and ORTEP-33. 
 
6.1.4. Other general procedures 
All the glass reaction vessels were dried in an oven. The term “in vacuo” refers to the 
removal of solvent by use of a rotary evaporator. The residual solvent of purified 
material was removed by utilizing a high vacuum pump (ca.0.1 mm Hg) at ambient 
temperature until constant mass was achieved. 
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6.2. Experimental Work Pertaining to the Diels-Alder Approach to 
Naphthoquinones 
6.2.1. Synthesis of 3-Hydroxy-3-methyl-3,4-dihydro-1H-isochromene-5,8-dione 
170 
 
 
5,8-Dimethoxy-3-methylisochroman-3-ol 7 (2.20 g, 9.86 mmol) was dissolved in a 
mixture of CH3CN and H2O (200 ml, 50:50 v/v ratio). CAN (16.2 g, 29.6 mmol, 3.0 
equiv.) was added to the reaction mixture which was then stirred vigorously for 30 
min at rt. EtOAc (50 ml) and NaCl (aq) (50 ml) were then added and the upper 
organic layer was separated, dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. Column chromatography (eluant 30 % EtOAc/hexane) of 
the residue afforded 3-hydroxy-3-methyl-3,4-dihydro-1H-isochromene-5,8-dione 8 as 
an amorphous red solid (1.053 g, 55 %). Rf = 0.26 (30 % EtOAc/hexane); IR νmax(cm-
1) = 3353 (OH), 1738 (C=O), 1654 (C=O); 1H NMR (300 MHz, MeOD) δH  = 6.80-6.71 
(2H, m, H-6 and H-7), 4.56-4.56 (1H, m, ArCHaHbO), 4.30-4.20 (1H, m, ArCHaHbO), 
2.68-2.58 (1H, m, HaHb-4), 2.46-2.36 (1H, ddd, J 18.9 and 4.3 and 2.8, HaHb-4), 1.47 
(3 H, CH3); 13C NMR (75 MHz, MeOD) δC = 187.4 (C=O), 186.9 (C=O), 139.9 (C-8a), 
138.4 (C-4a), 137.6 (C-6), 137.2 (C-7), 98.4 (C-3), 58.6 (C-1), 33.2 (C-4), 23.0 (CH3). 
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6.2.2. Synthesis of 3-Methyl-1H-isochromene-5,8-dione 171 
 
 
5,8-dimethoxy-3-methy-1H-isochromene 9 (1.20 g, 5.82 mmol) was dissolved in a 
mixture of CH3CN and H2O (100 ml, 50:50 v/v ratio). CAN (9.47 g, 17.5 mmol, 3.0 
equiv.) was added to the reaction mixture which was then stirred vigorously for 30 
min at rt. EtOAc (50 ml) and NaCl (aq) (50 ml) were then added and the upper 
organic layer was separated, dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. Column chromatography (eluant 30 % EtOAc/hexane) of 
the residue afforded 3-methyl-1H-isochromene-5,8-dione 10 as an amorphous 
orange solid (0.646 g, 63 %). Rf = 0.41 (30 % EtOAc/hexane); IR νmax(cm-1) = 3428 
(OH), 1652 (C=O), 1600 (C=O); 1H NMR (300 MHz, CDCl3) δH  = 6.70-6.63 (2H, m, 
H-6 and H-7), 5.75 (1H, s, H-4), 5.02 (2H, s, ArCH2O), 2.01 (3H, s, CH3); 13C NMR 
(75 MHz, CDCl3) δC =184.8 (C=O), 184.2 (C=O) 165.3 (C-3), 137.1 (C-7), 135.0 (C-
8a) 134.8 (C-6), 119.5 (C-4a), 94.4 (C-4), 62.7 (C-1), 20.3 (CH3). 
 
6.2.3. Attempted Diels Alder reaction of 3-Methyl-1H-isochromene-5,8-dione 
171 with furan 64 
 
 
Quinone 171 (0.300 g, 1.70 mmol) and furan 64 (2.31 g, 34.0 mmol, 20.0 equiv.) 
were refluxed for 6 h. The reaction was cooled to rt and purified by chromatography 
column which only resulted in the full recovery of starting material. 
Chapter 6: Experimental Procedures 
 
 142 
 
6.2.4. Attempted Diels Alder reaction of 3-Hydroxy-3-methyl-3,4-dihydro-1H-
isochromene-5,8-dione 170 with 2-methoxyfuran 58 
 
 
Quinone 170 (0.500 g, 2.57 mmol) and 2-methoxyfuran 58 (0.253 g, 2.57 mmol, 1.0 
equiv.) were dissolved in dichlorobenzene (10 ml) and refluxed for 1 h (after this time 
TLC analysis showed that the starting material was fully consumed). The reaction 
was cooled to rt and directly loaded onto a silica chromatography column. The 
material from the reaction decomposed on contact with the purification column. 
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6.3. Experimental Work Pertaining to the Syntheisis of 
Dehydroherbarin and Unusual Analogues 
6.3.1. Synthesis of Ethyl 4-acetoxy-6,8-dimethoxy-2-naphthoate 189 
 
 
To a solution of 2,4-dimethoxybenzaldehyde (4.00 g, 24.1 mmol) and diethyl 
succinate (5.45 g, 31.3 mmol) in dry THF (50 ml), at 0 °C, was added NaOEt (3.28 g, 
48.1 mmol). The reaction mixture was refluxed for 2 h, cooled to rt and then acidified 
to pH 3 with aqueous HCl [33% (v/v)]. The product precipitated and was extracted 
with EtOAc (2 × 50 ml). The combined organic extracts were dried over anhydrous 
MgSO4, filtered, and the filtrate was concentrated in vacuo. The residue and 
anhydrous NaOAc (2.57 g, 31.3 mmol) were dissolved in acetic anhydride (50 ml) 
and refluxed for 3 h. The solvent was removed in vacuo and the resulting residue 
was dissolved in EtOAc (60 ml). Aqueous NaHCO3 was slowly added to the EtOAc 
layer until all the traces of acetic anhydride were removed. The organic layer was 
then separated, dried over MgSO4, filtered, and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography (30% EtOAc /hexane) to 
afford ethyl 4-acetoxy-6,8-dimethoxy-2-naphthoate 189 (8.69 g, 82%) as a yellow 
solid. Rf = 0.64 (40 % EtOAc/hexane); 1H NMR (300 MHz, CDCl3) δH = 8.79 (1H, d, J 
1.1, H-1), 7.81 (1H, d, J 1.1, H-3), 6.66 (1H, d, J 1.9, H-5), 6.51 (1H, d, J 1.9, H-7), 
4.42 (2H, q, J 7.1, OCH2CH3), 3.98 (3H, s, OCH3), 3.91 (3H, s, OCH3), 2.46 
(CH3CO2), 1.42 (3H, t, J 7.1, OCH2CH3); 13C NMR (75 MHz, CDCl3) δC = 169.3 
(CH3CO2), 166.3 (ArCO2Et), 161.0, 157.9, 145.4 (C-4), 133.2 (C-4a), 124.4 (C-2), 
123.4 (C-1), 122.2 (C-8a) 119.1 (C-3), 98.6 (C-5), 91.7 (C-7) 61.0 (OCH2CH3), 55.8  
(OCH3), 55.4 (OCH3), 20.9 (CH3CO2), 14.4 (OCH2CH3).4 
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6.3.2. Synthesis of Allyl 4-(allyloxy)-6,8-dimethoxy-2-naphthoate 191 
 
 
Ethyl 4-acetoxy-6,8-dimethoxy-2-naphthoate 189 (10.0 g, 31.4 mmol) was dissolved 
in MeOH (100 ml) followed by the drop-wise addition of an aqueous KOH solution 
(8.81 g, 157 mmol, 200 ml H2O). The dark-orange reaction was stirred for 6 h at rt, 
before the MeOH was removed in vacuo. The aqueous solution was then carefully 
acidified to pH 4.0 with aqueous HCl (30%), and then extracted with EtOAc (3 × 150 
ml). The organic layers were combined, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude, off-white solid was then dissolved 
in acetone (150 ml), and allyl bromide (9.41 g, 78.5 mmol) and anhydrous K2CO3 
(10.8 g, 78.5 mmol) were added to the reaction mixture which was then refluxed for 
18 h under a N2(g) atmosphere. The mixture was then allowed to cool to rt, filtered 
through a bed of celite, and the solvent was removed in vacuo. The light-yellow 
residue was then purified via column chromatography (10% EtOAc/hexane) to yield 
allyl 4-(allyloxy)-6,8-dimethoxy-2-naphthoate 191 as a yellow amorphous solid (8.56 
g, 83%). Rf = 0.65 (20 % EtOAc /hexane); Mp = 64-65 °C; IR νmax(cm-1) = 1647 
(C=O), 1600 (C=C), 1429, 1285, 1217, 1146; 1H NMR (400 MHz, CDCl3) δH = 8.53 
(1H s, H-1), 7.41 (1H, d, J 1.3, H-3), 7.13 (1H, d, J 2.0, H-5), 6.51 (1H, d, J 2.2, H-7), 
6.26–6.01 (2H, m, COOCH2CH=CH2 and OCH2CH=CH2), 5.57–5.39 (2H, m, 
COOCH2CH=CH2), 5.38–5.25 (2H, m, OCH2CH=CH2), 4.87 (2H, dt, J 5.6, 1.3, 
COOCH2CH=CH2), 4.75 (2H, d, J 5.2, OCH2CH=CH2), 3.95 (3H, s, OCH3), 3.93 (3H, 
s, OCH3); 13C NMR (100 MHz, CDCl3) δC = 167.0 (C=O), 160.4, 157.8, 153.3, 133.3 
(OCH2CH=CH2), 132.8 (COOCH2CH=CH2), 130.2 (C-2), 124.4 (C-4a), 121.8 (C-8a), 
118.4 (C-1) 118.2 (OCH2CH=CH2), 117.8 (COOCH2CH=CH2), 105.9 (C-3), 98.8 (C-
4), 92.9 (C-6), 69.4 (OCH2CH=CH2) 65.7 (COOCH2CH=CH2), 55.8 (OCH3), 55.6 
(OCH3); HR-TOF-MS: m/z found 329.1389 [M+H]+ (calculated for C19H21O5, 
329.1389). 
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6.3.3. Synthesis of Allyl 3-allyl-4-hydroxy-6,8-dimethoxy-2-naphthoate 192 
 
 
Allyl 4-(allyloxy)-6,8-dimethoxy-2-naphthoate 191 (7.20 g, 21.9 mmol) was loaded 
neat into a round-bottomed flask (100 ml) equipped with a reflux condenser and a 
magnetic stirrer bar. The reaction vessel was then heated to 180 oC for 18 h under a 
N2(g) atmosphere. The dark viscous residue was allowed to cool to rt and was then 
purified using column chromatography (20% EtOAc/hexane) to yield allyl 3-allyl-4-
hydroxy-6,8-dimethoxy-2-naphthoate 192 as a yellow amorphous solid (6.48 g, 
90%). Rf = 0.60 (20 % EtOAc /hexane);  Mp. = 90-91 °C; IR νmax(cm-1) = 3539 (OH), 
1673 (C=O), 1580 (C=C), 1461, 1291, 1249, 1158; 1H NMR (300 MHz, CDCl3) δH = 
8.43 (1H, s, H-1), 7.04 (1H, d, J 1.8, H-5), 6.48 (1H, d, J 2.2, H-7), 6.20–6.01 (2H, m, 
COOCH2CH=CH2 and ArCH2CH=CH2), 5.82 (1H, s, OH), 5.44 (1H, ddd, J 17.2, 3.0, 
1.5, one of COOCH2CH=CH2), 5.37–5.25 (1H, m, one of COOCH2CH=CH2), 5.18 
(2H, ddd, J 5.1, 3.9, 1.7, ArCH2CH=CH2), 4.88–4.80 (2H, m, COOCH2CH=CH2), 
3.97–3.88 (2H, m, ArCH2CH=CH2, under OCH3) 3.94 (3H, s, OCH3), 3.91 (OCH3); 
13C NMR (75 MHz, CDCl3) δC = 167.8 (C=O), 160.1, 157.3, 149.7, 136.5 
(COOCH2CH=CH2), 132.5 (ArCH2CH=CH2), 128.5 (C-8a), 125.1 (C-4a), 120.3 (C-3), 
119.2 (C-2), 118.9 (C-1), 118.3 (COOCH2CH=CH2), 116.1 (ArCH2CH=CH2), 98.3 (C-
5), 92.1 (C-7), 65.7 (COOCH2CH=CH2), 55.7 (OCH3), 55.5 (OCH3), 31.7 
(ArCH2CH=CH2); HR-TOF-MS: m/z found 329.1376 [M+H]+ (calculated for C19H21O5, 
329.1389). 
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6.3.4. Synthesis of Allyl 3-allyl-4-(tert-butyldimethylsilyloxy)-6,8-dimethoxy-2-
naphthoate 193 
 
 
Allyl 3-allyl-4-hydroxy-6,8-dimethoxy-2-naphthoate 192 (7.20 g, 21.9 mmol), tert-
butyldimethylsilyl chloride (4.96 g, 32.9 mmol), imidazole (2.23 g, 32.9 mmol) and 
dimethylaminopyridine (0.400 g) were dissolved in CH2Cl2 (150 ml) and stirred at rt 
for 24 h under a N2(g) atmosphere. The mixture was then washed with H2O (2 × 100 
ml), dried over anhydrous MgSO4, filtered, and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography (10% EtOAc/hexane) to 
afford allyl 3-allyl-4-(tert-butyldimethylsilyloxy)-6,8-dimethoxy-2-naphthoate 193 (9.01 
g, 93%) as a clear oil. Rf = 0.67 (10 % EtOAc/hexane); IR νmax(cm-1) = 1767 (C=O), 
1589 (C=C), 1468, 1317, 1251, 1188; 1H NMR (300 MHz, CDCl3) δH = 8.44 (1H, s, 
H-1), 6.96 (1H, d, J 1.9, H-5), 6.47 (1H, d, J 2.1, H-7), 6.08 (1H, ddd, J 16.1, 10.9, 
5.7, COOCH2CH=CH2), 5.93 (1H, ddt, J 16.3, 10.4, 5.9, ArCH2CH=CH2), 5.43 (1H, 
dd, J 17.2, 1.5, one of COOCH2CH=CH2), 5.29 (1H, dd, J 10.4, 1.2, one of 
COOCH2CH=CH2), 4.99–4.86 (2H, m, ArCH2CH=CH2), 4.82 (2H, d, J 5.7, 
COOCH2CH=CH2), 3.99–3.93 (2H, m, ArCH2CH=CH2,under OCH3), 3.95 (3H, s, 
OCH3), 3.92 (3H, s, OCH3), 1.13 (9H, s, OSi(CH3)2C(CH3)3), 0.23 (6H, s, 
OSi(CH3)2C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 168.0 (C=O), 159.6, 157.4, 
148.3, 137.5 (ArCH2CH=CH2), 132.7 (COOCH2CH=CH2), 131.6, 126.4, 126.2, 120.4, 
119.9, 118.1 (COOCH2CH=CH2), 114.9 (ArCH2CH=CH2), 97.9 (C-5), 94.2 (C-7), 
65.6 (COOCH2CH=CH2), 55.7 (OCH3), 55.4 (OCH3), 31.2 (ArCH2CH=CH2), 26.2 
(OSi(CH3)2C(CH3)3), 18.8 (OSi(CH3)2C(CH3)3), -2.9 (OSi(CH3)2C(CH3)3); HR-TOF-
MS: m/z found 443.2248 [M+H]+ (calculated for C25H35O5Si, 443.2254). 
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6.3.5. Synthesis of (3-Allyl-4-(tert-butyldimethylsilyloxy)-6,8-
dimethoxynaphthalen2-yl)methanol 175 
 
 
Allyl 3-allyl-4-(tert-butyldimethylsilyloxy)-6,8-dimethoxy-2-naphthoate 193 (7.90 g, 
18.4 mmol) was in dissolved dry THF (100 ml) and cooled to 0 oC in an ice bath. 
Lithium aluminium hydride (2.09 g, 55.1 mmol) was added slowly over 15 min. The 
reaction mixture was then stirred vigorously for 2 h at rt under a N2 atmosphere. The 
solution was then cooled to 0 oC in an ice bath and cold H2O (1.5 ml) was added 
drop-wise until the fizzing stopped. Aqueous NaOH (1.5 ml, 15% m/v) and H2O (4.5 
ml) were then added and the resulting mixture was stirred for 3 h at rt.  EtOAc (100 
ml) was then added and the organic layer was separated, dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. Column chromatography 
(20% EtOAc/hexane) of the residue afforded (3-allyl-4-(tert-butyldimethylsilyloxy)-
6,8-dimethoxynaphthalen2-yl)methanol 175 as a clear oil (6.86 g, 96%). Rf = 0.36 
(20 % EtOAc /hexane); 1H NMR (300 MHz, CDCl3) δH = 7.90 (1H, s, H-1), 6.97 (1H, 
d, J 1.9, H-5), 6.46 (1H, d, J 2.2, H-7), 5.96 (1H, dq, J 10.3, 5.7, ArCH2CH=CH2), 
4.98 (1 H, dd, J 10.2, 1.7, one of ArCH2CH=CH2), 4.91 (1 H, dd, J 17.2, 1.7, one of 
ArCH2CH=CH2), 4.77 (2H, s, ArCH2), 3.91 (3H, s, OCH3), 3.90 (3H, s, OCH3), 3.66 
(2H, br d, J 5.7, ArCH2CH=CH2), 2.60 (1H, brs, OH), 1.14 (9H, s, OSi(CH3)2C(CH3)3), 
0.25 (6H, s, OSi(CH3)2C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 160.0 (ArC-O), 
159.0 (ArC-O), 150.5 (ArC-O),  139.5 (ArCH2CH=CH2), 137.9 (C-1), 131.5 (C-3a), 
127.4 (C-2), 123.8 (C-7a), 117.8 (C-8), 117.4 (ArCH2CH=CH2), 99.8 (C-6), 64.4 
(ArCH2), 55.7 (OCH3), 55.5 (OCH3), 30.9 (ArCH2CH=CH2), 26.3 (OSi(CH3)2C(CH3)3), 
19.0 (OSi(CH3)2C(CH3)3), -2.6 (OSi(CH3)2C(CH3)3).5 
 
Chapter 6: Experimental Procedures 
 
 148 
 
6.3.6. Synthesis of tert-butyl(7,9-dimethoxy-3-methyl-1H-
benzo[g]isochromene-5-yloxy)dimethylsilane 174 
 
 
Compound 175 (1.27 g, 3.27 mmol) was dissolved in a DMF/H2O mixture (1:1 v/v, 40 
ml). PdCl2 (0.0589 g, 0.327 mmol) and CuCl2.2H2O (0.558 g, 3.27 mmol) were 
added to the solution which was stirred vigorously for 24 h at rt under an O2(g) 
atmosphere. The reaction was filtered, and EtOAc (2 × 40 ml) was added. The 
organic layers were combined, washed with H2O (3 × 20 ml), separated, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (15% EtOAc/hexane) of the residue afforded tert-butyl(7,9-
dimethoxy-3-methyl-1H-benzo[g]isochromene-5-yloxy)dimethylsilane 174 as a clear 
oil (0.657 g, 52 %). Rf = 0.71 (10 % EtOAc/hexane); IR νmax(cm-1) = 1504, 1450, 
1367, 1257, 1154; 1H NMR (300 MHz, CDCl3) δH  = 7.50 (1H, s, H-10), 6.95 (1H, d, J 
2.0, H-6), 6.41 (1H, d, J 2.2, H-8), 5.99 (1H, s, H-4), 5.14 (2H, d, J 0.8, H-1), 3.92 
(3H, s, OCH3), 3.90 (3H, s, OCH3), 2.01 (3H, d, J 0.5, CH3), 1.17 (9H, s, 
OSi(CH3)2C(CH3)3), 0.21 (6H, s, OSi(CH3)2C(CH3)3); 13C NMR (75 MHz, CDCl3) δC = 
157.7, 156.6 (C-3), 154.6, 141.8, 129.8 (C-9a), 125.1 (C-10a), 120.9 (C-5a), 119.9 
(C-4a), 110.7 (C-10), 97.9 (C-4), 96.9 (C-8), 94.0 (C-6), 69.3 (C-1), 55.6 (OCH3), 
55.3 (OCH3), 26.2 (OSi(CH3)2C(CH3)3),), 20.1 (CH3), 18.8 (OSi(CH3)2C(CH3)3),), -3.1 
(OSi(CH3)2C(CH3)3); HR-TOF-MS: m/z found 387.1984 [M+H]+ (calculated for 
C22H31O4Si, 387.1992). 
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6.3.7. Synthesis of 7,9-Dimethoxy-3-methyl-1H-benzo[g]isochromene-5-ol 173 
 
 
Tert-butyl(7,9-dimethoxy-3-methyl-1H-benzo[g]isochromene-5-yloxy)dimethylsilane 
174 (0.456 g, 1.16 mmol) was dissolved in dry THF (3 ml) and was treated with tetra-
n-butylammonium fluoride (0.609 g, 2.33 mmol) and stirred for 18 h at rt under a 
N2(g) atmosphere. H2O (10 ml) and EtOAc (15 ml) were added and the upper 
organic layer was separated, dried over anhydrous MgSO4, filtered, and the filtrate 
was concentrated in vacuo. The residue was purified by column chromatography 
(10% EtOAc/hexane) to afford 7,9-dimethoxy-3-methyl-1H-benzo[g]isochromene-5-ol 
173 (0.256 g, 73%) as a white crystalline solid. Rf = 0.33 (10 % EtOAc/hexane); Mp. 
= 156-157 °C; IR νmax(cm-1) = 3348 (OH), 1508, 1435, 1290, 1204, 1185;  1H NMR 
(500 MHz, acetone) δH = 7.91 (1H, br s, OH), 7.34 (1H, s, H-10), 7.11 (1H, d, J 2.1, 
H-6), 6.44 (1H, d, J 2.1, H-8), 6.15 (1H, s, H-4), 5.07 (2H, d, J 0.8, H-1), 3.91 (3H, s, 
OCH3), 3.84 (3H, s, OCH3), 1.91 (3H, d, J 0.6, CH3); 13C NMR (125 MHz, acetone) 
δC = 158.9, 157.5, 155.3 (C-3), 143.7, 127.8 (C-9a), 125.8 (C-4a), 121.5 (C-5a), 
116.1 (C-10a), 109.6 (C-10), 97.7 (C-8), 96.9 (C-4), 93.5 (C-6), 69.7 (C-1), 55.9 
(OCH3), 55.5 (OCH3),20.0 (CH3); HR-TOF-MS: m/z found 273.1118 [M+H]+ 
(calculated for C16H17O4, 273.1127). 
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6.3.8. Synthesis of (3-Formyl-4-hydroxy-6,8-dimethoxynaphthalen-2-yl)methyl 
acetate 201 
 
 
7,9-Dimethoxy-3-methyl-1H-benzo[g]isochromene-5-ol 173 (0.200 g, 0.764 mmol) 
and salcomine complex N,N′-bis(salicylidene)ethylenediaminocobalt(II) hydrate 
(0.148 g, 0.44 mmol) were dissolved in CH3CN (30 ml) and stirred for 3 h at rt under 
an O2(g) atmosphere. The reaction was then filtered through celite and the solvent 
was removed in vacuo. The resulting residue was purified by column 
chromatography (30% EtOAc/hexane) to afford (3-formyl-4-hydroxy-6,8-
dimethoxynaphthalene-2-yl)methyl acetate 201 (0.070 g , 30%) as an orange solid. 
Rf = 0.25 (20 % EtOAc/hexane); Mp. = 118-119 °C; IR νmax(cm-1)  = 3455 (OH), 1737 
(C=O), 1620 (C=O), 1578 (C=C), 1433, 1282, 1208, 1160; 1H NMR (300 MHz, 
CDCl3) δH = 13.48 (1H, br s, OH), 10.26 (1H, s, CHO), 7.64 (1H, s, H-1), 7.27 (1H, d, 
J 2.1, H-5), 6.67 (1H, d, J 2.2, H-7), 5.44 (2H, s, ArCH2O), 3.96 (3H, s, OCH3), 3.95 
(3H, s, OCH3), 2.10 (3H, s, OCOCH3); 13C NMR (75 MHz, CDCl3) δC = 195.4 (C=O), 
170.6 (C=O), 162.6, 159.4, 156.6, 128.5, 127.1, 124.6, 116.0, 113.1, 102.5, 94.6, 
64.3 (ArCH2O), 55.9 (OCH3), 55.8 (OCH3), 21.1 (CH3); HR-TOF-MS: m/z found 
305.1027 [M+H]+ (calculated for C16H17O6, 305.1025). 
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6.3.9. Synthesis of (3R,4R) 3-Hydroxy-7,9-dimethoxy-3-methyl-5,10-dioxo-
3,4,5,10-tetrahydro-1H-benzo[g]isochromen-4-yl nitrate 202 
 
 
7,9-Dimethoxy-3-methyl-1H-benzo[g]isochromene-5-ol 173 (0.308, 1.01 mmol) was 
dissolved in CH3CN/H2O mixture (2:1 v/v ratio, 75 ml), and CAN (2.41, 4.40 mmol) in 
H2O (25 ml) was added drop-wise. The reaction was then stirred for 1 h at rt followed 
by the addition of H2O (100 ml) and EtOAc (100 ml). The organic layer was 
separated, dried over anhydrous MgSO4, filtered, and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography (30% EtOAc/hexane) to 
afford (3R,4R) 3-hydroxy-7,9-dimethoxy-3-methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-
benzo[g]isochromen-4-yl nitrate 202 (0.201 g, 54%) as an orange solid. Rf = 0.10 (50 
% EtOAc/hexane); Mp. = 105-106 °C; IR νmax(cm-1) = 3427 (OH), 1728 (C=O), 1658 
(C=O), 1591, 1457, 1269, 1203; 1H NMR (300 MHz, acetone-d6) δH = 7.17 (1H, d, J 
2.4, H-6), 6.93 (1H, d, J 2.4, H-8), 5.95 (1H, s, H-4), 4.62–4.56 (2H, m, H-1), 3.97 
(3H, s, OCH3), 3.94 (3H, s, OCH3), 2.87 (1H, br s, OH), 1.52 (3H, s, CH3); 13C NMR 
(75 MHz, acetone-d6) δC = 183.3 (C=O), 180.6 (C=O), 166.0, 163.4, 149.0 (C-4a), 
136.1 (C-5a), 131.6 (C-10a), 114.6 (C-9a), 105.0 (C-6)*, 104.8 (C-8)*, 95.9 (C-3), 
73.3 (C-4), 58.6 (C-1), 56.8 (OCH3), 56.6 (OCH3), 24.1 (CH3). *assignments may be 
interchanged. 
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6.3.10. Synthesis of Allyl 3-allyl-4-hydroxy-1,6,8-trimethoxy-2-naphthoate 210 
 
Allyl 3-allyl-4-hydroxy-6,8-dimethoxy-2-naphthoate 192 (2.00 g, 6.10 mmol) was 
dissolved in MeOH (80 ml) in a round-bottom flask (100 ml). PIFA (3.41 g, 7.93 
mmol) was added and the reaction was stirred for 15 min at rt. Aqueous NaHCO3 
was added until fizzing stopped and the MeOH was removed in vacuo to leave only 
an aqueous medium. The H2O layer was extracted with EtOAc (2 × 50 ml). The 
organic layers were combined, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The residue was then treated with an 
ethanolic solution of NaOEt (10.9 ml, 33.5 mmol) with vigorous stirring for 20 min at 
rt. The reaction was then quenched with the addition of saturated aqueous NH4Cl 
(10 ml). EtOAc (30 ml) was added and the resulting upper organic layer was 
removed, dried over anhydrous MgSO4, filtered and concentrated in vacuo. Column 
chromatography (10% EtOAc/hexane) of the residue afforded allyl 3-allyl-4-hydroxy-
1,6,8-trimethoxy-2-naphthoate 210 as a brown oil (1.21 g, 60%). Rf = 0.54 (20 % 
EtOAc/hexane);  Mp. = 58-59 °C; IR νmax(cm-1) = 3257 (OH), 1738 (C=O), 1601 
(C=C), 1441, 1274, 1229, 1189; 1H NMR (300 MHz, CDCl3) δH = 7.08 (1H, br s, H-5), 
6.52 (1H, br s, H-7), 6.10–5.90 (2H, m, COOCH2CH=CH2 and ArCH2CH=CH2), 5.57 
(1H, s, OH), 5.41 (1H, ddd, J 17.2, 2.9, 1.4, one of COOCH2CH=CH2), 5.33–5.14 
(3H, m, one of COOCH2CH=CH2 and ArCH2CH=CH2), 4.89–4.79 (2H, m, 
COOCH2CH=CH2), 3.94 (3H, s, OCH3), 3.89 (3H, s, OCH3), 3.82 (3H, s, OCH3), 3.43 
(2H, br d, J 6.1, ArCH2CH=CH2); 13C NMR (75 MHz, CDCl3) δC = 168.2 (C=O), 
158.7, 157.4, 147.6, 145.3, 135.3 (COOCH2CH=CH2 and C-4a, overlapped), 131.9 
(ArCH2CH=CH2), 129.5 (C-3), 124.3 (C-8a), 118.8 (COOCH2CH=CH2), 116.8 
(ArCH2CH=CH2), 116.7 (C-2), 114.9, 99.4 (C-7), 92.9 (C-5), 66.0 
(COOCH2CH=CH2), 63.9 (OCH3), 55.9 (OCH3), 55.2 (OCH3), 32.6 (ArCH2CH=CH2); 
HR-TOF-MS-ES: m/z found 381.1314 [M+Na]+ (calculated for C20H22O6Na, 
381.1314). 
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6.3.11. Synthesis of Allyl 3-allyl-1,4,6,8-tetramethoxy-2-naphthoate 212 
 
 
Allyl 3-allyl-4-hydroxy-1,6,8-trimethoxy-2-naphthoate 210 (0.513 g, 1.40 mmol), 
anhydrous K2CO3 (0.289 g, 2.10 mmol) and Me2SO4 (0.264 g, 2.10 mmol) were 
dissolved in acetone (30 ml). The mixture was then refluxed for 18 h, cooled to rt, 
filtered, and the solvent was removed in vacuo. The residue was then dissolved in 
EtOAc (50 ml) and was successively washed with aqueous NH3 (25%, 50 ml) and 
H2O (50 ml). The organic layer was dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (10% 
EtOAc/hexane) of the residue afforded allyl 3-allyl-1,4,6,8-tetramethoxy-2-
naphthoate 212 as a yellow solid (0.466 g, 89%). Rf = 0.60 (25 % EtOAc/hexane); 
Mp. = 60-61 °C; IR νmax(cm-1) = 1718 (C=O), 1581 (C=C), 1450, 1299, 1214, 1191; 
1H NMR (500 MHz, CDCl3) δH = 6.97 (1H, s, H-5), 6.52 (1H, s, H-7), 6.07–5.90 (2H, 
m, COOCH2CH=CH2 and ArCH2CH=CH2), 5.41 (1H, d, J 17.2, one of 
COOCH2CH=CH2), 5.26 (1H, d, J 10.4, one of COOCH2CH=CH2), 5.04 (2H, t, J 
14.0, ArCH2CH=CH2), 4.80 (2H, dd, J 6.0, 0.8, COOCH2CH=CH2), 3.93 (3H, s, 
OCH3), 3.90 (3H, s, OCH3), 3.84 (3H, s, OCH3) 3.82 (3H, s, OCH3), 3.55 (2H, d, J 
6.2, ArCH2CH=CH2); 13C NMR (125 MHz, CDCl3) δC = 167.7 (C=O), 159.4, 157.9, 
150.6, 149.2, 136.2 (COOCH2CH=CH2), 132.7 (C-4a), 132.1 (ArCH2CH=CH2), 126.6 
(C-3), 124.7 (C-8a), 118.8 (COOCH2CH=CH2), 115.9 (ArCH2CH=CH2), 115.3 (C-2), 
99.3 (C-5), 93.2 (C-7), 65.9 (COOCH2CH=CH2), 63.9 (OCH3), 61.5 (OCH3), 56.1 
(OCH3), 55.3 (OCH3), 31.7 (ArCH2CH=CH2); HR-TOF-MS-ES: m/z found 395.1466 
[M+Na]+ (calculated for C21H24O6Na, 395.1471). 
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6.3.12. Synthesis of (3-Allyl-1,4,6,8-tetramethoxynaphthalen-2-yl)methanol 213 
OCH3
H3CO
OH
OCH3
OCH3
1 2
345
6
7
8
213
 
 
Allyl 3-allyl-1,4,6,8-tetramethoxy-2-naphthoate 212 (6.30 g, 16.9 mmol) was 
dissolved in dry Et2O (100 ml) and cooled to 0 °C in an ice bath. Lithium aluminium 
hydride (1.29 g, 33.8 mmol) was added slowly over 5 min. The reaction mixture was 
then stirred vigorously for 2 h at rt under a N2(g) atmosphere. The solution was then 
cooled to 0 °C in an ice bath and cold H2O was added drop-wise until the fizzing 
ceased. EtOAc (100 ml) was added and the solution was washed with HCl (aq) (2 M, 
30 ml). The organic layer was then dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (40% 
EtOAc/hexane) of the residue afforded (3-allyl-1,4,6,8-tetramethoxynaphthalen-2-
yl)methanol 213 as a white crystalline solid (4.50 g, 84%). Rf = 0.22 (40 % 
EtOAc/hexane); Mp. = 122-123 °C; IR νmax(cm-1) = 3481 (OH), 1580 (C=C), 1447, 
1262, 1204, 1114; 1H NMR (300 MHz, CDCl3) δH = 6.97 (1H, d, J 2.3, H-5), 6.52 (1H, 
d, J 2.3, H-7), 6.19–5.98 (1H, m, ArCH2CH=CH2), 5.05 (1H, dd, J 10.2, 1.7, one of 
ArCH2CH=CH2), 4.90 (1H, dd, J 17.2, 1.8, one of ArCH2CH=CH2), 4.78 (2H, s, 
ArCH2), 3.96 (3H, s, OCH3), 3.91 (3H, s, OCH3), 3.84 (3H, s, OCH3), 3.83 (3H, s, 
OCH3), 3.70 (2H, dt, J 5.3, 1.7, ArCH2CH=CH2), 2.55 (1H, br s, OH); 13C NMR (75 
MHz, CDCl3) δC = 158.7, 157.6, 152.2, 149.5, 137.9 (ArCH2CH=CH2), 131.9 (C-4a), 
129.1 (C-3), 128.1 (C-2), 115.6 (C-8a), 115.4 (ArCH2CH=CH2), 99.0 (C-5), 93.2 (C-
7), 63.3 (OCH3), 61.6 (OCH3), 57.5 (ArCH2), 56.1 (OCH3), 55.3 (OCH3), 30.7 
(ArCH2CH=CH2); HR-TOF-MS-ES: m/z found 341.1367 [M+Na]+ (calculated for 
C18H22O5Na, 341.1365). 
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6.3.13. Synthesis of 5,7,9,10-Tetramethoxy-3-methyl-1H-benzo[g]isochromene 
214 
 
 
(3-Allyl-1,4,6,8-tetramethoxynaphthalen-2-yl)methanol 213 (4.00 g, 12.6 mmol) was 
dissolved in a DMF/H2O mixture (1:1 v/v, 100 ml). PdCl2 (0.223 g, 1.26 mmol) and 
CuCl2.2H2O (2.14 g, 12.6 mmol) were added to the solution and O2(g) was bubbled 
through the solution which was stirred vigorously for 2 h at rt. The reaction was 
filtered, and EtOAc (2 × 50 ml) was added. The organic layers were combined, 
washed with H2O (3 × 20 ml), separated, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (eluant 15 % 
EtOAc/hexane) of the residue afforded 5,7,9,10-tetramethoxy-3-methyl-1H-
benzo[g]isochromene 214 as a white crystalline solid (2.62 g, 66%). Rf = 0.63 (20 % 
EtOAc/hexane);  Mp. = 134-135 °C; IR νmax(cm-1) = 1601 (C=C), 1501, 1444, 1256, 
1217, 1155; 1H NMR (300 MHz, CDCl3) δH = 6.96 (1H, d, J 2.3, H-6), 6.46 (1H, d, J 
2.2, H-8), 5.95 (1H, s, H-4), 5.28 (2H, s, H-1), 3.94 (3H, s, OCH3), 3.91 (3H, s, 
OCH3), 3.85 (3H, s, OCH3), 3.76 (3H, s, OCH3), 2.02 (3H, s, CH3); 13C NMR (125 
MHz, CDCl3) δC = 158.5, 157.7, 156.1 (C-3), 147.5, 143.0, 131.9 (C-5a), 122.3 (C-
4a), 116.9 (C-10a), 114.9 (C-9a), 98.3 (C-6), 95.6 (C-4), 93.1 (C-8), 64.0 (C-1), 62.2 
(OCH3), 61.2 (OCH3), 56.0 (OCH3), 55.3 (OCH3), 20.1 (CH3); HR-TOF-MS-ES: m/z 
found 339.1209 [M+Na]+ (calculated for C18H20O5Na, 339.1208). 
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6.3.14. Synthesis of 7,9-Dimethoxy-3-methyl-1H-benzo[g]isochromene-5,10-
dione 31 
 
 
5,7,9,10-Tetramethoxy-3-methyl-1H-benzo[g]isochromene 214 (0.200 g, 0.632 
mmol) was dissolved in a CH3CN/H2O mixture (1:1 v/v, 8 ml), followed by the 
addition of PIFA (0.408 g, 0.948 mmol). The reaction was stirred for 2 h at rt, before 
being quenched by aqueous NaHCO3 (15 ml). EtOAc was added (2 × 30 ml), and 
the organic layers were separated, combined, dried over anhydrous MgSO4, filtered, 
and the solvent was removed in vacuo. The residue was purified by column 
chromatography (30% EtOAc/hexane) to afford 7,9-dimethoxy-3-methyl-1H-
benzo[g]isochromene-5,10-dione 31 (0.045 g, 25%) as a dark-red amorphous solid. 
Rf = 0.10 (50 % EtOAc/hexane); 1H NMR (500 MHz, CDCl3) δH = 7.21 (1H, d, J 2.4, 
H-6), 6.68 (1H, d, J 2.4, H-8), 5.81 (1H, s, H-4), 5.09 (2H, s, H-1), 3.93 (3H, s, 
OCH3), 3.92 (3H, s, OCH3), 1.98 (3H, s, CH3); 13C NMR (125 MHz, CDCl3) δC 182.4 
(C=O), 181.0 (C=O), 164.3, 163.4, 161.6 (C-3), 135.7 (C-4a), 135.5 (C-5a), 124.9 
(C-10a), 114.7 (C-9a), 104.4 (C-8) 103.7 (C-6), 93.9 (C-4), 63.5 (C-1), 56.5 (OCH3), 
56.0 (OCH3), 20.2 (CH3)6. 
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6.3.15. Synthesis of 3,4-Dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-
benzo[g]isochromene-5,10-dione 218 
 
 
5,7,9,10-Tetramethoxy-3-methyl-1H-benzo[g]isochromene 20 (0.400 g, 1.26 mmol) 
was dissolved in a CH3CN/H2O mixture (1:1 v/v, 20 ml), followed by the addition of 
PIFA (0.815 g, 1.90 mmol). The reaction was stirred for 2 h at rt, before being 
quenched by aqueous NaHCO3 (30 ml). EtOAc was added (2 × 30 ml), and the 
organic layers were separated, combined, dried over anhydrous MgSO4, filtered, and 
the solvent was removed in vacuo. The residue was purified by column 
chromatography (60% EtOAc/hexane) to afford 3,4-dihydroxy-7,9-dimethoxy-3-
methyl-3,4-dihydro-1H-benzo[g]isochromene-5,10-dione 21 (0.098 g, 24%) as a 
brown amorphous solid. Rf = 0.10 (70 % EtOAc/hexane); IR νmax(cm-1) = 3415 (OH), 
1725 (C=O), 1649 (C=O), 1383, 1321, 1274, 1200; 1H NMR (300 MHz, acetone-d6) 
δH = 7.20 (1H, d, J 2.3, H-6), 6.91 (1H, d, J 2.4, H-8), 4.53 (2H, s, H-1), 4.35 (1H, s, 
H-4),  3.99 (3H, s, OCH3), 3.95 (3H, s, OCH3), 1.56 (3H, s, CH3); 13C NMR (75 MHz, 
DMSO-d6) δC = 182.8 (C=O), 181.1 (C=O), 164.4 (ArC-O), 161.7 (ArC-O), 143.4 (C-
4a), 137.5 (C-5a), 135.3 (C-10a), 112.9 (C-9a), 103.8 (C-8) 103.7 (C-6), 95.9 (C-3), 
61.7 (C-4), 57.5 (C-1), 56.4 (OCH3), 56.0 (OCH3), 24.5 (CH3); HR-TOF-MS-ES: m/z 
found 343.0791 [M-Na] (calculated for C16H16O7Na, 343.0794). 
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6.4. Experimental Work Pertaining to the Synthesis of 
Anhydrofusarubin 
6.4.1. Synthesis of Ethyl 4-acetoxy-5,6,8-trimethoxy-2-naphthoate 162 
OCH3
H3CO
OCH2CH3
O
1 2
3
45
6
7
8
162
O
O
OCH3
 
 
To a solution of 2,4,5-trimethoxybenzaldehyde (4.00 g, 24.1 mmol) and diethyl 
succinate (5.45 g, 31.29 mmol) in dry THF (50 ml), at 0 °C, was added NaOEt (3.28 
g, 48.1 mmol). The reaction mixture was refluxed for 2 h, cooled to rt and then 
acidified to pH 3 with aqueous HCl [33% (v/v)]. The product precipitated and was 
extracted with EtOAc (2 × 50 ml). The combined organic extracts were dried over 
MgSO4, filtered, and the filtrate was concentrated in vacuo. The residue and 
anhydrous NaOAc (2.57 g, 31.3 mmol) were dissolved in acetic anhydride (50 ml) 
and refluxed for 3 h. The solvent was removed in vacuo and the resulting residue 
was dissolved in EtOAc (60 ml). Aqueous NaHCO3 was slowly added to the EtOAc 
layer until no effervescence was visible and all the traces of acetic acid were 
eliminated. The organic layer was then separated, dried over MgSO4, filtered, and 
the filtrate was concentrated in vacuo. The residue was purified by column 
chromatography (30% EtOAc/hexane) to afford ethyl 4-acetoxy-6,8-dimethoxy-2-
naphthoate 162 (8.69 g, 82%) as a yellow solid. Rf = 0.64 (40 % EtOAc/hexane); 1H 
NMR (300 MHz, CDCl3) δH = 8.83 (1H, d, J 1.6, H-1), 7.68 (1H, d, J 1.6, H-3), 6.67 
(1H, s, H-7), 4.39 (2H, q, J 7.1, OCH2CH3), 3.98 (6H, s,  2 x OCH3), 3.82 (3H, s, 
OCH3), 2.38 (CH3CO2), 1.42 (3H, t, J 7.1, OCH2CH3)7. 
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6.4.2. Synthesis of Allyl 4-(allyloxy-)-5,6,8-trimethoxy-2-naphthoate 220 
 
 
Ethyl 4-acetoxy-5,6,8-trimethoxy-2-naphthoate 162 (5.40 g, 15.5 mmol) was 
dissolved in MeOH (80 ml) followed by the drop-wise addition of aqueous KOH (4.35 
g, 77.5 mmol, 150 ml H2O). The dark-orange reaction was stirred for 6 h at rt, before 
the MeOH was removed in vacuo. The aqueous solution was then carefully acidified 
to pH 4.0 with aqueous HCl (30%), and then extracted with EtOAc (3 × 100 ml). The 
organic layers were combined, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude, off-white solid was then dissolved 
in Me2CO (100 ml). Allyl bromide (4.69 g, 38.8 mmol), anhydrous K2CO3 (5.36 g, 
38.8 mmol) was then added to the solution which was refluxed for 18 h under a N2(g) 
atmosphere. The mixture was then allowed to cool to rt, filtered through a bed of 
celite, and the solvent was removed in vacuo. The light-yellow residue was then 
purified using column chromatography (10% EtOAc/hexane) to yield allyl 4-(allyloxy)-
5,6,8-trimethoxy-2-naphthoate 220 as a yellow solid (4.67 g, 84%). Rf = 0.65 (20 % 
EtOAc/hexane); Mp. = 70-71°C; IR νmax(cm-1) = 1712 (C=O), 1505, 1465, 1258, 
1201, 1180; 1H NMR (300 MHz, CDCl3) δH = 8.57 (1H, d, J 1.2, H-1), 7.41 (1H, d, J 
1.0, H-3), 6.66 (1H, s, H-7), 6.28–5.97 (2H, m, COOCH2CH=CH2 and 
OCH2CH=CH2), 5.57 (1H, dd, J 17.2, 1.4, one of COOCH2CH=CH2), 5.41 (1H, dd, J 
17.2, 1.3, one of COOCH2CH=CH2), 5.30 (2H, dd, J 15.1, 5.7, OCH2CH=CH2), 4.84 
(2H, d, J 5.6, COOCH2CH=CH2), 4.69 (2H, d, J 5.1, OCH2CH=CH2), 3.97 (3H, s, 
OCH3), 3.96 (3H, s, OCH3), 3.80 (3H, s, OCH3); 13C NMR (75 MHz, CDCl3) δC = 
166.5 (C=O), 154.6, 153.5, 152.3, 137.7, 133.2 (OCH2CH=CH2), 132.6 
(COOCH2CH=CH2), 124.5 (C-2), 124.2 (C-4a), 122.1 (C-8a), 118.8 (C-1), 118.1 
(OCH2CH=CH2), 117.5 (COOCH2CH=CH2), 107.7 (C-3), 96.0 (C-7), 70.4 
(OCH2CH=CH2) 65.6 (COOCH2CH=CH2), 62.0 (OCH3), 55.1 (OCH3), 55.9 (OCH3); 
HR-TOF-MS: m/z found 359.1499 [M+H]+ (calculated for C20H23O6, 359.1495). 
Chapter 6: Experimental Procedures 
 
 160 
 
6.4.3. Synthesis of Allyl 3-allyl-4-hydroxy-5,6,8-trimethoxy-2-naphthoate 221 
 
 
Allyl 4-(allyloxy)-5,6,8-trimethoxy-2-naphthoate 220 (3.10 g, 8.65 mmol) was loaded 
neat into a round-bottom flask (50 ml) equipped with a reflux condenser and a 
magnetic stirrer bar. The reaction vessel was then heated to 190 °C for 18 h under a 
N2(g) atmosphere. The dark viscous residue was allowed to cool to rt and was then 
purified by column chromatography (20% EtOAc/hexane) to yield allyl 3-allyl-4-
hydroxy-5,6,8-trimethoxy-2-naphthoate 221 as a yellow amorphous solid (2.73 g, 
88%). Rf = 0.50 (20 % EtOAc/hexane); Mp. = 68-69 °C; IR νmax(cm-1) = 3280 (OH), 
1738 (C=O), 1604 (C=C), 1365, 1229, 1208, 1182; 1H NMR (300 MHz, CDCl3) δH = 
10.07 (1H, br s, OH), 8.25 (1H, s, H-1), 6.55 (1H, s, H-7), 6.15–5.99 (2H, m, 
COOCH2CH=CH2 and ArCH2CH=CH2 overlapped), 5.41 (1H, dd, J 17.2, 1.5, one of 
COOCH2CH=CH2), 5.27 (1H, dd, J 10.4, 1.3, one of COOCH2CH=CH2), 5.06–4.97 
(2H, m, ArCH2CH=CH2), 4.86–4.77 (2H, m, COOCH2CH=CH2), 3.98 (3H, s, OCH3), 
3.97 (3H, s, OCH3), 3.95 (3H, s, OCH3), 3.88 (2H, br d, J 5.9, ArCH2CH=CH2); (75 
MHz, CDCl3) δC = 167.7 (C=O), 153.9, 151.1, 149.3, 137.4 (COOCH2CH=CH2), 
135.9, 132.6 (ArCH2CH=CH2), 127.4 (C-3) 121.1 (C-4a), 120.0 (C-8a), 119.6 (C-2), 
118.2 (COOCH2CH=CH2), 116.7 (C-1), 114.4 (ArCH2CH=CH2), 94.8 (C-7), 65.6 
(COOCH2CH=CH2), 62.3 (OCH3), 57.0 (OCH3), 55.8 (OCH3), 30.1 (ArCH2CH=CH2); 
HR-TOF-MS-ES: m/z found 381.1307 [M+Na]+ (calculated for C20H22O6Na, 
381.1314). 
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6.4.4. Synthesis of Allyl 3-allyl-4,5,6,8-tetramethoxy-2-naphthoate 222 
 
 
Allyl 3-allyl-4-hydroxy-5,6,8-trimethoxy-2-naphthoate 221 (2.60 g, 7.25 mmol), 
anhydrous K2CO3 (1.50 g, 10.9 mmol) and Me2SO4 (1.37 g, 10.9 mmol) were 
dissolved in acetone (50 ml) in a round-bottom flask (100 ml). The solution was 
refluxed for 12 h under a N2(g) atmosphere. The mixture was then allowed to cool to 
rt, filtered through a bed of celite, and the solvent was removed in vacuo. The 
residue was then dissolved in EtOAc (50 ml) and was successively washed with 
aqueous NH3 (25%, 3 × 20 ml), HCl (0.5 M, 2 × 20 ml) and H2O (50 ml). The EtOAc 
layer was dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. Column chromatography (10% EtOAc/hexane) of the residue afforded allyl 
3-allyl-4,5,6,8-tetramethoxy-2-naphthoate 222 (2.43 g, 90%) as an off-white solid. Rf 
= 0.60 (25 % EtOAc/hexane); Mp. = 66-67 °C; IR νmax(cm-1) = 1740 (C=O), 1602 
(C=C), 1358, 1442, 1225, 1137; 1H NMR (300 MHz, CDCl3) δH = 8.52 (1H, s, H-1), 
6.65 (1H, s, H-7), 6.13–5.95 (2H, m, COOCH2CH=CH2 and ArCH2CH=CH2 
overlapped), 5.39 (1H, ddd, J 17.2, 3.0, 1.5, one of COOCH2CH=CH2), 5.26 (1H, dd, 
J 10.4, 1.3, one of COOCH2CH=CH2), 4.98–4.91 (2H, m, ArCH2CH=CH2), 4.79 (2H, 
dt, J 5.6, 1.3, COOCH2CH=CH2), 3.98 (3H, s, OCH3), 3.96 (5H, br s, OCH3 and 
ArCH2CH=CH2 overlapped), 3.79 (3H, s, OCH3), 3.79 (3H, s, OCH3); 13C NMR (75 
MHz, CDCl3) δC = 167.4 (C=O), 156.6, 153.1, 152.2, 138.2 (COOCH2CH=CH2), 
135.8, 132.4 (ArCH2CH=CH2), 130.4 (C-3) 126.3 (C-4a), 125.4 (C-8a), 122.2 (C-1), 
120.7 (C-2) 118.2 (COOCH2CH=CH2), 114.7 (ArCH2CH=CH2), 94.8 (C-7), 65.5 
(COOCH2CH=CH2), 62.7 (OCH3), 62.0 (OCH3), 56.9 (OCH3), 55.8 (OCH3), 30.1 
(ArCH2CH=CH2); HR-TOF-MS-ES: m/z found 395.1465 [M+Na]+ (calculated for 
C21H24O6Na, 395.1471). 
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6.4.5. Synthesis of (3-Allyl-4,5,6,8-tetramethoxynaphthalen-2-yl)methanol 223 
 
 
Allyl 3-allyl-4,5,6,8-tetramethoxy-2-naphthoate 222 (1.80 g, 4.83 mmol) was 
dissolved dry Et2O (50 ml) and cooled to 0 °C in an ice bath. Lithium aluminium 
hydride (0.367 g, 9.67 mmol) was added slowly over 5 min. The reaction mixture was 
then stirred vigorously for 2 h at rt under a nitrogen atmosphere. The solution was 
then cooled to 0 °C in an ice bath and cold H2O was added drop-wise until the fizzing 
stopped. EtOAc (50 ml) was added and the solution was washed with aqueous HCl 
(2 M, 10 ml). The organic layer was then dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (40% 
EtOAc/hexane) of the residue afforded (3-allyl-4,5,6,8-tetramethoxynaphthalen-2-
yl)methanol 233 as a white crystalline solid (1.32 g, 86%). Rf = 0.24 (40 % 
EtOAc/hexane); 1H NMR (300 MHz, CDCl3) δH = 8.02 (1H, s, H-1), 6.64 (1H, s, H-7), 
6.07 (1H, tdd, J 15.7, 10.5, 5.5, ArCH2CH=CH2), 5.05–4.94 (1H, m, one of 
ArCH2CH=CH2), 4.94–4.81 (1H, m, one of ArCH2CH=CH2), 4.76 (2H, s, ArCH2OH), 
3.98 (3H, s, OCH3), 3.94 (3H, s, OCH3), 3.82 (3H, s, OCH3), 3.81 (3H, s, OCH3), 
3.71–3.61 (2H, m, ArCH2CH=CH2), 2.33 (1H, br s, OH); 13C NMR (75 MHz, CDCl3) 
δC = 152.9, 152.6, 150.0, 138.0 (ArCH2CH=CH2), 136.2 (C-4a), 135.8, 129.3 (C-3), 
123.2 (C-2), 122.0 (C-8a), 117.5 (C-1), 115.1 (ArCH2CH=CH2), 95.0 (C-7), 63.6 
(ArCH2OH), 62.8 (OCH3), 62.0 (OCH3), 57.1 (OCH3), 55.8 (OCH3), 29.8 
(ArCH2CH=CH2).7 
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6.4.6. Synthesis of 5,6,7,9-Tetramethoxy-3-methyl-1H-benzo[g]isochromene 
169 
 
 
(3-Allyl-4,5,6,8-tetramethoxynaphthalen-2-yl)methanol 223 (1.40 g, 4.40 mmol) was 
dissolved in a DMF/H2O mixture (1:1 v/v, 20 ml). PdCl2 (0.0780 g, 0.440 mmol) and 
CuCl2.2H2O (0.750 g, 4.40 mmol) were added to the solution and O2(g) was bubbled 
through the solution which was stirred vigorously for 2 h at rt. The reaction was 
filtered, and EtOAc (2 × 30 ml) was added. The organic layers were combined, 
washed with H2O (3 × 20 ml), separated, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (15% 
EtOAc/hexane) of the residue afforded 5,6,7,9-tetramethoxy-3-methyl-1H-
benzo[g]isochromene 169 as a white crystalline solid (0.890 g, 64%). Rf = 0.65 (20 
% EtOAc/hexane); Mp. = 101-102 °C; 1H NMR (300 MHz, CDCl3) δH = 7.61 (1H, s, 
H-10), 6.57 (1H, s, H-8), 6.18–6.03 (1H, m, H-4), 5.12 (2H, s, H-1), 3.97 (3H, s, 
OCH3), 3.93 (3H, s, OCH3), 3.84 (3H, s, OCH3), 3.84 (3H, s, OCH3), 2.00 (3H, s, 
CH3); 13C NMR (75 MHz, CDCl3) δC = 156.1 (C-3), 152.6, 149.9, 146.1, 136.6, 125.5 
(C-4a), 123.9 (C-10a), 123.4 (C-9a), 121.4 (C-5a), 113.0 (C-10), 96.0 (C-4), 94.3 (C-
8), 68.7 (C-1), 62.3 (OCH3), 62.0 (OCH3), 55.8 (OCH3), 55.7 (OCH3), 20.1 (CH3); 
HR-TOF-MS-ES: m/z found 339.1207 [M+Na]+ (calculated for C18H20O5Na, 
339.1209). 
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6.4.7. Synthesis of Allyl 3-allyl-4-hydroxy-1,5,6,8-tetramethoxy-2-naphthoate 
225 
 
 
Allyl 3-allyl-4-hydroxy-5,6,8-trimethoxy-2-naphthoate 221 (8.00 g, 22.3 mmol) was 
dissolved in MeOH (120 ml) in a round-bottom flask (250 ml). PIFA (12.5 g, 29.0 
mmol) was added and the reaction was stirred for 10 min at rt. Aqueous NaHCO3 
was added until fizzing stopped and the MeOH was removed in vacuo to leave only 
an aqueous medium. The H2O layer was extracted with EtOAc (2 × 100 ml). The 
organic layers were combined, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The residue was then treated with an 
ethanolic solution of NaOEt (36.1 ml, 111.5 mmol) with vigorous stirring for 20 min at 
rt. The reaction was quenched with the addition of saturated aqueous NH4Cl (50 ml). 
EtOAc (100 ml) was added and the resulting upper organic layer was removed, dried 
over anhydrous MgSO4, filtered and concentrated in vacuo. Column chromatography 
(15% EtOAc/hexane) of the residue afforded allyl 3-allyl-4-hydroxy-1,5,6,8-
tetramethoxy-2-naphthoate 225 as an orange amorphous solid (4.70 g, 54%). Rf = 
0.54 (20 % EtOAc/hexane); IR νmax(cm-1) = 3215 (OH), 1724 (C=O), 1609 (C=C), 
1580 (C=C), 1287, 1260, 1152; 1H NMR (300 MHz, CDCl3) δH = 10.18 (1H, br s, 
OH), 6.59 (1H, s, H-7), 6.07–5.89 (2H, m, COOCH2CH=CH2 and ArCH2CH=CH2), 
5.44–5.33 (1H, m, one of COOCH2CH=CH2), 5.24 (1H, dd, J 10.4, 1.3, one of 
COOCH2CH=CH2), 5.08–4.93 (2H, m, ArCH2CH=CH2), 4.83–4.77 (2H, m, 
COOCH2CH=CH2), 3.92 (3H, s, OCH3), 3.91 (3H, s, OCH3), 3.91 (3H, s, OCH3), 3.74 
(3H, s, OCH3), 3.42 (2H, br d, J 6.3 ArCH2CH=CH2); 13C NMR (75 MHz, CDCl3) δC = 
167.8 (C=O), 154.0, 148.3, 147.1, 145.7, 136.5 (C-4a), 135.9 (ArCH2CH=CH2), 
132.1 (COOCH2CH=CH2), 126.3 (C-3), 120.2 (C-8a), 118.8 (COOCH2CH=CH2), 
118.0 (C-2), 115.23 (ArCH2CH=CH2), 115.19, 96.8 (C-7), 65.9 (COOCH2CH=CH2), 
63.9 (OCH3), 62.3 (OCH3), 56.8 (OCH3), 56.7 (OCH3), 31.5 (ArCH2CH=CH2); HR-
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TOF-MS-ES: m/z found 411.1417 [M+Na]+ (calculated for C21H24O7Na, 411.1420). 
 
6.4.8. Synthesis of Allyl 3-allyl-1,4,5,6,8-pentamethoxy-2-naphthoate 226 
 
 
Allyl 3-allyl-4-hydroxy-1,5,6,8-tetramethoxy-2-naphthoate 225 (3.80 g, 10.09 mmol), 
anhydrous K2CO3 (2.09 g, 15.1 mmol) and Me2SO4 (1.91 g, 15.1 mmol) were 
dissolved in acetone (60 ml). The mixture was then refluxed for 18 h, cooled to rt, 
filtered, and the solvent was removed in vacuo. The residue was then dissolved in 
EtOAc (80 ml) and was successively washed with aqueous NH3 (25%, 80 ml) and 
H2O (80 ml). The organic layer was dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (15% 
EtOAc/hexane) of the residue afforded allyl 3-allyl-1,4,5,6,8-pentamethoxy-2-
naphthoate 226 as a yellow oil (3.30 g, 81%). Rf = 0.59 (20 % EtOAc/hexane); IR 
νmax(cm-1) = 1738 (C=O), 1603 (C=C), 1438, 1364, 1216, 1045; 1H NMR (300 MHz, 
CDCl3) δH = 6.69 (1H, s, H-7), 6.07–5.86 (2H, m, COOCH2CH=CH2 and 
ArCH2CH=CH2), 5.38 (1H, dd, J 17.2, 1.5, one of COOCH2CH=CH2), 5.23 (1H, dd, J 
10.4, 1.2, one of COOCH2CH=CH2), 5.07–4.93 (2H, m, ArCH2CH=CH2), 4.82–4.73 
(2H, m, COOCH2CH=CH2), 3.95 (3H, s, OCH3), 3.93 (3H, s, OCH3), 3.77 (3H, s, 
OCH3), 3.75 (3H, s, OCH3), 3.73 (3H, s, OCH3), 3.53 (2H, br d, J 6.2, 
ArCH2CH=CH2); 13C NMR (75 MHz, CDCl3) δC = 167.7 (C=O), 153.8, 151.1, 150.2, 
149.2, 136.7 (C-4a), 136.6 (ArCH2CH=CH2), 132.1 (COOCH2CH=CH2), 127.7 (C-
8a), 126.5 (C-2)*, 125.3 (C-3)*, 119.0 (COOCH2CH=CH2), 116.0 (ArCH2CH=CH2), 
115.9, 97.1 (C-7), 66.1 (COOCH2CH=CH2), 63.9 (OCH3), 62.8 (OCH3), 62.1 (OCH3), 
56.9 (OCH3), 56.8 (OCH3), 31.6 (ArCH2CH=CH2); *assignments may be 
interchanged; HR-TOF-MS-ES: m/z found 425.1573 [M+Na]+ (calculated for 
C22H26O7Na, 425.1576). 
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6.4.9. Synthesis of 5,6,7,9,10-Pentamethoxy-3-methyl-1H-
benzo[g]isochromene 228 
 
 
Allyl 3-allyl-1,4,5,6,8-pentamethoxy-2-naphthoate 226 (3.30 g, 8.20 mmol) was 
dissolved in dry Et2O (100 ml) and cooled to 0 °C in an ice bath. Lithium aluminium 
hydride (0.622 g, 16.4 mmol) was added slowly over 5 min. The reaction mixture was 
stirred vigorously for 2 h at 40 °C under a N2(g) atmosphere. The solution was then 
cooled to 0 °C in an ice bath and cold H2O was added drop-wise until the fizzing 
stopped. EtOAc (100 ml) was added and the solution was washed with aqueous HCl 
(2M, 20 ml). The organic layer was then dried over anhydrous MgSO4, filtered 
through a short pad of silica, and concentrated under reduced pressure to yield a 
yellow residue of what was presumed to be (3-allyl-1,4,5,6,8-pentamethoxy-2-
naphthalen-2-yl)methanol 227. This residue was dissolved in a DMF/H2O mixture 
(1:1 v/v, 70 ml). PdCl2 (0.145 g, 0.820 mmol) and CuCl2.2H2O (1.40 g, 8.20 mmol) 
were added to the solution and O2(g) was bubbled through the solution which was 
stirred vigorously for 2 h at rt. The reaction was filtered, and EtOAc (2 × 50 ml) was 
added. The organic layers were combined, washed with H2O (3 × 50 ml), separated, 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. 
Column chromatography (10% EtOAc/hexane) of the residue afforded 5,6,7,9,10-
pentamethoxy-3-methyl-1H-benzo[g]isochromene 228 as a white crystalline solid 
(1.40 g, 49% over two steps). Rf = 0.64 (20 % EtOAc/hexane); Mp. = 122-123 °C; IR 
νmax(cm-1) = 1654 (C=C), 1597 (C=C), 1339, 1178, 1134; (500 MHz, CDCl3) δH = 
6.64 (1H, s, H-8), 6.03 (1H, s, H-4), 5.26 (2H, s, H-1), 3.99 (3H, s, OCH3), 3.97 (3H, 
s, OCH3), 3.80 (3H, s, OCH3), 3.79 (3H, s, OCH3), 3.74 (3H, s, OCH3), 2.00 (3H, s, 
CH3); 13C NMR (125 MHz, CDCl3) δC = 156.9 (C-3), 153.3, 150.0, 147.3, 142.6, 
136.8, 125.8 (C-5a), 122.6 (C-10a), 117.6 (C-4a), 115.7 (C-9a), 96.1 (C-8), 95.6 (C-
4), 63.8 (C-1), 62.3 (OCH3), 62.2 (OCH3), 62.0 (OCH3), 56.9 (OCH3), 56.5 (OCH3), 
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20.1 (CH3); HR-TOF-MS-ES: m/z found 369.1312 [M+Na]+ (calculated for 
C19H22O6Na, 369.1314). 
 
6.4.10. Synthesis of 5,7,10-Trimethoxy-3-methyl-1H-benzo[g]isochromene-
6,9-dione 229 and 5,9,10-trimethoxy-3-methyl-1H-benzo[g]isochromene-6,7-
dione 230 
 
5,6,7,9,10-Pentamethoxy-3-methyl-1H-benzo[g]isochromene 228 (0.400 g, 1.15 
mmol) was dissolved in 1,4-dioxane (30 ml) at RT. AgO (5.77 mmol, 0.715 g) was 
then added to the stirred solution, followed by the dropwise addition of HNO3 (6 M, 
6.4 ml) to the solution which was the stirred for a further 5 min. CH2Cl2 (50 ml) and 
H2O (50 ml) were added and the lower organic layer was separated, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (20% EtOAc/hexane) of the residue afforded 5,7,10-trimethoxy-3-
methyl-1H-benzo[g]isochromene-6,9-dione 229 as an orange amorphous solid 
(0.230 g, 63%). Rf = 0.62 (40 % EtOAc/hexane); Mp. = 205-206 °C. IR νmax(cm-1) = 
1782 (C=O), 1755 (C=O), 1705 (C=C), 1440, 1407; 1H NMR (500 MHz, CDCl3) δH = 
5.98 (1H, s, H-8), 5.96 (1H, s, H-4), 5.22 (2H, s, H-1), 3.84 (3H, s, OCH3), 3.82 (6H, 
s, 2 × OCH3), 2.00 (3H, s, CH3); 13C NMR (125 MHz, CDCl3) δC = 183.7 (C=O), 
179.3 (C=O), 159.8 (C-3), 159.0, 151.8, 149.8, 134.6 (C-10a), 128.2 (C-4a), 124.3 
(C-5a), 122.0 (C-9a), 110.2 (C-8), 95.2 (C-4), 63.5 (C-1), 61.8 (OCH3), 61.6 (OCH3), 
56.3 (OCH3), 20.0 (CH3); HR-TOF-MS-ES: m/z found 317.1022 [M+H]+ (calculated 
for C17H17O6, 317.1025).  
 
Further elution (50% EtOAc/hexane) led to the isolation of 5,9,10-trimethoxy-3-
methyl-1H-benzo[g]isochromene-6,7-dione 230 as a dark red solid (0.100 g, 27%). 
Rf = 0.27 (40 % EtOAc/hexane); Mp. = 205-206 °C; IR νmax (cm-1) = 1794 (C= O), 
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1758 (C= O), 1698 (C=C), 1465, 1401; 1H NMR (500 MHz, CDCl3) δH = 5.91 (1H, s, 
H-4), 5.88 (1H, s, H-8), 5.17 (2H, s, H-1), 3.99 (3H, s, OCH3), 3.81 (3H, s, OCH3), 
3.73 (3H, s, OCH3), 2.00 (3H, s, CH3); 13C NMR (125 MHz, CDCl3) δC = 179.8 
(C=O), 179.4 (C=O), 170.7, 159.4 (C-3), 152.6, 150.4, 132.8 (C-10a), 129.0 (C-4a), 
123.6 (C-5a), 121.2 (C-9a), 101.9 (C-8), 95.0 (C-4), 63.5 (C-1), 62.4 (OCH3), 61.8 
(OCH3), 57.0 (OCH3), 20.0 (CH3); HR-TOF-MS-ES: m/z found 317.1027 [M+H]+ 
(calculated for C17H17O6, 317.1025). 
 
6.4.11. Synthesis of 5,10-dihydroxy-7-methoxy-3-methyl-1H-
benzo[g]isochromene-6,9-dione (anhydrofusarubin) 26 
 
5,7,10-Trimethoxy-3-methyl-1H-benzo[g]isochromene-6,9-dione 229 (0.200 g, 1.15 
mmol) was dissolved in dry CH2Cl2 (50 ml) and cooled to – 78 °C under a N2(g) 
atmosphere. BCl3 (1.58 ml, 1.58 mmol) was added dropwise to the solution which 
was stirred for a further 40 min at – 78 °C, and then allowed to warm to rt. The 
reaction was then carefully quenched with a few drops of cold H2O and then CH2Cl2 
(50 ml) and H2O (100 ml) were added. The lower organic layer was separated, dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (20% EtOAc/hexane) of the residue afforded 5,10-dihydroxy-7-
methoxy-3-methyl-1H-benzo[g]isochromene-6,9-dione 26 as a crystalline purple 
solid (0.130 g, 65%). Rf = 0.60 (30 % EtOAc/hexane); Mp. = 195-196 °C (199-202 
°C)18; 1H NMR (500 MHz, CDCl3) δH = 13.04 (1H, s, OH), 12.65 (1H, s, OH), 6.17 
(1H, s, H-8), 5.99 (1H, s, H-4), 5.22 (2H, s, H-1), 3.92 (3H, s, OCH3), 2.02 (3H, s, 
CH3); 13C NMR (125 MHz, CDCl3) δC = 183.0 (C=O), 177.9 (C=O), 161.7 (C-3), 
160.1, 158.1, 158.0, 133.2 (C-4a), 122.9 (C-10a), 111.1 (C-5a), 110.1 (C-8), 108.1 
(C-9a), 94.9 (C-4), 63.1 (C-1), 56.8 (OCH3), 20.2 (CH3); HR-TOF-MS-ES: m/z found 
288.0633 [M]+ (calculated for C15H12O6, 288.0634)8. 
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6.5. Experimental Work Pertaining to the Syntheisis of Bicyclic Acetal 
Compounds 
6.5.1. Synthesis of 1-(5-Allyloxy-2-hydroxyphenyl)ethanone 243 
 
 
2,5-Dihydroxyacetophenone (8.00 g, 52.6 mmol) was dissolved in Me2CO (300 ml) in 
a round-bottom flask (500 ml) equipped with a reflux condenser and a magnetic 
stirrer bar. Allyl bromide (8.28 g, 68.4mmol) and anhydrous K2CO3 (9.45 g, 68.4 
mmol) were added to the solution, which was then refluxed for 18h under a N2(g) 
atmosphere. The mixture was then allowed to cool to rt, filtered through a bed of 
celite, and the solvent was removed in vacuo. The residue was purified by column 
chromatography (20% EtOAc/hexane) to afford 1-(5-allyloxy-2-
hydroxyphenyl)ethenone 234 (8.69 g, 86%) as a yellow crystalline solid. Rf = 0.79 
(20 % EtOAc/hexane); 1H NMR (300 MHz, CDCl3) δH = 11.84 (1H, s, OH), 7.16 (1H, 
d, J 3.0, H-6), 7.08 (1H, dd, J 9.0, 3.0, H-4), 6.86 (1H, d, J 9.0, H-3), 6.02 (1H, ddt, J 
17.2, 10.5, 5.3, OCH2CH=CH2), 5.38 (1H, dt, J 17.2, 3.6, one of OCH2CH=CH2), 5.28 
(1H, dd, J 10.5, 1.3, one of OCH2CH=CH2), 4.47 (2H, dt, J 5.3, 1.3, OCH2CH=CH2), 
2.56 (3H, s, COCH3; 13C NMR (75 MHz, CDCl3) δC = 204.0 (C=O), 156.8 (ArC-O), 
150.6 (ArC-O), 133.1 (OCH2CH=CH2), 124.9 (C-3), 119.2 (ArC), 119.1 (C-6), 117.8 
(OCH2CH=CH2) 114.9 (C-4′), 69.8 (OCH2CH=CH2), 26.6 (COCH3).10 
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6.5.2. Synthesis of 1-(2-Allyl-3,6-dimethoxyphenyl)ethanone 182 
 
 
1-[5-(Allyloxy)-2-hydroxyphenyl]ethanone 243 (5.82 g, 30.3 mmol) was loaded neat 
into in a round-bottom flask (50 ml) equipped with a reflux condenser and a magnetic 
stirrer bar. The reaction vessel was then heated to 140 °C for 18 h under a N2(g) 
atmosphere. The dark viscous residue was allowed to cool to rt and was then 
purified via column chromatography (15% EtOAc/hexane) to yield 1-(2-allyl-3,6-
dihydroxyphenyl)ethanone 244 as a yellow oil (4.26 g, 73%). Rf = 0.24 (30 % 
EtOAc/hexane); 1H NMR (300 MHz, acetone) δH = 8.39 (1H, br s, OH), 7.93 (1H, br 
s, OH), 6.79 (1H, d, J 8.7, H-4′*), 6.66 (1H, d, J 8.7, H-5′*), 5.92 (1H, ddt, J 16.5, 
10.2, 6.3, ArCH2CH=CH2), 5.00–4.88 (2H, m, ArCH2CH=CH2), 3.36 (2H, d, J 6.3, 
ArCH2CH=CH2), 2.48 (3H, s, COCH3); 13C NMR (75 MHz, acetone) δC = 205.4 
(C=O), 149.0 (ArC-O), 148.2 (ArC-O), 137.8 (ArCH2CH=CH2), 131.3 (ArC), 124.3 
(ArC), 117.8 (C-5), 115.3 (C-4), 115.3 (ArCH2CH=CH2), 32.6 (COCH3), 31.4 
(ArCH2CH=CH2)10. The intermediate, 1-(2-allyl-3,6-dihydroxyphenyl)ethanone 244 
(3.68 g, 19.1 mmol), anhydrous K2CO3 (7.94 g, 57.4 mmol) and Me2SO4 (9.66 g, 
75.6 mmol) were dissolved in Me2CO (200 ml). The solution was refluxed for 24 h 
under a N2(g) atmosphere. The mixture was then allowed to cool to rt, filtered 
through a bed of celite, and the solvent was removed in vacuo. The residue was then 
dissolved in EtOAc (100 ml) and was successively washed with aqueous NH3 (25%, 
3 × 50 ml), HCl (0.5 M, 2 × 50 ml) and H2O (100 ml). The EtOAc layer was dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (10% EtOAc/hexane) of the residue afforded 1-(2-allyl-3,6-
dimethoxyphenyl)ethanone 182 as a yellow oil (3.20 g, 76%). Rf = 0.57 (20 % ethyl 
acetate/hexane); 1H NMR (300 MHz, CDCl3) δH = 6.77 (1H, d, J 9.0, H-4), 6.69 (1H, 
d, J 9.0, H-5), 5.86 (1H, ddt, J 18.0, 9.3, 6.2, ArCH2CH=CH2), 4.96–4.86 (2H, m, 
ArCH2CH=CH2), 3.72 (3H, s, OCH3), 3.70 (3H, s, OCH3), 3.28 (2H, br d, J 6.3, 
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ArCH2CH=CH2), 2.42 (3H, s, COCH3); 13C NMR (75 MHz, CDCl3) δC = 205.1 (C=O), 
151.8 (ArC-O), 149.8 (ArC-O), 136.5 (ArCH2CH=CH2), 132.8 (ArC), 125.5 (ArC), 
115.1 (ArCH2CH=CH2), 111.6 (C-4), 109.4 (C-5), 55.9 (2 × OCH3), 32.3 (COCH3), 
30.7 (ArCH2CH=CH2).10 
 
6.5.3. Synthesis of (Z)-Ethyl 4-(2-allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-
oxobut-2-enoate 181a 
 
 
To a stirred solution of 1-(2-allyl-3,6-dihydroxyphenyl)ethanone 182 (3.00 g, 13.6 
mmol) and diethyl oxalate (3.98 g, 27.2 mmol) in dry THF (50 ml) at 0 °C, NaOEt 
(1.85 g, 27.2 mmol) was slowly added. The reaction mixture was then stirred 
vigorously for 3 h at rt before being acidified with aqueous HCl (100 ml, 2.0 M). 
EtOAc (100 ml) was then added to the mixture. The organic layer was separated, 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. 
Column chromatography (10% EtOAc/hexane) of the residue afforded (Z)-ethyl 4-(2-
allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-oxobut-2-enoate 181a as a yellow solid (3.92 
g, 90%). Rf = 0.55 (20 % EtOAc/hexane); Mp. = 65-66 °C; IR νmax (cm-1)= 3007 (OH), 
1738 (C=O), 1730 (C=O), 1625 (C=C), 1597 (C=C), 1228, 1216; 1H NMR (300 MHz, 
CDCl3) δH = 14.30 (1H, br s, OH), 6.89 (1H, d, J 9.0, H-4), 6.77 (1H, d, J 9.0, H-5), 
6.57 (1H, s, COCH=C(OH)CO2Et), 5.87 (1H, ddt, J 16.6, 10.3, 6.2, ArCH2CH=CH2), 
4.97–4.84 (2 H, m, ArCH2CH=CH2), 4.34 (3H, q, J 7.1, CO2CH2CH3), 3.78 (3H, s, 
OCH3), 3.75 (3H, s, OCH3), 3.35 (2H, d, J 6.2, ArCH2CH=CH2), 1.35 (3H, t, J 7.1, 
CO2CH2CH3); 13C NMR (75 MHz, CDCl3) δC = 197.6 (C=O), 164.5 
(COCH=C(OH)CO2Et), 162.3 (COCH=C(OH)CO2Et), 151.8 (ArC-O), 150.5 (ArC-O), 
136.1 (ArCH2CH=CH2), 128.8 (ArC), 127.5 (ArC), 115.3 (ArCH2CH=CH2), 113.15 (C-
4), 109.7 (C-5), 105.92 (COCH=C(OH)CO2Et), 62.8 (CO2CH2CH3), 56.2 (2 × OCH3), 
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30.9 (ArCH2CH=CH2), 13.9 (CO2CH2CH3); HR-TOF-MS: m/z found 321.1338 [M-H]+ 
(calculated for C17H21O6, 321.1342).  
 
6.5.4. Synthesis of Ethyl 4-(2-allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-
oxobutanoate 248 
 
 
(Z)-Ethyl 4-(2-allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-oxobut-2-enoate 181a (3.00 g, 
9.37 mmol) was dissolved in dry THF (50 ml) and cooled to 0 °C in an ice bath. 
Sodium borohydride (0.711 g, 18.7 mmol) was added to the stirred reaction solution 
over 15 min. The reaction mixture was then stirred vigorously for 2 h at rt, before 
being acidified with a dilute aqueous solution of HCl (100 ml, 0.5 M). Once the fizzing 
stopped, the mixture was extracted with EtOAc (100 ml). The organic layer was then 
separated, dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure. Column chromatography (20% EtOAc/hexane) of the residue afforded 
ethyl 4-(2-allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-oxobutanoate 248 as a yellow 
liquid (1.20 g, 40%). Rf = 0.15 (30 % EtOAc/hexane); IR νmax (cm-1) = 3015 (OH), 
1738 (C=O), 1588 (C=C), 1228, 1216; 1H NMR (300 MHz, CDCl3) δH = 6.82 (1H, d, J 
9.0, H-4), 6.72 (1H, d, J 9.0, H-5), 5.97–5.81 (1H, m, ArCH2CH=CH2), 5.01–4.90 
(2H, m, ArCH2CH=CH2), 4.56 (1H, br s, COCH2CH(OH)CO2Et), 4.25 (2H, q, J 7.1, 
CO2CH2CH3), 3.76 (3H, s, OCH3), 3.74 (3H, s, OCH3), 3.34 (1H, dd, J 18.3, 3.7, one 
of COCH2CH(OH)CO2Et), 3.32 (1H, br s, OH), 3.26 (2H, d, J 6.3, ArCH2CH=CH2), 
3.23 (1H, dd, J 18.3, 6.3, one of COCH2CH(OH)CO2Et), 1.28 (3H, t, J 7.1, 
CO2CH2CH3); 13C NMR (75 MHz, CDCl3) δC = 204.4 (C=O), 173.8 (CO2Et), 151.9 
(ArC-O), 149.9 (ArC-O), 136.4 (ArCH2CH=CH2), 131.1 (ArC), 126.4 (ArC), 115.3 
(ArCH2CH=CH2), 112.2 (C-4′)*, 109.4 (C-5′)*, 66.9 (COCH2CH(OH)CO2Et), 61.6 
(CO2CH2CH3), 56.1 (2 × OCH3), 48.3 (COCH2CH(OH)CO2Et), 30.9 (ArCH2CH=CH2), 
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14.1 (CO2CH2CH3); HR-TOF-MS: m/z found 323.1495, [M-H]+ (calculated for 
C17H23O6, 323.1484). 
 
6.5.5. Synthesis of Ethyl 4-[3,6-dimethoxy-2-(2-oxopropyl)phenyl]-2-hydroxy-4-
oxobutanoate 249 
 
 
Ethyl 4-(2-allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-oxobutanoate 248 (1.10 g, 3.41 
mmol) was dissolved in a DMF/H2O mixture (1:1 v/v, 20 ml). PdCl2 (0.0605 g, 0.341 
mmol) and CuCl2.2H2O (0.582 g, 3.41 mmol) were added to the solution. Oxygen 
gas was bubbled through the solution which was stirred vigorously for 2 h at 70 °C. 
The reaction was filtered, and EtOAc (30 ml) was added. The organic layer was 
washed with H2O (3 × 30 ml), separated, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (30% 
EtOAc/hexane) of the residue afforded ethyl 4-[3,6-dimethoxy-2-(2-
oxopropyl)phenyl]-2-hydroxy-4-oxobutanoate 249 as a yellow liquid (0.773 g, 67%). 
Rf = 0.15 (40 % EtOAc/hexane); IR νmax (cm-1) = 3015 (OH), 1738 (C=O), 1257, 
1216; 1H NMR (300 MHz, CDCl3) δH = 6.86 (1H, d, J 9.0, H-4), 6.79 (1H, d, J 9.0, H-
5), 4.54 (1H, ddd, J 6.8, 5.6, 3.6, COCH2CH(OH)CO2Et), 4.24 (2H, q, J 7.1, 
CO2CH2CH3), 3.77 (3H, s, OCH3), 3.73 (3H, s, OCH3), 3.68 (2H, s, ArCH2COCH3), 
3.39 (1H, dd, J 17.6, 3.6, one of COCH2CH(OH)CO2Et), 3.25 (1H, d, J 5.6, OH), 3.23 
(2H, dd, J 17.6, 6.8, one of COCH2CH(OH)CO2Et), 2.16 (3H, s, ArCH2COCH3), 1.28 
(3H, t, J 7.1, CO2CH2CH3); 13C NMR (75 MHz, CDCl3) δC = 206.3 (ArCH2COCH3), 
204.3 (COCH2CH(OH)CO2Et), 173.6 (COCH2CH(OH)CO2Et), 151.9 (ArC-O), 150.4 
(ArC-O), 122.6 (ArC), 112.5 (ArC), 110.3 (C-4), 77.1 (C-5), 67.4 
(COCH2CH(OH)CO2Et), 61.7 (CO2CH2CH3), 56.1 (2 × OCH3), 48.0 
(COCH2CH(OH)CO2Et), 41.1 (ArCH2COCH3), 29.6 (ArCH2COCH3), 14.1 
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(CO2CH2CH3); HR-TOF-MS: m/z found 339.1444, [M-H]+ (calculated for C17H23O7, 
339.1437). 
 
6.5.6. Synthesis of 1-(2-Allyl-3,6-dimethoxyphenyl)-3,4-dihydroxybutan-1-one 
255 
 
 
(Z)-Ethyl 4-(2-allyl-3,6-dimethoxyphenyl)-2-hydroxy-4-oxobut-2-enoate 181a (1.00 g, 
3.12 mmol) was dissolved in dry THF (20 ml). The solution was cooled to -10 °C in a 
Me2CO-ice bath and lithium aluminium hydride (0.237 g, 6.24 mmol) was added 
slowly over 5 min. The reaction mixture was then stirred vigorously for 2 h at rt under 
a N2(g) atmosphere. The solution was then cooled to 0 °C in an ice bath and cold 
H2O was added drop-wise until the fizzing stopped. EtOAc (20 ml) was added and 
the solution was washed with aqueous HCl (2 M, 20 ml). The organic layer was then 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. 
Column chromatography (eluant 40% EtOAc/hexane) of the residue afforded 1-(2-
allyl-3,6-dimethoxyphenyl)-3,4-dihydroxybutan-1-one 255 as a yellow liquid (0.30 g, 
34%). Rf = 0.26 (50 % EtOAc/hexane); IR νmax (cm-1) = 3015 (OH), 1738 (C=O), 
1595 (C=C), 1255, 1228; 1H NMR (300 MHz, CDCl3) δH = 6.78 (1H, d, J 9.0, H-4), 
6.69 (1H, d, J 9.0, H-5), 5.92–5.76 (1H, m, ArCH2CH=CH2), 4.95–4.85 (2H, m, 
ArCH2CH=CH2), 4.31–4.21 (1H, m, COCH2CH(OH)CH2OH), 3.72 (3H, s, OCH3), 
3.70 (3H, s, OCH3), 3.63 (2H, dd, J 11.7, 2.8, one of COCH2CH(OH)CH2OH and 
OH), 3.48 (1H, dd, J 11.3, 6.6, one of COCH2CH(OH)CH2OH), 3.25 (2H, d, J 5.0, 
ArCH2CH=CH2), 2.92 (2H, d, J 6.1, COCH2CH(OH)CH2OH); 13C NMR (75 MHz, 
CDCl3) δC = 207.3 (C=O), 151.8 (ArC-O), 149.7 (ArC-O), 136.4 (ArCH2CH=CH2), 
131.6 (ArC), 126.3 (ArC), 115.3 (ArCH2CH=CH2), 112.1 (C-4), 109.5 (C-5), 68.6 
(COCH2CH(OH)CH2OH), 65.8 (COCH2CH(OH)CH2OH), 55.8 (2 × OCH3), 47.7 
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(COCH2CH(OH)CH2OH), 30.1 (ArCH2CH=CH2); HR-TOF-MS: m/z found 281.1389, 
[M-H]+ (calculated for C15H21O5, 281.1382). 
 
6.5.7. Synthesis of 1-(2-Allyl-3,6-dimethoxyphenyl)butane-1,4-diol 256 
 
 
1-(2-Allyl-3,6-dimethoxyphenyl)-3,4-dihydroxybutan-1-one 255 (2.20 g, 7.85 mmol) 
was dissolved in dry THF (50 ml). The solution was cooled to -10 °C in a Me2CO-ice 
bath and lithium aluminium hydride (0.447 g, 11.8 mmol) was added slowly over 5 
min. The reaction mixture was heated for 3 h at reflux under a N2(g) atmosphere. 
The solution was then cooled to 0 °C in an ice bath and cold H2O was added drop-
wise until the fizzing stopped. EtOAc (50 ml) was added and the solution was 
washed with aqueous HCl (2 M, 50 ml). The organic layer was then dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (40% EtOAc/hexane) of the residue afforded 1-(2-allyl-3,6-
dimethoxyphenyl)butane-1,4-diol 256 as a clear liquid (1.30 g, 62%). Rf = 0.25 (50 % 
EtOAc/hexane); IR νmax (cm-1) = 3373 (OH), 1596 (C=C), 1228, 1217, 1051; 1H NMR 
(300 MHz, CDCl3) δH = 6.74 (1H, d, J 9.0, H-4′)*, 6.70 (1H, d, J 9.0, H-5′)*, 5.88 (1H, 
ddt, J 16.3, 10.2, 5.8, ArCH2CH=CH2), 5.02–4.87 (2H, m, ArCH2CH=CH2), 4.83 (1H, 
dd, J 9.6, 3.2, CH(OH)CH2CH2CH2OH), 3.80 (3H, s, OCH3), 3.73 (3H, s, OCH3), 
3.68–3.58 (2H, m, CH(OH)CH2CH2CH2OH), 3.54–3.32 (2H, m, ArCH2CH=CH2), 
2.09–1.55 (4H, m, CH(OH)CH2CH2CH2OH); 13C NMR (75 MHz, CDCl3) δC 151.8 
(ArC-O), 151.7 (ArC-O), 136.5 (ArCH2CH=CH2), 131.6 (ArC), 126.4 (ArC), 114.9 
(ArCH2CH=CH2), 109.6 (C-4), 109.5 (C-5), 71.3 (CH(OH)CH2CH2CH2OH), 62.7 
(CH(OH)CH2CH2CH2OH), 55.8 (2 × OCH3), 34.4 (CH(OH)CH2CH2CH2OH), 30.2 
(CH(OH)CH2CH2CH2OH), 29.9 (ArCH2CH=CH2). 
Chapter 6: Experimental Procedures 
 
 176 
 
6.5.8. Synthesis of 3,6-Dimethoxy-9-methyl-10,14-
dioxatricyclo[7.3.1.02,7]tetradeca-2,4,6-triene 259 
 
 
1-(2-Allyl-3,6-dimethoxyphenyl)butane-1,4-diol 256 (1.20 g, 4.51 mmol) was 
dissolved in a DMF/H2O mixture (1:1 v/v, 50 ml). PdCl2 (0.0800 g, 0.451 mmol) and 
CuCl2.2H2O (0.768 g, 4.51 mmol) were added to the solution. Oxygen gas was 
bubbled through the solution which was stirred vigorously for 2 h at 70 °C. The 
reaction was filtered, and EtOAc (20 ml) was added. The organic layer was washed 
with H2O (3 × 20 ml), separated, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (30% 
EtOAc/hexane) of the residue afforded 259 as a clear liquid (0.858 g, 72 %). Rf = 
0.54 (40 % EtOAc/hexane); IR νmax (cm-1) = 1254, 1228, 1065; 1H NMR (300 MHz, 
CDCl3) δH = 6.67 (1H, d, J 9.0, H-4), 6.63 (1H, d, J 9.0, H-5), 5.17 (1H, br d, J 4.8, H-
1), 3.80 (1H, dd, J 11.8, 1.5, H-11a), 3.76 (3H, s, OCH3), 3.75 (3H, s, OCH3), 3.56 
(1H, ddd, J 11.8, 3.3, 2.0, H-11b), 3.05 (1H, d, J 16.8, H-8a), 2.65–2.54 (1H, m, H-
13a), 2.50 (1H, d, J 16.8, H-8b), 1.90–1.76 (1H, m, H-13b), 1.64–1.54 (1 H, m, H-
12a), 1.49 (3H, s, CH3), 1.47–1.32 (1H, m, H-12b); 13C NMR (75 MHz, CDCl3) δC = 
151.1 (ArC-O), 149.4 (ArC-O), 125.1 (C-2), 123.0 (C-7), 107.8 (C-5), 107.4 (C-4), 
97.4 (C-9), 72.2 (C-1), 61.8 (C-11), 55.4 (2 × OCH3), 33.6 (C-8), 32.3 (C-13), 27.6 
(C-12), 25.0 (CH3); HR-TOF-MS: m/z found 265.1440, [M-H]+ (calculated for 
C15H21O4, 265.1429). 
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6.5.9. Synthesis of 1-(2-Allyl-3,6-dimethoxyphenyl)-4-
(tertbutyldimethylsilyloxy)-3-hydroxybutan-1-one 260 
 
 
1-(2-Allyl-3,6-dimethoxyphenyl)-3,4-dihydroxybutan-1-one 255 (2.44 g, 8.74 mmol) 
was dissolved in dry CH3CN at 0 °C under a N2(g) atmosphere. Imidazole (0.595 g, 
8.74 mmol) and tert-butyldimethylsilyl chloride (1.32 g, 8.74 mmol) were added in 
three portions to the reaction mixture, every 15 min for a 45 min period. Once 
addition of the reactants was complete, the mixture was stirred for 1 h at rt. The 
solution was then filtered and the solvent was removed in vacuo. The residue was 
then dissolved in EtOAc (50 ml), and was sequentially washed with aqueous 
NaHCO3 (50 ml) followed by aqueous NaCl (50 ml). The organic layer was then dried 
over anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (10% EtOAc/hexane) of the residue afforded 1-(2-allyl-3,6-
dimethoxyphenyl)-4-(tert-butyldimethylsilyloxy)-3-hydroxybutan-1-one 260 as a clear 
liquid (2.20 g, 64%). Rf = 0.37 (20 % EtOAc/hexane); IR νmax (cm-1) = 3015 (OH), 
1738 (C=O), 1255, 1228; 1H NMR (300 MHz, CDCl3) δH = 6.83 (1H, d, J 9.0, H-4), 
6.74 (1H, d, J 9.0, H-5), 5.90 (1H, ddt, J 16.6, 10.4, 6.2, ArCH2CH=CH2), 5.01–4.90 
(2H, m, ArCH2CH=CH2), 4.31–4.19 (1H, m, COCH2CH(OH)CH2OTBDMS), 3.78 (3H, 
s, OCH3), 3.75 (3H, s, OCH3), 3.69–3.56 (2H, m, COCH2CH(OH)CH2OTBDMS), 3.30 
(2H, dd, J 6.2, 1.4, ArCH2CH=CH2), 3.04 (1H, dd, J 17.9, 4.4, one of 
COCH2CH(OH)CH2OTBDMS), 2.98 (1H, d, J 3.6, OH), 2.91 (1H, dd, J 17.9, 7.8, one 
of COCH2CH(OH)CH2OTBDMS), 0.89 (9H, s, 3 × CH3), 0.07 (6H, s, 2 × CH3); 13C 
NMR (75 MHz, CDCl3) δC = 207.0 (C=O), 151.9 (ArC-O), 149.8 (ArC-O), 136.4 
(ArC), 131.5 (ArC), 126.1 (ArCH2CH=CH2), 115.3 (ArCH2CH=CH2), 111.9 (C-4), 
109.4 C-5), 68.3 (COCH2CH(OH)CH2OTBDMS), 66.4 
(COCH2CH(OH)CH2OTBDMS) 56.1 (2 × OCH3), 48.1 
(COCH2CH(OH)CH2OTBDMS), 30.9 (ArCH2CH=CH2), 25.9 (OSi(CH3)2C(CH3)3), 
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18.3 (OSi(CH3)2C(CH3)3), -5.4 (OSi(CH3)2C(CH3)3); HR-TOF-MS: m/z found 
395.2254, [M-H]+ (calculated for C21H35O5Si, 395.2245). 
 
6.5.10. Synthesis of (3,6-Dimethoxy-9-methyl-10,13-
dioxatricyclo[7.3.1.02,7]trideca-2,4,6-trien-11-yl)methanol 254 
 
 
1-(2-Allyl-3,6-dimethoxyphenyl)-4-(tert-butyldimethylsilyloxy)-3-hydroxybutan-1-one 
260 (2.10 g, 5.34 mmol) was dissolved in dry THF (80 ml). The solution was cooled 
to -10 °C in a Me2CO-ice bath and lithium aluminium hydride (0.303 g, 8.00 mmol) 
was added slowly over 5 min. The reaction mixture was then heated for 2 h at reflux 
under a N2(g) atmosphere. The solution was then cooled to 0 °C in an ice bath and 
cold water was added drop-wise until the fizzing stopped. EtOAc (60 ml) was added 
and the solution was washed with aqueous HCl (2 M, 60 ml). The organic layer was 
then dried over anhydrous MgSO4, filtered and concentrated under reduced pressure 
to afford a clear crystalline compound (0.700 g) of presumably 253. A 1H NMR 
spectrum of the crude mixture confirmed that no starting material was present. The 
crystalline material (0.423 g, 2.48 mmol) was dissolved in a mixture of DMF/H2O (1:1 
v/v, 40 ml). Oxygen gas was bubbled through the solution which was stirred 
vigorously for 2 h at 70 °C. The reaction was filtered, and EtOAc (50 ml) was added. 
The organic layer was washed with H2O (3 × 30 ml), separated, dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (50% EtOAc/hexane) of the residue afforded of mixture of 
diastereoisomers of 254 as a white solid (0.601 g, 86%) in a ratio of 1:0.43 as 
determined by 1H NMR spectroscopy. Rf = 0.58 (50 % EtOAc/hexane); Mp. = 142-
143 °C; IR νmax (cm-1) = 1229, 1215, 1172; 1H NMR (500 MHz, CDCl3) δH Major 
diastereomer 254a = 6.67 (1H, d, J 8.8, H-4), 6.64 (1H, d, J 8.8, H-5), 5.40 (1H, brd, 
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J 3.9, H-1), 3.91–3.83 (1H, m, H-11), 3.79 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.48 
(2H, br s, CH2OH), 2.98 (1H, d, J 18.8, H-8a), 2.85 (1H, d, J 18.8, H-8b), 2.20 (1H, br 
t, J 5.8, OH), 2.09–2.02 (1H, m, H-12a), 1.53 (3H, s, CH3), 1.40 (1H, dt, J 12.9, 2.0, 
H-12b); Minor diastereomer 254b = 6.67 (1H, d, J 8.8, H-4)*, 6.63 (1H, d, J 8.8, H-
5)*, 5.25 (1H, brd, J 9.1, H-1)*, 4.09–4.03 (1H, m, H-11)*, 3.77 (3H, s, OCH3), 3.76 
(3H, s, OCH3), 3.60–3.54 (1H, m, one of CH2OH), 3.41–3.35 (1H, m, one of CH2OH), 
2.83 (1H, d, J 17.3, H-8a)*, 2.59 (1H, d, J 17.3, H-8b)*, 2.30 (1H, ddd, J 13.0, 10.1, 
5.3, H-12a)*, 2.08 (1H, br s, OH), 1.57 (1H, ddd, J 13.0, 11.1, 1.55, H-12b)*, 1.52 
(3H, s, CH3); 13C NMR (125 MHz, CDCl3) Major diastereomer 254a δC = 149.9 (ArC-
O), 148.7 (ArC-O), 126.0 (C-7), 124.1 (C-2), 107.8 (C-5), 107.3 (C-4), 96.0 (C-9), 
68.3 (C-11), 65.9 (CH2OH), 65.7 (C-1), 55.9 (OCH3), 55.3 (OCH3), 32.8 (C-8), 30.4 
(C-12), 29.5 (CH3); Minor diastereomer 254b δC = 151.2 (ArC-O), 148.6 (ArC-O), 
128.9 (C-2*), 121.5 (C-7*), 107.9 (C-5*), 107.0 (C-4*), 97.4 (C-9*), 66.7 (C-11*), 65.0 
(C-1*), 64.9 (CH2OH), 55.5 (OCH3), 55.4 (OCH3), 33.2 (C-8*), 32.8 (C-12*), 24.6 
(CH3); HR-TOF-MS: m/z found 281.1389, [M-H]+ (calculated for C15H21O5, 
281.1382). 
 
6.5.11. Attempted Dess-Martin Periodinane 270 oxidation of (3,6-Dimethoxy-9-
methyl-10,13-dioxatricyclo[7.3.1.02,7]trideca-2,4,6-trien-11-yl)methanol 254 
 
 
Acetal 254 (0.120 g, 0.431 mmol) was dissolved in DCM (10 ml) and the Dess-Martin 
Periodinane reagent 270 was added slowly over 5 min to the stirred reaction mixture. 
The solution was stirred vigorously for 24 h at rt. H2O (20 ml) was then added and 
the lower organic layer was separated, dried over anhydrous MgSO4, filtered and 
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concentrated under reduced pressure. The column chromatography of the resultant 
residue yielded no characterizable product(s) or recovered starting material. 
 
6.5.12. Synthesis of 11-(Hydroxymethyl)-9-methyl-10,13-
dioxatricyclo[7.3.1.02,7]trideca-2(7),4-diene-3,6-dione 271 
 
 
Compound 254 (0.400 g, 1.44 mmol) was dissolved in a mixture of CH3CN and H2O 
(40 ml, 50:50 v/v ratio). CAN (2.36 g, 4.31 mmol) was added to the reaction mixture 
which was stirred vigorously for 30 min at rt. EtOAc (40 ml) and aqueous NaCl were 
then added and the upper organic layer was separated, dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. Column chromatography 
(30% EtOAc/hexane) of the residue afforded 271 as an amorphous red solid (0.320 
g, 89%). Rf = 0.36 (50 % EtOAc/hexane); IR νmax (cm-1) = 3015 (OH), 1754 (C=O), 
1111; 1H NMR (300 MHz, CDCl3) δH Major diastereomer 271a =  6.79 (1H, d, J 10.2, 
H-4), 6.74 (1H, d, J 10.2, H-5), 5.15 (1H, d, J 5.3, H-1), 3.90–3.80 (1H, m, H-11), 
3.55 (2H, brs, CH2OH), 2.82 (1H, d, J 20.9, H-8a), 2.82 (1H, d, J 20.9, H-8b), 2.17–
2.06 (1H, m, H-12a), 1.52 (3H, s, CH3), 1.40–1.33 (1H, m, H-12b); Minor 
diastereomer 271b = 6.77 (1H, d, J 10.1, H-4)*, 6.74 (1H, d, J 10.2, H-5)*, 5.03 (1H, 
brd, J 10.7, H-1)*, 4.06–3.95 (1H, m, H-11)*, 3.58–3.69 (1H, m, one of CH2OH), 
3.50–3.37 (1H, m, one of CH2OH), 2.64 (1H, d, J 19.1, H-8a)*, 2.82 (1H, d, J 19.1, H-
8b)*, 2.36–2.23 (1H, m, H-12a)*, 1.58–1.52 (1H, m, H-12b)*, 1.52 (3H, s, CH3); 13C 
NMR (75 MHz, CDCl3) δC Major diastereomer 271a = 185.3 (C=O), 184.7 (C=O), 
141.3 (C-2), 141.1 (C-7), 136.1 (C-4), 136.0 (C-5), 96.0 (C-9), 68.2 (C-11), 65.6 
(CH2OH), 64.4 (C-1), 32.3 (C-8), 28.8 (C-12), 29.4 (CH3); Minor diastereomer 271b = 
186.4 (C=O), 185.3 (C=O), 143.6 (C-2*), 137.7 (C-7*), 136.1 (C-4)*, 136.0 (C-5)*, 
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97.5 (C-9*), 66.1 (C-11*), 64.6 (CH2OH), 63.7 (C-1*), 33.6 (C-8*), 29.7 (C-12*), 24.1 
(CH3).  
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Appendices 
A1 X-ray crystallographic data 
The intensity data were collected on a Bruker APEX II CCD area detector 
diffractometer with graphite monochromated Mo Kα radiation (50kV, 30mA) using the 
APEX 2 data collection software1. The data collection process involved ω-scans of 
width 0.5° and 512×512 bit data frames. Data reduction was carried out using the 
program SAINT+ and face indexed absorption corrections were made using 
XPREP2. Crystal structures were solved by direct methods using SHELXTL3. Non-
hydrogen atoms were first refined isotropically followed by anisotropic refinement by 
full matrix least-squares calculations based on F2 using SHELXTL. Hydrogen atoms 
were first located in the difference map and then positioned geometrically and 
allowed to ride on their respective parent atoms. Figures and publication material 
were generated using SHELXTL, PLATON11 and ORTEP-312. 
 
A1.1 X-Ray crystallographic data for (3-Formyl-4-hydroxy-6,8-
dimethoxynaphthalene-2-yl)methyl acetate 201 
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Table A1.1.1 Crystal data and structure refinement for 201 
 
Empirical formula  C16H16O6 
Formula weight  304.29 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/m 
Unit cell dimensions a = 19.2003(6) Å α = 90°. 
 b = 6.7203(2) Å β = 99.379(2)°. 
 c = 11.0340(4) Å γ = 90°. 
Volume 1404.70(8) Å3 
Z 4 
Density (calculated) 1.439 Mg/m3 
Absorption coefficient 0.111 mm-1 
F(000) 640 
Crystal size 0.42 x 0.25 x 0.22 mm3 
Theta range for data collection 1.87 to 27.99°. 
Index ranges -25<=h<=23, -8<=k<=8, -12<=l<=14 
Reflections collected 8613 
Independent reflections 1842 [R(int) = 0.0473] 
Completeness to theta = 27.99° 100.0 %  
Absorption correction None 
Max. and min. transmission 0.9760 and 0.9550 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1842 / 0 / 140 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.1176 
R indices (all data) R1 = 0.0561, wR2 = 0.1261 
Largest diff. peak and hole 0.247 and -0.363 e.Å-3 
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Table A1.1.2 Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 201. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
C(1) 3554(1) 0 4961(2) 21(1) 
C(2) 3191(1) 0 3731(1) 20(1) 
C(3) 3564(1) 0 2724(1) 23(1) 
C(4) 3191(1) 0 1559(2) 24(1) 
C(5) 2442(1) 0 1344(1) 24(1) 
C(6) 2083(1) 0 2321(1) 21(1) 
C(7) 2448(1) 0 3557(1) 19(1) 
C(8) 2081(1) 0 4576(1) 19(1) 
C(9) 2435(1) 0 5747(1) 19(1) 
C(10) 3193(1) 0 5963(1) 21(1) 
C(11) 4232(1) 0 657(2) 34(1) 
C(12) 982(1) 0 988(2) 44(1) 
C(13) 2046(1) 0 6832(1) 22(1) 
C(14) 3595(1) 0 7188(2) 28(1) 
C(15) 876(1) 287(12) 7218(2) 26(2) 
C(16) 125(1) 557(4) 6628(2) 45(1) 
O(1) 4261(1) 0 5103(1) 32(1) 
O(2) 3480(1) 0 506(1) 32(1) 
O(3) 1367(1) 0 2213(1) 29(1) 
O(4) 1307(1) 0 6368(1) 32(1) 
O(5) 1081(1) 0 8294(1) 43(1) 
O(6) 4245(1) 0 7431(1) 38(1) 
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Table A1.1.3.   Bond lengths [Å] and angles [°] for 201. 
 
C(1)-O(1)  1.3410(17) 
C(1)-C(10)  1.397(2) 
C(1)-C(2)  1.421(2) 
C(2)-C(7)  1.4090(19) 
C(2)-C(3)  1.416(2) 
C(3)-C(4)  1.367(2) 
C(3)-H(3)  0.9500 
C(4)-O(2)  1.3670(18) 
C(4)-C(5)  1.417(2) 
C(5)-C(6)  1.371(2) 
C(5)-H(5)  0.9500 
C(6)-O(3)  1.3601(16) 
C(6)-C(7)  1.428(2) 
C(7)-C(8)  1.421(2) 
C(8)-C(9)  1.359(2) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.4353(19) 
C(9)-C(13)  1.511(2) 
C(10)-C(14)  1.444(2) 
C(11)-O(2)  1.4269(18) 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-O(3)  1.4320(18) 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-O(4)  1.4285(17) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-O(6)  1.2333(19) 
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C(14)-H(14)  0.9500 
C(15)-O(5)  1.204(3) 
C(15)-O(4)  1.361(2) 
C(15)-C(16)  1.494(3) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
O(1)-H(1)  0.8400 
O(4)-C(15)#1  1.361(2) 
O(5)-C(15)#1  1.204(3) 
O(1)-C(1)-C(10) 122.15(14) 
O(1)-C(1)-C(2) 116.13(13) 
C(10)-C(1)-C(2) 121.72(14) 
C(7)-C(2)-C(3) 121.56(14) 
C(7)-C(2)-C(1) 117.27(14) 
C(3)-C(2)-C(1) 121.16(14) 
C(4)-C(3)-C(2) 118.89(13) 
C(4)-C(3)-H(3) 120.6 
C(2)-C(3)-H(3) 120.6 
C(3)-C(4)-O(2) 125.15(14) 
C(3)-C(4)-C(5) 121.33(14) 
O(2)-C(4)-C(5) 113.52(14) 
C(6)-C(5)-C(4) 119.61(14) 
C(6)-C(5)-H(5) 120.2 
C(4)-C(5)-H(5) 120.2 
O(3)-C(6)-C(5) 124.17(14) 
O(3)-C(6)-C(7) 114.52(13) 
C(5)-C(6)-C(7) 121.31(13) 
C(2)-C(7)-C(8) 120.98(13) 
C(2)-C(7)-C(6) 117.29(13) 
C(8)-C(7)-C(6) 121.73(13) 
C(9)-C(8)-C(7) 121.04(13) 
C(9)-C(8)-H(8) 119.5 
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C(7)-C(8)-H(8) 119.5 
C(8)-C(9)-C(10) 119.68(14) 
C(8)-C(9)-C(13) 121.18(13) 
C(10)-C(9)-C(13) 119.15(13) 
C(1)-C(10)-C(9) 119.30(14) 
C(1)-C(10)-C(14) 118.78(14) 
C(9)-C(10)-C(14) 121.91(14) 
O(2)-C(11)-H(11A) 109.5 
O(2)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
O(2)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
O(3)-C(12)-H(12A) 109.5 
O(3)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
O(3)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
O(4)-C(13)-C(9) 107.87(12) 
O(4)-C(13)-H(13A) 110.1 
C(9)-C(13)-H(13A) 110.1 
O(4)-C(13)-H(13B) 110.1 
C(9)-C(13)-H(13B) 110.1 
H(13A)-C(13)-H(13B) 108.4 
O(6)-C(14)-C(10) 124.87(16) 
O(6)-C(14)-H(14) 117.6 
C(10)-C(14)-H(14) 117.6 
O(5)-C(15)-O(4) 121.3(3) 
O(5)-C(15)-C(16) 125.95(19) 
O(4)-C(15)-C(16) 111.60(18) 
C(1)-O(1)-H(1) 109.5 
C(4)-O(2)-C(11) 116.43(13) 
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C(6)-O(3)-C(12) 116.26(12) 
C(15)#1-O(4)-C(13) 115.63(14) 
C(15)-O(4)-C(13) 115.63(14) 
Symmetry transformations used to generate equivalent atoms  
 
Table A1.1.4.   Anisotropic displacement parameters (Å2x 103) for 201.  The 
anisotropic displacement factor exponent takes the form: -2pi2[ h2a*2U11 + ... + 
2 h k a* b* U12 ]. 
 
 U11 U22 U33 U23 U13 U12 
C(1) 17(1)  22(1) 24(1)  0 0(1)  0 
C(2) 20(1)  19(1) 21(1)  0 4(1)  0 
C(3) 17(1)  27(1) 26(1)  0 6(1)  0 
C(4) 24(1)  29(1) 21(1)  0 10(1)  0 
C(5) 23(1)  33(1) 15(1)  0 3(1)  0 
C(6) 16(1)  26(1) 20(1)  0 2(1)  0 
C(7) 20(1)  18(1) 18(1)  0 3(1)  0 
C(8) 18(1)  20(1) 20(1)  0 4(1)  0 
C(9) 22(1)  17(1) 18(1)  0 3(1)  0 
C(10) 22(1)  20(1) 19(1)  0 1(1)  0 
C(11) 23(1)  54(1) 28(1)  0 13(1)  0 
C(12) 25(1)  86(2) 18(1)  0 -2(1)  0 
C(13) 24(1)  25(1) 15(1)  0 2(1)  0 
C(14) 26(1)  35(1) 22(1)  0 -1(1)  0 
C(15) 33(1)  24(5) 25(1)  1(1) 15(1)  -2(1) 
C(16) 30(1)  70(3) 37(1)  0(1) 13(1)  2(1) 
O(1) 16(1)  52(1) 26(1)  0 0(1)  0 
O(2) 23(1)  55(1) 21(1)  0 11(1)  0 
O(3) 17(1)  54(1) 15(1)  0 1(1)  0 
O(4) 21(1)  59(1) 18(1)  0 7(1)  0 
O(5) 46(1)  65(1) 21(1)  0 14(1)  0 
O(6) 26(1)  59(1) 28(1)  0 -5(1)  0 
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Table A1.1.5.   Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (Å2x 103) for 201. 
 
 x  y  z  U(eq) 
H(3) 4066 0 2857 28 
H(5) 2191 0 527 28 
H(8) 1579 0 4436 23 
H(11A) 4381 0 -152 51 
H(11B) 4416 -1191 1113 51 
H(11C) 4416 1191 1113 51 
H(12A) 475 102 1015 65 
H(12B) 1076 -1239 574 65 
H(12C) 1130 1136 534 65 
H(13A) 2174 -1195 7345 26 
H(13B) 2174 1195 7345 26 
H(14) 3340 0 7857 34 
H(16A) -87 -745 6405 67 
H(16B) 107 1373 5887 67 
H(16C) -137 1222 7204 67 
H(1) 4429 0 5855 48 
 
Table A1.1.6.  Torsion angles [°] for 201. 
 
O(1)-C(1)-C(2)-C(7) 180.0 
C(10)-C(1)-C(2)-C(7) 0.0 
O(1)-C(1)-C(2)-C(3) 0.0 
C(10)-C(1)-C(2)-C(3) 180.0 
C(7)-C(2)-C(3)-C(4) 0.0 
C(1)-C(2)-C(3)-C(4) 180.0 
C(2)-C(3)-C(4)-O(2) 180.0 
C(2)-C(3)-C(4)-C(5) 0.0 
C(3)-C(4)-C(5)-C(6) 0.0 
O(2)-C(4)-C(5)-C(6) 180.0 
A1 X-ray crystallographic data 
 
 190 
 
C(4)-C(5)-C(6)-O(3) 180.0 
C(4)-C(5)-C(6)-C(7) 0.0 
C(3)-C(2)-C(7)-C(8) 180.0 
C(1)-C(2)-C(7)-C(8) 0.0 
C(3)-C(2)-C(7)-C(6) 0.0 
C(1)-C(2)-C(7)-C(6) 180.0 
O(3)-C(6)-C(7)-C(2) 180.0 
C(5)-C(6)-C(7)-C(2) 0.0 
O(3)-C(6)-C(7)-C(8) 0.0 
C(5)-C(6)-C(7)-C(8) 180.0 
C(2)-C(7)-C(8)-C(9) 0.0 
C(6)-C(7)-C(8)-C(9) 180.0 
C(7)-C(8)-C(9)-C(10) 0.0 
C(7)-C(8)-C(9)-C(13) 180.0 
O(1)-C(1)-C(10)-C(9) 180.0 
C(2)-C(1)-C(10)-C(9) 0.0 
O(1)-C(1)-C(10)-C(14) 0.0 
C(2)-C(1)-C(10)-C(14) 180.0 
C(8)-C(9)-C(10)-C(1) 0.0 
C(13)-C(9)-C(10)-C(1) 180.0 
C(8)-C(9)-C(10)-C(14) 180.0 
C(13)-C(9)-C(10)-C(14) 0.0 
C(8)-C(9)-C(13)-O(4) 0.0 
C(10)-C(9)-C(13)-O(4) 180.0 
C(1)-C(10)-C(14)-O(6) 0.0 
C(9)-C(10)-C(14)-O(6) 180.0 
C(3)-C(4)-O(2)-C(11) 0.0 
C(5)-C(4)-O(2)-C(11) 180.0 
C(5)-C(6)-O(3)-C(12) 0.0 
C(7)-C(6)-O(3)-C(12) 180.0 
O(5)-C(15)-O(4)-C(15)#1 74.0(6) 
C(16)-C(15)-O(4)-C(15)#1 -94.3(5) 
O(5)-C(15)-O(4)-C(13) -20.0(8) 
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C(16)-C(15)-O(4)-C(13) 171.7(3) 
C(9)-C(13)-O(4)-C(15)#1 171.0(4) 
C(9)-C(13)-O(4)-C(15) -171.0(4) 
O(4)-C(15)-O(5)-C(15)#1 -74.5(6) 
C(16)-C(15)-O(5)-C(15)#1 92.0(7) 
Symmetry transformations used to generate equivalent atoms  
 
A1.2 X-Ray crystallographic data for (3R,4R) 3-Hydroxy-7,9-dimethoxy-3-
methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-benzo[g]isochromen-4-yl 
nitrate 202 
 
 
Table A1.2.1 Crystal data and structure refinement for 202 
 
Empirical formula  C16H15NO9 
Formula weight  365.29 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 13.913(4) Å α = 90°. 
 b = 13.475(4) Å β = 94.246(9)°. 
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 c = 8.404(3) Å γ = 90°. 
Volume 1571.2(9) Å3 
Z 4 
Density (calculated) 1.544 Mg/m3 
Absorption coefficient 0.129 mm-1 
F(000) 760 
Crystal size 0.32 x 0.06 x 0.03 mm3 
Theta range for data collection 1.47 to 25.00°. 
Index ranges -16<=h<=16, -14<=k<=16, -9<=l<=9 
Reflections collected 7954 
Independent reflections 2722 [R(int) = 0.1022] 
Completeness to theta = 25.00° 98.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2722 / 0 / 239 
Goodness-of-fit on F2 0.874 
Final R indices [I>2sigma(I)] R1 = 0.0497, wR2 = 0.0821 
R indices (all data) R1 = 0.1857, wR2 = 0.1160 
Largest diff. peak and hole 0.184 and -0.196 e.Å-3 
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Table A1.2.2 Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 202. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
C(1) 7945(3) 1080(3) 4411(5) 28(1) 
C(2) 7955(3) 2193(3) 4379(5) 27(1) 
C(3) 8691(3) 2662(3) 5322(5) 31(1) 
C(4) 8726(3) 3694(4) 5297(5) 35(1) 
C(5) 8058(3) 4232(3) 4356(5) 36(1) 
C(6) 7334(3) 3772(3) 3420(5) 29(1) 
C(7) 7251(3) 2724(3) 3442(5) 29(1) 
C(8) 6490(3) 2185(3) 2524(5) 32(1) 
C(9) 6534(3) 1081(3) 2477(5) 28(1) 
C(10) 7196(3) 571(3) 3377(5) 28(1) 
C(11) 10123(3) 3787(3) 7148(5) 47(1) 
C(12) 6764(3) 5339(3) 2411(5) 42(1) 
C(13) 5786(3) 576(3) 1393(5) 36(1) 
C(14) 7220(3) -544(3) 3320(5) 32(1) 
C(15) 6283(3) -989(4) 2535(5) 36(1) 
C(16) 6377(3) -2054(3) 2016(5) 44(1) 
N(1) 8732(3) -1393(3) 3048(6) 55(1) 
O(1) 8538(2) 597(2) 5232(3) 36(1) 
O(2) 9372(2) 4262(2) 6185(4) 44(1) 
O(3) 6672(2) 4274(2) 2468(3) 38(1) 
O(4) 5792(2) 2579(2) 1775(3) 47(1) 
O(5) 6003(2) -441(2) 1120(3) 37(1) 
O(6) 5612(2) -862(2) 3695(3) 43(1) 
O(7) 7998(2) -789(2) 2317(3) 39(1) 
O(8) 8618(3) -1766(3) 4321(5) 75(1) 
O(9) 9389(2) -1480(3) 2182(4) 76(1) 
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Table A1.2.3.   Bond lengths [Å] and angles [°] for 202. 
 
C(1)-O(1)  1.223(4) 
C(1)-C(10)  1.475(5) 
C(1)-C(2)  1.501(5) 
C(2)-C(3)  1.398(5) 
C(2)-C(7)  1.406(5) 
C(3)-C(4)  1.392(6) 
C(3)-H(3)  0.9500 
C(4)-O(2)  1.361(5) 
C(4)-C(5)  1.380(5) 
C(5)-C(6)  1.379(5) 
C(5)-H(5)  0.9500 
C(6)-O(3)  1.354(4) 
C(6)-C(7)  1.417(5) 
C(7)-C(8)  1.457(5) 
C(8)-O(4)  1.237(5) 
C(8)-C(9)  1.490(6) 
C(9)-C(10)  1.338(5) 
C(9)-C(13)  1.495(5) 
C(10)-C(14)  1.504(5) 
C(11)-O(2)  1.425(4) 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-O(3)  1.442(4) 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-O(5)  1.425(4) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-O(7)  1.458(4) 
A1 X-ray crystallographic data 
 
 195 
 
C(14)-C(15)  1.539(5) 
C(14)-H(14)  1.0000 
C(15)-O(6)  1.409(4) 
C(15)-O(5)  1.430(5) 
C(15)-C(16)  1.510(5) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
N(1)-O(8)  1.203(5) 
N(1)-O(9)  1.216(4) 
N(1)-O(7)  1.411(4) 
O(6)-H(6)  0.8400 
O(1)-C(1)-C(10) 120.2(4) 
O(1)-C(1)-C(2) 122.3(4) 
C(10)-C(1)-C(2) 117.4(4) 
C(3)-C(2)-C(7) 122.5(4) 
C(3)-C(2)-C(1) 116.7(4) 
C(7)-C(2)-C(1) 120.8(4) 
C(4)-C(3)-C(2) 117.9(4) 
C(4)-C(3)-H(3) 121.1 
C(2)-C(3)-H(3) 121.1 
O(2)-C(4)-C(5) 114.1(4) 
O(2)-C(4)-C(3) 125.2(4) 
C(5)-C(4)-C(3) 120.7(4) 
C(6)-C(5)-C(4) 121.6(4) 
C(6)-C(5)-H(5) 119.2 
C(4)-C(5)-H(5) 119.2 
O(3)-C(6)-C(5) 123.3(4) 
O(3)-C(6)-C(7) 116.9(4) 
C(5)-C(6)-C(7) 119.8(4) 
C(2)-C(7)-C(6) 117.4(4) 
C(2)-C(7)-C(8) 119.5(4) 
C(6)-C(7)-C(8) 123.1(4) 
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O(4)-C(8)-C(7) 124.6(4) 
O(4)-C(8)-C(9) 116.6(4) 
C(7)-C(8)-C(9) 118.8(4) 
C(10)-C(9)-C(8) 121.7(4) 
C(10)-C(9)-C(13) 122.0(4) 
C(8)-C(9)-C(13) 116.3(4) 
C(9)-C(10)-C(1) 121.4(4) 
C(9)-C(10)-C(14) 120.7(4) 
C(1)-C(10)-C(14) 117.8(4) 
O(2)-C(11)-H(11A) 109.5 
O(2)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
O(2)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
O(3)-C(12)-H(12A) 109.5 
O(3)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
O(3)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
O(5)-C(13)-C(9) 113.0(3) 
O(5)-C(13)-H(13A) 109.0 
C(9)-C(13)-H(13A) 109.0 
O(5)-C(13)-H(13B) 109.0 
C(9)-C(13)-H(13B) 109.0 
H(13A)-C(13)-H(13B) 107.8 
O(7)-C(14)-C(10) 105.3(3) 
O(7)-C(14)-C(15) 107.8(3) 
C(10)-C(14)-C(15) 112.5(4) 
O(7)-C(14)-H(14) 110.3 
C(10)-C(14)-H(14) 110.3 
C(15)-C(14)-H(14) 110.3 
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O(6)-C(15)-O(5) 111.0(4) 
O(6)-C(15)-C(16) 113.0(4) 
O(5)-C(15)-C(16) 106.0(3) 
O(6)-C(15)-C(14) 103.9(3) 
O(5)-C(15)-C(14) 109.0(4) 
C(16)-C(15)-C(14) 113.9(4) 
C(15)-C(16)-H(16A) 109.5 
C(15)-C(16)-H(16B) 109.5 
H(16A)-C(16)-H(16B) 109.5 
C(15)-C(16)-H(16C) 109.5 
H(16A)-C(16)-H(16C) 109.5 
H(16B)-C(16)-H(16C) 109.5 
O(8)-N(1)-O(9) 130.3(5) 
O(8)-N(1)-O(7) 119.3(4) 
O(9)-N(1)-O(7) 110.3(4) 
C(4)-O(2)-C(11) 119.0(4) 
C(6)-O(3)-C(12) 117.3(3) 
C(13)-O(5)-C(15) 114.2(3) 
C(15)-O(6)-H(6) 109.5 
N(1)-O(7)-C(14) 115.0(3) 
Symmetry transformations used to generate equivalent atoms  
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Table A1.2.4.   Anisotropic displacement parameters (Å2x 103) for 202.  The 
anisotropic displacement factor exponent takes the form: -2pi2[ h2a*2U11 + ... + 
2 h k a* b* U12 ]. 
 
 U11 U22 U33 U23 U13 U12 
C(1) 22(2)  35(3) 27(3)  0(2) 3(2)  -1(2) 
C(2) 30(3)  28(3) 23(3)  -3(2) 3(2)  -3(2) 
C(3) 25(3)  36(3) 32(3)  -2(2) 3(2)  5(2) 
C(4) 30(3)  41(4) 32(3)  -9(2) -1(2)  0(2) 
C(5) 37(3)  33(3) 38(3)  0(3) 2(2)  3(3) 
C(6) 26(3)  38(3) 23(3)  4(2) -1(2)  3(2) 
C(7) 30(3)  34(3) 22(3)  1(2) -1(2)  2(2) 
C(8) 26(3)  36(3) 33(3)  -3(2) -1(2)  3(2) 
C(9) 21(2)  38(3) 24(3)  -4(2) -2(2)  0(2) 
C(10) 27(2)  28(3) 28(3)  -3(2) 2(2)  -2(2) 
C(11) 35(3)  54(4) 50(3)  -6(3) -12(2)  -1(2) 
C(12) 52(3)  35(3) 41(3)  10(2) 5(3)  12(3) 
C(13) 32(3)  35(3) 38(3)  -2(2) -7(2)  3(2) 
C(14) 28(2)  44(3) 25(3)  -3(2) 3(2)  -4(2) 
C(15) 32(3)  44(3) 31(3)  -3(2) -2(2)  -6(2) 
C(16) 55(3)  35(3) 41(3)  -5(3) -4(3)  -6(3) 
N(1) 48(3)  40(3) 77(4)  2(3) 3(3)  15(3) 
O(1) 34(2)  35(2) 37(2)  1(2) -14(2)  1(2) 
O(2) 44(2)  35(2) 52(2)  -8(2) -14(2)  1(2) 
O(3) 43(2)  33(2) 36(2)  5(2) -5(2)  7(2) 
O(4) 38(2)  43(2) 56(2)  -7(2) -18(2)  11(2) 
O(5) 37(2)  43(2) 30(2)  -5(2) -9(1)  -3(2) 
O(6) 35(2)  52(2) 42(2)  -7(2) 3(2)  -16(2) 
O(7) 35(2)  37(2) 44(2)  5(2) 0(2)  7(2) 
O(8) 95(3)  69(3) 61(3)  17(2) -4(2)  36(2) 
O(9) 57(3)  57(3) 117(4)  12(2) 24(2)  25(2) 
A1 X-ray crystallographic data 
 
 199 
 
Table A1.2.5.   Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (Å2x 103) for 202. 
 
 x  y  z  U(eq) 
H(3) 9152 2288 5961 37 
H(5) 8099 4935 4353 44 
H(11A) 9841 3330 7891 70 
H(11B) 10507 4289 7752 70 
H(11C) 10537 3417 6464 70 
H(12A) 6677 5617 3468 64 
H(12B) 6272 5609 1635 64 
H(12C) 7405 5514 2090 64 
H(13A) 5157 620 1864 43 
H(13B) 5728 929 357 43 
H(14) 7358 -822 4416 39 
H(16A) 6593 -2463 2939 66 
H(16B) 6848 -2097 1208 66 
H(16C) 5750 -2295 1563 66 
H(6) 5116 -1199 3442 64 
 
Table A1.2.6.  Torsion angles [°] for 202. 
 
O(1)-C(1)-C(2)-C(3) 1.0(6) 
C(10)-C(1)-C(2)-C(3) -177.8(4) 
O(1)-C(1)-C(2)-C(7) -178.8(4) 
C(10)-C(1)-C(2)-C(7) 2.4(6) 
C(7)-C(2)-C(3)-C(4) -1.2(6) 
C(1)-C(2)-C(3)-C(4) 179.0(4) 
C(2)-C(3)-C(4)-O(2) 177.6(4) 
C(2)-C(3)-C(4)-C(5) -0.5(6) 
O(2)-C(4)-C(5)-C(6) -177.9(4) 
C(3)-C(4)-C(5)-C(6) 0.4(7) 
C(4)-C(5)-C(6)-O(3) -179.2(4) 
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C(4)-C(5)-C(6)-C(7) 1.5(7) 
C(3)-C(2)-C(7)-C(6) 3.0(6) 
C(1)-C(2)-C(7)-C(6) -177.3(4) 
C(3)-C(2)-C(7)-C(8) -178.2(4) 
C(1)-C(2)-C(7)-C(8) 1.5(6) 
O(3)-C(6)-C(7)-C(2) 177.6(4) 
C(5)-C(6)-C(7)-C(2) -3.1(6) 
O(3)-C(6)-C(7)-C(8) -1.1(6) 
C(5)-C(6)-C(7)-C(8) 178.2(4) 
C(2)-C(7)-C(8)-O(4) 173.5(4) 
C(6)-C(7)-C(8)-O(4) -7.8(7) 
C(2)-C(7)-C(8)-C(9) -6.0(6) 
C(6)-C(7)-C(8)-C(9) 172.7(4) 
O(4)-C(8)-C(9)-C(10) -172.7(4) 
C(7)-C(8)-C(9)-C(10) 6.8(6) 
O(4)-C(8)-C(9)-C(13) 6.1(6) 
C(7)-C(8)-C(9)-C(13) -174.4(4) 
C(8)-C(9)-C(10)-C(1) -2.8(6) 
C(13)-C(9)-C(10)-C(1) 178.4(4) 
C(8)-C(9)-C(10)-C(14) 179.4(4) 
C(13)-C(9)-C(10)-C(14) 0.6(6) 
O(1)-C(1)-C(10)-C(9) 179.5(4) 
C(2)-C(1)-C(10)-C(9) -1.8(6) 
O(1)-C(1)-C(10)-C(14) -2.7(6) 
C(2)-C(1)-C(10)-C(14) 176.1(3) 
C(10)-C(9)-C(13)-O(5) -15.0(6) 
C(8)-C(9)-C(13)-O(5) 166.1(3) 
C(9)-C(10)-C(14)-O(7) 101.4(4) 
C(1)-C(10)-C(14)-O(7) -76.5(4) 
C(9)-C(10)-C(14)-C(15) -15.8(5) 
C(1)-C(10)-C(14)-C(15) 166.4(3) 
O(7)-C(14)-C(15)-O(6) 170.7(3) 
C(10)-C(14)-C(15)-O(6) -73.6(4) 
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O(7)-C(14)-C(15)-O(5) -70.9(4) 
C(10)-C(14)-C(15)-O(5) 44.8(5) 
O(7)-C(14)-C(15)-C(16) 47.2(5) 
C(10)-C(14)-C(15)-C(16) 162.9(4) 
C(5)-C(4)-O(2)-C(11) -177.2(4) 
C(3)-C(4)-O(2)-C(11) 4.6(6) 
C(5)-C(6)-O(3)-C(12) 2.1(6) 
C(7)-C(6)-O(3)-C(12) -178.7(3) 
C(9)-C(13)-O(5)-C(15) 47.5(5) 
O(6)-C(15)-O(5)-C(13) 51.1(4) 
C(16)-C(15)-O(5)-C(13) 174.3(3) 
C(14)-C(15)-O(5)-C(13) -62.7(4) 
O(8)-N(1)-O(7)-C(14) 9.6(6) 
O(9)-N(1)-O(7)-C(14) -173.5(4) 
C(10)-C(14)-O(7)-N(1) 122.3(3) 
C(15)-C(14)-O(7)-N(1) -117.3(4) 
Symmetry transformations used to generate equivalent atoms  
  
Table A1.2.7. Hydrogen bonds for 202. 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O(6)-H(6)...O(4)#1 0.84 2.08 2.876(4) 159.2 
Symmetry transformations used to generate equivalent atoms 
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A1.3 X-Ray crystallographic data for 5,7,10-Trimethoxy-3-methyl-1H-
benzo[g]isochromene-6,9-dione 229 
 
Table A1.3.1 Crystal data and structure refinement for 229. 
 
Empirical formula  C17H16O6 
Formula weight  316.30 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.4652(2) Å α = 111.5360(10)°. 
 b = 9.6050(2) Å β = 90.649(2)°. 
 c = 9.6340(2) Å γ = 98.224(2)°. 
Volume 719.41(3) Å3 
Z 2 
Density (calculated) 1.460 Mg/m3 
Absorption coefficient 0.111 mm-1 
F(000) 332 
Crystal size 0.41 x 0.40 x 0.06 mm3 
Theta range for data collection 2.28 to 28.00°. 
Index ranges -11<=h<=11, -12<=k<=12, -12<=l<=12 
Reflections collected 17177 
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Independent reflections 3470 [R(int) = 0.0442] 
Completeness to theta = 28.00° 100.0 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3470 / 0 / 212 
Goodness-of-fit on F2 1.017 
Final R indices [I>2sigma(I)] R1 = 0.0421, wR2 = 0.1150 
R indices (all data) R1 = 0.0665, wR2 = 0.1269 
Largest diff. peak and hole 0.346 and -0.222 e.Å-3 
 
Table A1.3.2 Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 229. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
C(1) 8145(2) 10799(1) 4342(2) 21(1) 
C(2) 8556(2) 11047(2) 5838(2) 22(1) 
C(3) 9696(2) 12417(2) 6782(2) 26(1) 
C(4) 10179(2) 12539(2) 8322(2) 26(1) 
C(5) 9570(2) 11512(2) 8882(2) 29(1) 
C(6) 8411(2) 10186(2) 8018(2) 27(1) 
C(7) 7885(2) 9988(2) 6463(2) 22(1) 
C(8) 6756(2) 8747(2) 5582(2) 23(1) 
C(9) 6338(2) 8544(2) 4117(2) 24(1) 
C(10) 7024(2) 9540(2) 3473(2) 23(1) 
C(11) 8143(2) 12946(2) 3688(2) 41(1) 
C(12) 11724(2) 14075(2) 10558(2) 38(1) 
C(13) 6881(2) 6482(2) 5961(2) 39(1) 
C(14) 5227(2) 7148(2) 3121(2) 32(1) 
C(15) 6547(2) 9218(2) 1916(2) 26(1) 
C(16) 5255(2) 8193(2) 1244(2) 28(1) 
C(17) 4544(2) 7821(2) -294(2) 35(1) 
O(1) 8903(1) 11684(1) 3630(1) 27(1) 
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O(2) 10215(2) 13438(1) 6378(1) 47(1) 
O(3) 11257(1) 13790(1) 9025(1) 33(1) 
O(4) 7923(1) 9276(1) 8587(1) 39(1) 
O(5) 6009(1) 7698(1) 6117(1) 29(1) 
O(6) 4369(1) 7398(1) 1966(1) 33(1) 
 
Table A1.3.3.   Bond lengths [Å] and angles [°] for 229. 
 
C(1)-O(1)  1.3734(15) 
C(1)-C(2)  1.4027(19) 
C(1)-C(10)  1.4051(18) 
C(2)-C(7)  1.4181(19) 
C(2)-C(3)  1.4926(18) 
C(3)-O(2)  1.2105(17) 
C(3)-C(4)  1.492(2) 
C(4)-C(5)  1.335(2) 
C(4)-O(3)  1.3456(16) 
C(5)-C(6)  1.4569(19) 
C(5)-H(5)  0.9500 
C(6)-O(4)  1.2209(17) 
C(6)-C(7)  1.4932(19) 
C(7)-C(8)  1.4025(18) 
C(8)-O(5)  1.3742(16) 
C(8)-C(9)  1.3863(19) 
C(9)-C(10)  1.3874(19) 
C(9)-C(14)  1.5088(18) 
C(10)-C(15)  1.4553(18) 
C(11)-O(1)  1.4360(19) 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-O(3)  1.4392(18) 
C(12)-H(12A)  0.9800 
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C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-O(5)  1.4318(18) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-O(6)  1.4322(18) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(15)-C(16)  1.3391(19) 
C(15)-H(15)  0.9500 
C(16)-O(6)  1.3667(17) 
C(16)-C(17)  1.488(2) 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
O(1)-C(1)-C(2) 122.15(11) 
O(1)-C(1)-C(10) 117.14(12) 
C(2)-C(1)-C(10) 120.49(12) 
C(1)-C(2)-C(7) 119.87(12) 
C(1)-C(2)-C(3) 120.59(12) 
C(7)-C(2)-C(3) 119.54(12) 
O(2)-C(3)-C(4) 118.76(12) 
O(2)-C(3)-C(2) 123.71(13) 
C(4)-C(3)-C(2) 117.51(12) 
C(5)-C(4)-O(3) 126.44(13) 
C(5)-C(4)-C(3) 122.16(12) 
O(3)-C(4)-C(3) 111.39(12) 
C(4)-C(5)-C(6) 122.05(13) 
C(4)-C(5)-H(5) 119.0 
C(6)-C(5)-H(5) 119.0 
O(4)-C(6)-C(5) 118.76(13) 
O(4)-C(6)-C(7) 122.70(12) 
A1 X-ray crystallographic data 
 
 206 
 
C(5)-C(6)-C(7) 118.54(12) 
C(8)-C(7)-C(2) 118.73(12) 
C(8)-C(7)-C(6) 121.23(12) 
C(2)-C(7)-C(6) 120.02(12) 
O(5)-C(8)-C(9) 117.13(11) 
O(5)-C(8)-C(7) 122.45(12) 
C(9)-C(8)-C(7) 120.41(12) 
C(8)-C(9)-C(10) 121.55(12) 
C(8)-C(9)-C(14) 120.85(12) 
C(10)-C(9)-C(14) 117.38(12) 
C(9)-C(10)-C(1) 118.87(12) 
C(9)-C(10)-C(15) 117.89(12) 
C(1)-C(10)-C(15) 123.24(12) 
O(1)-C(11)-H(11A) 109.5 
O(1)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
O(1)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
O(3)-C(12)-H(12A) 109.5 
O(3)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
O(3)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
O(5)-C(13)-H(13A) 109.5 
O(5)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
O(5)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
O(6)-C(14)-C(9) 112.87(12) 
O(6)-C(14)-H(14A) 109.0 
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C(9)-C(14)-H(14A) 109.0 
O(6)-C(14)-H(14B) 109.0 
C(9)-C(14)-H(14B) 109.0 
H(14A)-C(14)-H(14B) 107.8 
C(16)-C(15)-C(10) 120.03(13) 
C(16)-C(15)-H(15) 120.0 
C(10)-C(15)-H(15) 120.0 
C(15)-C(16)-O(6) 122.01(13) 
C(15)-C(16)-C(17) 126.53(14) 
O(6)-C(16)-C(17) 111.38(12) 
C(16)-C(17)-H(17A) 109.5 
C(16)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 
C(16)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(1)-O(1)-C(11) 114.85(11) 
C(4)-O(3)-C(12) 116.00(12) 
C(8)-O(5)-C(13) 113.75(11) 
C(16)-O(6)-C(14) 115.51(11) 
Symmetry transformations used to generate equivalent atoms 
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Table A1.3.4.   Anisotropic displacement parameters (Å2x 103) for 229.  The 
anisotropic displacement factor exponent takes the form: -2pi2[ h2a*2U11 + ... + 
2 h k a* b* U12 ]. 
 
 U11 U22 U33 U23 U13 U12 
C(1) 21(1)  21(1) 25(1)  11(1) 5(1)  4(1) 
C(2) 21(1)  20(1) 24(1)  8(1) 2(1)  3(1) 
C(3) 28(1)  23(1) 27(1)  10(1) 2(1)  2(1) 
C(4) 21(1)  24(1) 28(1)  6(1) -2(1)  3(1) 
C(5) 29(1)  32(1) 23(1)  9(1) -2(1)  2(1) 
C(6) 26(1)  29(1) 25(1)  11(1) 4(1)  3(1) 
C(7) 22(1)  22(1) 23(1)  9(1) 2(1)  5(1) 
C(8) 22(1)  22(1) 27(1)  11(1) 5(1)  2(1) 
C(9) 23(1)  21(1) 26(1)  8(1) 1(1)  3(1) 
C(10) 22(1)  22(1) 24(1)  9(1) 3(1)  5(1) 
C(11) 39(1)  37(1) 58(1)  31(1) -3(1)  4(1) 
C(12) 41(1)  34(1) 32(1)  5(1) -13(1)  -2(1) 
C(13) 50(1)  28(1) 43(1)  19(1) 3(1)  4(1) 
C(14) 36(1)  28(1) 29(1)  11(1) -4(1)  -5(1) 
C(15) 28(1)  26(1) 24(1)  11(1) 2(1)  3(1) 
C(16) 27(1)  29(1) 27(1)  10(1) 2(1)  5(1) 
C(17) 32(1)  41(1) 30(1)  10(1) -3(1)  3(1) 
O(1) 28(1)  27(1) 28(1)  15(1) 3(1)  0(1) 
O(2) 65(1)  33(1) 36(1)  17(1) -12(1)  -19(1) 
O(3) 35(1)  28(1) 31(1)  9(1) -8(1)  -5(1) 
O(4) 48(1)  42(1) 29(1)  20(1) -3(1)  -10(1) 
O(5) 29(1)  28(1) 33(1)  17(1) 2(1)  -2(1) 
O(6) 31(1)  35(1) 30(1)  13(1) -5(1)  -6(1) 
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Table A1.3.5.   Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (Å2x 103) for 229. 
 
 x  y  z  U(eq) 
H(5) 9903 11649 9875 34 
H(11A) 7006 12592 3366 62 
H(11B) 8652 13414 3023 62 
H(11C) 8251 13694 4715 62 
H(12A) 10780 14188 11146 58 
H(12B) 12506 15007 10964 58 
H(12C) 12204 13223 10608 58 
H(13A) 6933 5880 4897 58 
H(13B) 6339 5836 6453 58 
H(13C) 7967 6899 6426 58 
H(14A) 5858 6323 2657 38 
H(14B) 4451 6814 3741 38 
H(15) 7153 9735 1377 31 
H(17A) 5238 8360 -803 53 
H(17B) 3485 8131 -236 53 
H(17C) 4439 6726 -854 53 
 
Table A1.3.6.  Torsion angles [°] for 229. 
 
O(1)-C(1)-C(2)-C(7) -171.86(11) 
C(10)-C(1)-C(2)-C(7) 2.6(2) 
O(1)-C(1)-C(2)-C(3) 8.1(2) 
C(10)-C(1)-C(2)-C(3) -177.50(12) 
C(1)-C(2)-C(3)-O(2) 6.6(2) 
C(7)-C(2)-C(3)-O(2) -173.48(14) 
C(1)-C(2)-C(3)-C(4) -175.07(12) 
C(7)-C(2)-C(3)-C(4) 4.85(19) 
O(2)-C(3)-C(4)-C(5) 175.25(14) 
C(2)-C(3)-C(4)-C(5) -3.2(2) 
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O(2)-C(3)-C(4)-O(3) -4.20(19) 
C(2)-C(3)-C(4)-O(3) 177.38(11) 
O(3)-C(4)-C(5)-C(6) -179.57(13) 
C(3)-C(4)-C(5)-C(6) 1.1(2) 
C(4)-C(5)-C(6)-O(4) 178.71(14) 
C(4)-C(5)-C(6)-C(7) -0.5(2) 
C(1)-C(2)-C(7)-C(8) -3.19(19) 
C(3)-C(2)-C(7)-C(8) 176.89(12) 
C(1)-C(2)-C(7)-C(6) 175.42(12) 
C(3)-C(2)-C(7)-C(6) -4.50(19) 
O(4)-C(6)-C(7)-C(8) 1.7(2) 
C(5)-C(6)-C(7)-C(8) -179.10(12) 
O(4)-C(6)-C(7)-C(2) -176.89(13) 
C(5)-C(6)-C(7)-C(2) 2.32(19) 
C(2)-C(7)-C(8)-O(5) -177.72(11) 
C(6)-C(7)-C(8)-O(5) 3.7(2) 
C(2)-C(7)-C(8)-C(9) 1.6(2) 
C(6)-C(7)-C(8)-C(9) -176.97(12) 
O(5)-C(8)-C(9)-C(10) 179.99(11) 
C(7)-C(8)-C(9)-C(10) 0.6(2) 
O(5)-C(8)-C(9)-C(14) -5.57(19) 
C(7)-C(8)-C(9)-C(14) 175.05(12) 
C(8)-C(9)-C(10)-C(1) -1.3(2) 
C(14)-C(9)-C(10)-C(1) -175.89(12) 
C(8)-C(9)-C(10)-C(15) 178.38(12) 
C(14)-C(9)-C(10)-C(15) 3.76(19) 
O(1)-C(1)-C(10)-C(9) 174.37(11) 
C(2)-C(1)-C(10)-C(9) -0.3(2) 
O(1)-C(1)-C(10)-C(15) -5.26(19) 
C(2)-C(1)-C(10)-C(15) -179.97(12) 
C(8)-C(9)-C(14)-O(6) 153.50(13) 
C(10)-C(9)-C(14)-O(6) -31.84(18) 
C(9)-C(10)-C(15)-C(16) 13.9(2) 
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C(1)-C(10)-C(15)-C(16) -166.46(13) 
C(10)-C(15)-C(16)-O(6) -1.4(2) 
C(10)-C(15)-C(16)-C(17) 175.08(13) 
C(2)-C(1)-O(1)-C(11) -92.92(15) 
C(10)-C(1)-O(1)-C(11) 92.46(15) 
C(5)-C(4)-O(3)-C(12) -3.5(2) 
C(3)-C(4)-O(3)-C(12) 175.90(12) 
C(9)-C(8)-O(5)-C(13) 93.52(15) 
C(7)-C(8)-O(5)-C(13) -87.12(16) 
C(15)-C(16)-O(6)-C(14) -28.69(19) 
C(17)-C(16)-O(6)-C(14) 154.31(13) 
C(9)-C(14)-O(6)-C(16) 44.03(17) 
Symmetry transformations used to generate equivalent atoms 
 
A1.4 X-Ray crystallographic data for (3,6-Dimethoxy-9-methyl-10,13-
dioxatricyclo[7.3.1.02,7]trideca-2,4,6-trien-11-yl)methanol 254 
 
 
Table A1.4.1 Crystal data and structure refinement for 254. 
 
Empirical formula  C15H20O5 
Formula weight  280.31 
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Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 9.8703(4) Å α = 90°. 
 b = 20.4560(7) Å β = 93.068(2)°. 
 c = 6.8483(3) Å γ = 90°. 
Volume 1380.74(9) Å3 
Z 4 
Density (calculated) 1.348 Mg/m3 
Absorption coefficient 0.101 mm-1 
F(000) 600 
Crystal size 0.48 x 0.15 x 0.05 mm3 
Theta range for data collection 1.99 to 26.00°. 
Index ranges -12<=h<=8, -25<=k<=25, -8<=l<=8 
Reflections collected 15409 
Independent reflections 2722 [R(int) = 0.0789] 
Completeness to theta = 26.00° 100.0 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2722 / 0 / 224 
Goodness-of-fit on F2 0.827 
Final R indices [I>2sigma(I)] R1 = 0.0400, wR2 = 0.0723 
R indices (all data) R1 = 0.0873, wR2 = 0.0831 
Largest diff. peak and hole 0.167 and -0.185 e.Å-3 
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Table A1.4.2 Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 254. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
C(1) 2376(2) 3662(1) 7657(3) 22(1) 
C(2) 3713(2) 3708(1) 8381(3) 23(1) 
C(3) 4721(2) 3369(1) 7428(3) 24(1) 
C(4) 4394(2) 3000(1) 5788(3) 28(1) 
C(5) 3055(2) 2959(1) 5056(3) 29(1) 
C(6) 2054(2) 3288(1) 5985(3) 25(1) 
C(7) 1280(2) 4033(1) 8642(3) 25(1) 
C(8) 948(2) 4682(1) 7615(3) 27(1) 
C(9) 2172(7) 5138(3) 7920(9) 24(1) 
C(10) 1831(5) 5833(4) 7439(12) 22(2) 
O(1) 2635(5) 5148(2) 9972(7) 24(1) 
O(2) 2872(8) 6289(5) 7642(12) 39(1) 
C(9A) 1745(12) 5246(5) 8580(20) 33(2) 
C(10A) 1838(18) 5793(9) 7180(30) 67(6) 
O(1A) 3023(9) 5027(4) 9301(15) 29(2) 
O(2A) 2446(17) 6368(9) 8120(30) 52(3) 
C(11) 4058(2) 4109(1) 10182(3) 29(1) 
C(12) 2895(2) 4524(1) 10854(3) 26(1) 
C(13) 3116(2) 4725(1) 12964(3) 41(1) 
C(14) 7096(2) 3152(1) 7249(3) 44(1) 
C(15) 319(2) 2887(1) 3721(3) 38(1) 
O(3) 1665(1) 4162(1) 10667(2) 28(1) 
O(4) 6013(1) 3433(1) 8280(2) 34(1) 
O(5) 693(1) 3283(1) 5389(2) 32(1) 
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Table A1.4.3.   Bond lengths [Å] and angles [°] for 254. 
 
C(1)-C(2)  1.388(2) 
C(1)-C(6)  1.399(2) 
C(1)-C(7)  1.509(2) 
C(2)-C(3)  1.402(2) 
C(2)-C(11)  1.505(2) 
C(3)-C(4)  1.377(2) 
C(3)-O(4)  1.380(2) 
C(4)-C(5)  1.391(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.379(2) 
C(5)-H(5)  0.9500 
C(6)-O(5)  1.383(2) 
C(7)-O(3)  1.4427(19) 
C(7)-C(8)  1.530(2) 
C(7)-H(7)  1.0000 
C(8)-C(9A)  1.527(11) 
C(8)-C(9)  1.531(6) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(8)-H(8C)  0.9900 
C(8)-H(8D)  0.9900 
C(9)-O(1)  1.454(8) 
C(9)-C(10)  1.494(10) 
C(9)-H(9)  1.0000 
C(10)-O(2)  1.390(12) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
O(1)-C(12)  1.429(4) 
O(2)-H(2)  0.8400 
C(9A)-O(1A)  1.402(16) 
C(9A)-C(10A)  1.48(2) 
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C(9A)-H(9A)  1.0000 
C(10A)-O(2A)  1.46(3) 
C(10A)-H(10C)  0.9900 
C(10A)-H(10D)  0.9900 
O(1A)-C(12)  1.491(8) 
O(2A)-H(2A)  0.8400 
C(11)-C(12)  1.518(2) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-O(3)  1.421(2) 
C(12)-C(13)  1.508(2) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-O(4)  1.432(2) 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-O(5)  1.4333(19) 
C(15)-H(15A)  0.9800 
C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 
C(2)-C(1)-C(6) 119.91(17) 
C(2)-C(1)-C(7) 119.80(16) 
C(6)-C(1)-C(7) 120.26(16) 
C(1)-C(2)-C(3) 119.02(17) 
C(1)-C(2)-C(11) 119.91(16) 
C(3)-C(2)-C(11) 121.06(15) 
C(4)-C(3)-O(4) 124.58(17) 
C(4)-C(3)-C(2) 120.63(17) 
O(4)-C(3)-C(2) 114.78(16) 
C(3)-C(4)-C(5) 120.27(17) 
C(3)-C(4)-H(4) 119.9 
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C(5)-C(4)-H(4) 119.9 
C(6)-C(5)-C(4) 119.59(17) 
C(6)-C(5)-H(5) 120.2 
C(4)-C(5)-H(5) 120.2 
C(5)-C(6)-O(5) 124.65(16) 
C(5)-C(6)-C(1) 120.57(17) 
O(5)-C(6)-C(1) 114.79(16) 
O(3)-C(7)-C(1) 111.30(14) 
O(3)-C(7)-C(8) 108.75(14) 
C(1)-C(7)-C(8) 111.82(15) 
O(3)-C(7)-H(7) 108.3 
C(1)-C(7)-H(7) 108.3 
C(8)-C(7)-H(7) 108.3 
C(9A)-C(8)-C(7) 111.3(4) 
C(7)-C(8)-C(9) 108.5(2) 
C(9A)-C(8)-H(8A) 85.9 
C(7)-C(8)-H(8A) 110.0 
C(9)-C(8)-H(8A) 110.0 
C(9A)-C(8)-H(8B) 127.7 
C(7)-C(8)-H(8B) 110.0 
C(9)-C(8)-H(8B) 110.0 
H(8A)-C(8)-H(8B) 108.4 
C(9A)-C(8)-H(8C) 109.4 
C(7)-C(8)-H(8C) 109.4 
C(9)-C(8)-H(8C) 87.6 
H(8A)-C(8)-H(8C) 128.2 
C(9A)-C(8)-H(8D) 109.5 
C(7)-C(8)-H(8D) 109.3 
C(9)-C(8)-H(8D) 130.8 
H(8B)-C(8)-H(8D) 85.1 
H(8C)-C(8)-H(8D) 108.0 
O(1)-C(9)-C(10) 104.8(6) 
O(1)-C(9)-C(8) 110.2(5) 
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C(10)-C(9)-C(8) 112.5(5) 
O(1)-C(9)-H(9) 109.7 
C(10)-C(9)-H(9) 109.7 
C(8)-C(9)-H(9) 109.7 
O(2)-C(10)-C(9) 117.4(6) 
O(2)-C(10)-H(10A) 107.9 
C(9)-C(10)-H(10A) 107.9 
O(2)-C(10)-H(10B) 107.9 
C(9)-C(10)-H(10B) 107.9 
H(10A)-C(10)-H(10B) 107.2 
C(12)-O(1)-C(9) 115.8(4) 
O(1A)-C(9A)-C(10A) 112.5(12) 
O(1A)-C(9A)-C(8) 110.2(10) 
C(10A)-C(9A)-C(8) 109.7(12) 
O(1A)-C(9A)-H(9A) 108.1 
C(10A)-C(9A)-H(9A) 108.1 
C(8)-C(9A)-H(9A) 108.1 
O(2A)-C(10A)-C(9A) 111.2(17) 
O(2A)-C(10A)-H(10C) 109.4 
C(9A)-C(10A)-H(10C) 109.4 
O(2A)-C(10A)-H(10D) 109.4 
C(9A)-C(10A)-H(10D) 109.4 
H(10C)-C(10A)-H(10D) 108.0 
C(9A)-O(1A)-C(12) 111.2(10) 
C(10A)-O(2A)-H(2A) 109.5 
C(2)-C(11)-C(12) 114.29(15) 
C(2)-C(11)-H(11A) 108.7 
C(12)-C(11)-H(11A) 108.7 
C(2)-C(11)-H(11B) 108.7 
C(12)-C(11)-H(11B) 108.7 
H(11A)-C(11)-H(11B) 107.6 
O(3)-C(12)-O(1) 107.1(2) 
O(3)-C(12)-O(1A) 113.6(3) 
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O(3)-C(12)-C(13) 107.94(15) 
O(1)-C(12)-C(13) 100.1(2) 
O(1A)-C(12)-C(13) 118.8(4) 
O(3)-C(12)-C(11) 109.76(14) 
O(1)-C(12)-C(11) 119.4(3) 
O(1A)-C(12)-C(11) 94.3(5) 
C(13)-C(12)-C(11) 111.72(15) 
C(12)-C(13)-H(13A) 109.5 
C(12)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
C(12)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
O(4)-C(14)-H(14A) 109.5 
O(4)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
O(4)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
O(5)-C(15)-H(15A) 109.5 
O(5)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15B) 109.5 
O(5)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 
H(15B)-C(15)-H(15C) 109.5 
C(12)-O(3)-C(7) 111.23(13) 
C(3)-O(4)-C(14) 116.79(15) 
C(6)-O(5)-C(15) 116.37(14) 
Symmetry transformations used to generate equivalent atoms   
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Table A1.4.4.   Anisotropic displacement parameters (Å2x 103) for 254.  The 
anisotropic displacement factor exponent takes the form: -2pi2[ h2a*2U11 + ... + 
2 h k a* b* U12 ]. 
 
 U11 U22 U33 U23 U13 U12 
C(1) 25(1)  16(1) 25(1)  1(1) 3(1)  1(1) 
C(2) 24(1)  20(1) 25(1)  1(1) 3(1)  -2(1) 
C(3) 21(1)  25(1) 26(1)  0(1) -1(1)  -1(1) 
C(4) 28(1)  28(1) 28(1)  -4(1) 5(1)  5(1) 
C(5) 32(1)  26(1) 28(1)  -6(1) -2(1)  2(1) 
C(6) 25(1)  21(1) 29(1)  0(1) -4(1)  2(1) 
C(7) 25(1)  25(1) 25(1)  -3(1) 0(1)  -1(1) 
C(8) 24(1)  28(1) 28(1)  -4(1) -2(1)  5(1) 
C(9) 32(3)  23(2) 16(3)  -4(2) -1(2)  1(2) 
C(10) 15(3)  26(4) 24(3)  -1(2) -11(2)  5(2) 
O(1) 30(2)  24(2) 19(2)  0(1) 0(2)  -1(1) 
O(2) 42(3)  35(3) 39(3)  7(2) -8(2)  -11(2) 
C(9A) 35(6)  31(5) 35(6)  -3(4) 3(5)  10(4) 
C(10A) 139(14)  25(9) 39(8)  -2(6) 16(8)  -23(8) 
O(1A) 33(4)  24(3) 28(5)  1(3) 1(3)  -6(3) 
O(2A) 72(9)  29(5) 53(8)  9(5) -26(6)  -12(6) 
C(11) 25(1)  31(1) 30(1)  -7(1) 4(1)  -5(1) 
C(12) 33(1)  22(1) 23(1)  2(1) -1(1)  -3(1) 
C(13) 39(1)  52(1) 32(1)  -14(1) 0(1)  7(1) 
C(14) 24(1)  60(2) 48(1)  -7(1) 5(1)  6(1) 
C(15) 40(1)  30(1) 42(1)  -10(1) -14(1)  1(1) 
O(3) 27(1)  31(1) 25(1)  0(1) 5(1)  -1(1) 
O(4) 22(1)  44(1) 35(1)  -11(1) 2(1)  2(1) 
O(5) 28(1)  31(1) 37(1)  -10(1) -9(1)  3(1) 
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Table A1.4.5.   Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (Å2x 103) for 254. 
 
 x  y  z  U(eq) 
H(4) 5086 2773 5153 34 
H(5) 2831 2704 3923 34 
H(7) 440 3759 8588 30 
H(8A) 140 4883 8167 32 
H(8B) 749 4607 6201 32 
H(8C) 1169 4650 6226 32 
H(8D) -36 4770 7660 32 
H(9) 2923 4986 7107 28 
H(10A) 1458 5849 6069 27 
H(10B) 1098 5972 8281 27 
H(2) 3261 6254 8758 59 
H(9A) 1236 5403 9714 40 
H(10C) 2391 5655 6084 81 
H(10D) 918 5903 6626 81 
H(2A) 2900 6255 9132 78 
H(11A) 4828 4400 9918 34 
H(11B) 4360 3811 11258 34 
H(13A) 2360 5001 13336 61 
H(13B) 3967 4971 13134 61 
H(13C) 3165 4335 13794 61 
H(14A) 7008 2675 7244 66 
H(14B) 7968 3275 7898 66 
H(14C) 7053 3313 5900 66 
H(15A) 779 3048 2582 56 
H(15B) -666 2909 3454 56 
H(15C) 587 2433 3986 56 
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Table A1.4.6.  Torsion angles [°] for 254. 
 
C(6)-C(1)-C(2)-C(3) -0.8(3) 
C(7)-C(1)-C(2)-C(3) -178.94(16) 
C(6)-C(1)-C(2)-C(11) -179.87(16) 
C(7)-C(1)-C(2)-C(11) 2.0(3) 
C(1)-C(2)-C(3)-C(4) 0.6(3) 
C(11)-C(2)-C(3)-C(4) 179.61(17) 
C(1)-C(2)-C(3)-O(4) -178.65(15) 
C(11)-C(2)-C(3)-O(4) 0.4(2) 
O(4)-C(3)-C(4)-C(5) 179.02(17) 
C(2)-C(3)-C(4)-C(5) -0.1(3) 
C(3)-C(4)-C(5)-C(6) -0.1(3) 
C(4)-C(5)-C(6)-O(5) 179.87(16) 
C(4)-C(5)-C(6)-C(1) -0.1(3) 
C(2)-C(1)-C(6)-C(5) 0.6(3) 
C(7)-C(1)-C(6)-C(5) 178.73(16) 
C(2)-C(1)-C(6)-O(5) -179.41(15) 
C(7)-C(1)-C(6)-O(5) -1.3(2) 
C(2)-C(1)-C(7)-O(3) -25.0(2) 
C(6)-C(1)-C(7)-O(3) 156.91(15) 
C(2)-C(1)-C(7)-C(8) 96.89(19) 
C(6)-C(1)-C(7)-C(8) -81.2(2) 
O(3)-C(7)-C(8)-C(9A) 28.5(7) 
C(1)-C(7)-C(8)-C(9A) -94.8(7) 
O(3)-C(7)-C(8)-C(9) 55.4(3) 
C(1)-C(7)-C(8)-C(9) -67.9(3) 
C(9A)-C(8)-C(9)-O(1) 52.4(11) 
C(7)-C(8)-C(9)-O(1) -48.5(7) 
C(9A)-C(8)-C(9)-C(10) -64.2(13) 
C(7)-C(8)-C(9)-C(10) -165.0(5) 
O(1)-C(9)-C(10)-O(2) 61.0(11) 
C(8)-C(9)-C(10)-O(2) -179.3(5) 
A1 X-ray crystallographic data 
 
 222 
 
C(10)-C(9)-O(1)-C(12) 173.7(3) 
C(8)-C(9)-O(1)-C(12) 52.5(9) 
C(7)-C(8)-C(9A)-O(1A) 33.5(15) 
C(9)-C(8)-C(9A)-O(1A) -55.0(13) 
C(7)-C(8)-C(9A)-C(10A) 157.8(10) 
C(9)-C(8)-C(9A)-C(10A) 69.3(16) 
O(1A)-C(9A)-C(10A)-O(2A) -64(2) 
C(8)-C(9A)-C(10A)-O(2A) 173.1(9) 
C(10A)-C(9A)-O(1A)-C(12) 174.4(10) 
C(8)-C(9A)-O(1A)-C(12) -62.9(17) 
C(1)-C(2)-C(11)-C(12) -9.6(2) 
C(3)-C(2)-C(11)-C(12) 171.35(16) 
C(9)-O(1)-C(12)-O(3) -58.8(7) 
C(9)-O(1)-C(12)-O(1A) 50.1(9) 
C(9)-O(1)-C(12)-C(13) -171.3(6) 
C(9)-O(1)-C(12)-C(11) 66.6(6) 
C(9A)-O(1A)-C(12)-O(3) 27.5(13) 
C(9A)-O(1A)-C(12)-O(1) -53.1(12) 
C(9A)-O(1A)-C(12)-C(13) -101.1(10) 
C(9A)-O(1A)-C(12)-C(11) 141.2(11) 
C(2)-C(11)-C(12)-O(3) 40.6(2) 
C(2)-C(11)-C(12)-O(1) -83.5(3) 
C(2)-C(11)-C(12)-O(1A) -76.3(3) 
C(2)-C(11)-C(12)-C(13) 160.30(16) 
O(1)-C(12)-O(3)-C(7) 64.7(3) 
O(1A)-C(12)-O(3)-C(7) 37.7(5) 
C(13)-C(12)-O(3)-C(7) 171.64(14) 
C(11)-C(12)-O(3)-C(7) -66.37(17) 
C(1)-C(7)-O(3)-C(12) 58.11(18) 
C(8)-C(7)-O(3)-C(12) -65.51(17) 
C(4)-C(3)-O(4)-C(14) 7.1(3) 
C(2)-C(3)-O(4)-C(14) -173.78(16) 
C(5)-C(6)-O(5)-C(15) 2.1(3) 
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C(1)-C(6)-O(5)-C(15) -177.89(15) 
Symmetry transformations used to generate equivalent atoms  
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B1.1. (3-Formyl-4-hydroxy-6,8-dimethoxynaphthalene-2-yl)methyl acetate 
201 
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B1.2. (3R,4R) 3-Hydroxy-7,9-dimethoxy-3-methyl-5,10-dioxo-3,4,5,10-
tetrahydro-1H-benzo[g]isochromen-4-yl nitrate 202 
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B1.3. 7,9-Dimethoxy-3-methyl-1H-benzo[g]isochromene-5,10-dione 31 
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B1.4. 5,7,10-Trimethoxy-3-methyl-1H-benzo[g]isochromene-6,9-dione 229  
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B1.5. 5,9,10-trimethoxy-3-methyl-1H-benzo[g]isochromene-6,7-dione 230 
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B1.6. 5,1-dihydroxy-7-methoxy-3-methyl-1H-benzo[g]isochromene-6,9-
dione (anhydrofusarubin) 26 
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B1.7. 3,6-Dimethoxy-9-methyl-10,14-dioxatricyclo[7.3.1.02,7]tetradeca-
2,4,6-triene 259 
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B1.8. (3,6-Dimethoxy-9-methyl-10,13-dioxatricyclo[7.3.1.02,7]trideca-2,4,6-
trien-11-yl)methanol 254 
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